{
    "nodes": [
      {
        "parameters": {
          "functionCode": "const html = $('Write Article').item.json.output?.[1]?.text || $('Write Article').item.json.text || '';\nconst formatted = $('Format Bibliography').item.json.formatted || [];\nconst biblioHtml = '<h2>Quellen</h2><ol>' + formatted.map(x => `<li>${x}</li>`).join('') + '</ol>';\nconst cleaned = html.replace(/<h2[^>]*>\\s*Quellen[\\s\\S]*$/i, '').trim();\nreturn { json: { html: cleaned + '\\n\\n' + biblioHtml } };"
        },
        "type": "n8n-nodes-base.functionItem",
        "typeVersion": 1,
        "position": [
          4768,
          -720
        ],
        "id": "4a73a3d0-bcba-4c7c-9b1a-3fd5d6e6d5a2",
        "name": "Assemble Final HTML"
      },
      {
        "parameters": {
          "assignments": {
            "assignments": [
              {
                "id": "060e95f9-7249-4c93-aa30-5795ddcccf0c",
                "name": "Extracted URLs",
                "value": "={{$json[\"urlset\"][\"url\"].map(i => i.loc).join(\"\\n\")}}",
                "type": "string"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.set",
        "typeVersion": 3.4,
        "position": [
          1296,
          -1216
        ],
        "id": "173b2a87-16b6-4037-bdde-d28454327aab",
        "name": "Extract URLs"
      },
      {
        "parameters": {
          "model": "={{ $('Configuration').item.json.model_name }}",
          "options": {}
        },
        "type": "@n8n/n8n-nodes-langchain.lmChatAnthropic",
        "typeVersion": 1.2,
        "position": [
          1584,
          -992
        ],
        "id": "66225964-4dcd-46e7-939e-5baf4c35400c",
        "name": "Anthropic Chat Model",
        "credentials": {
          "anthropicApi": {
            "id": "kay2kK6GU12A3vZW",
            "name": "Anthropic Company Account"
          }
        }
      },
      {
        "parameters": {
          "assignments": {
            "assignments": [
              {
                "id": "23d7579b-abac-47fe-a180-1fb245be0fee",
                "name": "article_title",
                "value": "={{ $json.metadata['dc:title'] }}",
                "type": "string"
              },
              {
                "id": "bbedb276-ad8b-4cde-b112-f426683366be",
                "name": "article_outline",
                "value": "={{ $('1. Get Rated Paper1').item.json.outline }}",
                "type": "string"
              },
              {
                "id": "71cbb806-1ffb-4e61-a62f-466d7054a40a",
                "name": "article_citations",
                "value": "={{ $('1. Get Rated Paper1').item.json.citations }}",
                "type": "string"
              },
              {
                "id": "4cb802e2-3c5a-412d-b4e4-f587436db977",
                "name": "article_instructions",
                "value": "=={{`Titel <= 60 Zeichen, H2 als Fragen mit Kernsubstanz, logische Struktur H1->H2->H3, FAQ-Sektion, Keywords natürlich ohne Stuffing; kognitive Last: max. 1–2 neue Konzepte pro Absatz; Fachbegriffe sofort erklären, dann einfache Begriffe; komplexe Prozesse mit Analogien; narrativ: Problem -> Lösung -> Hoffnung -> Leserrelevanz; alle (Autor et al., Jahr) Referenzen unverändert übernehmen; keine unbelegten Claims; am Ende \"## Quellen\" alphabetisch aus Literatur-Extraktor; keine \"Was ist [Substanz]\"-Abschnitte, keine Meta-Texte, keine Prozessbeschreibungen.`}}\n",
                "type": "string"
              },
              {
                "id": "9f5da8d3-f90a-475f-816b-0db8b69b09c7",
                "name": "article_tone_of_voice",
                "value": "=={{`Empathisch, respektvoll, hoffnungsvoll; vorsichtige Evidenzsprache (\"könnte\", \"deutet darauf hin\", \"vielversprechend\"); Zitationsschutz: (Autor et al., Jahr) 1:1 beibehalten; laienverständlich, Fachbegriffe sofort erklären, danach einfache Sprache; angstfrei, patientenorientiert (\"Was bedeutet das für Sie?\"); transparent über Grenzen; narrativ mit alltagsnahen Analogien.`}}\n",
                "type": "string"
              },
              {
                "id": "26bbcba6-eed0-4a99-80cc-5b6a9847a54a",
                "name": "article_keywords",
                "value": "={{ $json.metadata['pdf:keywords'] }}",
                "type": "string"
              },
              {
                "id": "5f32112c-3a59-49f9-8849-dc2fb31adb35",
                "name": "article_status",
                "value": "={{ $('1. Get Rated Paper1').item.json.content_status }}",
                "type": "string"
              },
              {
                "id": "c04367af-9cf9-4d17-9171-89051cf9aa91",
                "name": "featured_image",
                "value": "={{ ($json[\"Featured Image\"] && $json[\"Featured Image\"][0] && $json[\"Featured Image\"][0].url) ? $json[\"Featured Image\"][0].url : \"\" }}",
                "type": "string"
              },
              {
                "id": "b1bd83e6-aa50-4fda-b0ab-366df90c9815",
                "name": "deep_research",
                "value": "={{ $('1. Get Rated Paper1').item.json.deep_research }}",
                "type": "string"
              },
              {
                "id": "9466916c-f5ea-49cb-b30b-fa780318a8d6",
                "name": "article_length",
                "value": "=4",
                "type": "string"
              },
              {
                "id": "76489fa3-1d75-4f59-a60b-9a3790f0e24c",
                "name": "randomSessionID",
                "value": "={{ Math.random() }}",
                "type": "string"
              },
              {
                "id": "7219cc14-adf7-4704-877d-a70d74ae899d",
                "name": "article_target_wordcount",
                "value": "=3",
                "type": "string"
              },
              {
                "id": "fe4f3b26-77dc-44e9-b15d-2e96f00fca21",
                "name": "article_tone_of_voice_examples",
                "value": "={{ $json['Tone of Voice Examples (Optional)'] }}",
                "type": "string"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.set",
        "typeVersion": 3.4,
        "position": [
          -208,
          -1088
        ],
        "id": "1da42a7a-3d02-46f9-8654-85bf8bd62d19",
        "name": "Article fields"
      },
      {
        "parameters": {
          "promptType": "define",
          "text": "=Pick up to 3 URLs from the URLs_list that are most relevant for the following topic: {{ $('Article fields').item.json.article_title }}\n\n<urls_list>\n{{ $json['Extracted URLs'] }}\n</urls_list>\n\nOnly respond with the chosen URLs separated by newlines."
        },
        "type": "@n8n/n8n-nodes-langchain.chainLlm",
        "typeVersion": 1.5,
        "position": [
          1520,
          -1216
        ],
        "id": "71b36237-2deb-412d-97b0-d01c2f7cd3fd",
        "name": "Pick Internal Links",
        "retryOnFail": false,
        "notesInFlow": false
      },
      {
        "parameters": {
          "rules": {
            "values": [
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "leftValue": "={{ $('Article fields').item.json.article_outline ? $('Article fields').item.json.article_outline.length : 0 }}",
                      "rightValue": 50,
                      "operator": {
                        "type": "number",
                        "operation": "lt"
                      },
                      "id": "8f1ba322-7824-4454-af66-e819f69794ba"
                    }
                  ],
                  "combinator": "and"
                }
              },
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "id": "52864ebc-9bad-4a07-afb4-c9d77e1be069",
                      "leftValue": "{{ $('Article fields').item.json.article_outline }}",
                      "rightValue": "",
                      "operator": {
                        "type": "string",
                        "operation": "notEmpty",
                        "singleValue": true
                      }
                    }
                  ],
                  "combinator": "and"
                }
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.switch",
        "typeVersion": 3.2,
        "position": [
          2000,
          -960
        ],
        "id": "b38de87e-9d45-4b97-aea4-1efccc1bc0a1",
        "name": "Outline Required?"
      },
      {
        "parameters": {
          "assignments": {
            "assignments": [
              {
                "id": "6a050473-7d5f-4a0c-a25b-e7e3f46058a8",
                "name": "article_outline",
                "value": "={{ $('Agentic RAG').isExecuted && $('Agentic RAG').item.json.article_outline || $('Article fields').item.json.article_outline }}",
                "type": "string"
              },
              {
                "id": "c70cdb94-ae29-4bf1-8898-becba67a1150",
                "name": "citations",
                "value": "={{ $('Agentic RAG').isExecuted && JSON.stringify($('Agentic RAG').item.json.output.citations) || $('Article fields').item.json.article_citations }}",
                "type": "string"
              },
              {
                "id": "42bef85d-8561-49ca-adee-3940a04e77ad",
                "name": "deep_research",
                "value": "={{ $('Agentic RAG').isExecuted && JSON.stringify($('Agentic RAG').item.json.output.research_findings) || $('Article fields').item.json.deep_research }}",
                "type": "string"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.set",
        "typeVersion": 3.4,
        "position": [
          2560,
          -1600
        ],
        "id": "2a7a1604-c60a-40ac-8d73-3cea5e36e16f",
        "name": "Merged outline and citations"
      },
      {
        "parameters": {
          "content": "# Agentic RAG Research & Article Outline Creation",
          "height": 720,
          "width": 1720,
          "color": 5
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          512,
          -2064
        ],
        "id": "e6df163c-fb46-430d-96a9-8ec0d82a8ea0",
        "name": "Sticky Note"
      },
      {
        "parameters": {
          "rule": {
            "interval": [
              {
                "triggerAtHour": 9
              }
            ]
          }
        },
        "type": "n8n-nodes-base.scheduleTrigger",
        "typeVersion": 1.2,
        "position": [
          -1184,
          -960
        ],
        "id": "a11311c4-c13c-4608-9c47-3a6b916ac3aa",
        "name": "Schedule Trigger"
      },
      {
        "parameters": {},
        "type": "n8n-nodes-base.noOp",
        "typeVersion": 1,
        "position": [
          1216,
          -416
        ],
        "id": "57bd22e0-d25a-422b-b4de-58522fa7901f",
        "name": "Continue"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "https://hook.eu1.make.com/jd97r0rx4p7thjz4x68lxc52w1b50l41",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "bodyParameters": {
            "parameters": [
              {
                "name": "text",
                "value": "={{ $('Get NocoDB Record').item.json['Facebook Post'] }}"
              },
              {
                "name": "image",
                "value": "={{ $('Get NocoDB Record').item.json['Featured Image'] }}"
              },
              {
                "name": "link",
                "value": "={{ $('Get NocoDB Record').item.json['Article Link'] }}"
              },
              {
                "name": "platform",
                "value": "facebook"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          1776,
          -640
        ],
        "id": "137ec6b1-f126-4d60-9ccd-f5bcff0a4f7d",
        "name": "Facebook post",
        "disabled": false
      },
      {
        "parameters": {
          "conditions": {
            "options": {
              "caseSensitive": true,
              "leftValue": "",
              "typeValidation": "strict",
              "version": 2
            },
            "conditions": [
              {
                "id": "6b85be8d-292f-42f2-a3ed-f02fb2fc13ee",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Facebook Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "exists",
                  "singleValue": true
                }
              },
              {
                "id": "5610f138-3bf4-4eb3-b4ab-7fd7dd79fd23",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Facebook Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "notEmpty",
                  "singleValue": true
                }
              }
            ],
            "combinator": "and"
          },
          "options": {}
        },
        "type": "n8n-nodes-base.filter",
        "typeVersion": 2.2,
        "position": [
          1536,
          -640
        ],
        "id": "887fe19e-9a78-49cf-bc72-fc479e32abff",
        "name": "Filter"
      },
      {
        "parameters": {
          "conditions": {
            "options": {
              "caseSensitive": true,
              "leftValue": "",
              "typeValidation": "strict",
              "version": 2
            },
            "conditions": [
              {
                "id": "6b85be8d-292f-42f2-a3ed-f02fb2fc13ee",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Twitter Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "exists",
                  "singleValue": true
                }
              },
              {
                "id": "5610f138-3bf4-4eb3-b4ab-7fd7dd79fd23",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Twitter Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "notEmpty",
                  "singleValue": true
                }
              }
            ],
            "combinator": "and"
          },
          "options": {}
        },
        "type": "n8n-nodes-base.filter",
        "typeVersion": 2.2,
        "position": [
          1536,
          -464
        ],
        "id": "a7968bad-ef0a-4c9e-af8d-80f99e696699",
        "name": "Filter1"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "https://hook.eu1.make.com/jd97r0rx4p7thjz4x68lxc52w1b50l41",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "bodyParameters": {
            "parameters": [
              {
                "name": "text",
                "value": "={{ $('Get Airtable Record').item.json[\"Twitter Post\"] }}"
              },
              {
                "name": "image",
                "value": "={{ $('Get Airtable Record').item.json[\"Featured Image\"][0].url }}"
              },
              {
                "name": "link",
                "value": "={{ $('Get Airtable Record').item.json[\"Article Link\"] }}"
              },
              {
                "name": "platform",
                "value": "twitter"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          1776,
          -464
        ],
        "id": "a6194e49-6eb7-49b2-b8ae-b2d541e96a6a",
        "name": "Twitter Post",
        "disabled": true
      },
      {
        "parameters": {
          "conditions": {
            "options": {
              "caseSensitive": true,
              "leftValue": "",
              "typeValidation": "strict",
              "version": 2
            },
            "conditions": [
              {
                "id": "6b85be8d-292f-42f2-a3ed-f02fb2fc13ee",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Instagram Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "exists",
                  "singleValue": true
                }
              },
              {
                "id": "5610f138-3bf4-4eb3-b4ab-7fd7dd79fd23",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Instagram Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "notEmpty",
                  "singleValue": true
                }
              }
            ],
            "combinator": "and"
          },
          "options": {}
        },
        "type": "n8n-nodes-base.filter",
        "typeVersion": 2.2,
        "position": [
          1536,
          -272
        ],
        "id": "c187b5ca-36c6-43f4-97f6-265eaeead952",
        "name": "Filter2"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "https://hook.eu1.make.com/jd97r0rx4p7thjz4x68lxc52w1b50l41",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "bodyParameters": {
            "parameters": [
              {
                "name": "text",
                "value": "={{ $('Get Airtable Record').item.json[\"Instagram Post\"] }}"
              },
              {
                "name": "image",
                "value": "={{ $('Get Airtable Record').item.json[\"Featured Image\"][0].url }}"
              },
              {
                "name": "link",
                "value": "={{ $('Get Airtable Record').item.json[\"Article Link\"] }}"
              },
              {
                "name": "platform",
                "value": "instagram"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          1776,
          -272
        ],
        "id": "8a72e9fe-d3a4-4897-a6cd-6834ed027b23",
        "name": "Instagram Post",
        "disabled": true
      },
      {
        "parameters": {
          "conditions": {
            "options": {
              "caseSensitive": true,
              "leftValue": "",
              "typeValidation": "strict",
              "version": 2
            },
            "conditions": [
              {
                "id": "6b85be8d-292f-42f2-a3ed-f02fb2fc13ee",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Instagram Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "exists",
                  "singleValue": true
                }
              },
              {
                "id": "5610f138-3bf4-4eb3-b4ab-7fd7dd79fd23",
                "leftValue": "={{ $('Get NocoDB Record').item.json[\"Instagram Post\"] }}",
                "rightValue": "",
                "operator": {
                  "type": "string",
                  "operation": "notEmpty",
                  "singleValue": true
                }
              }
            ],
            "combinator": "and"
          },
          "options": {}
        },
        "type": "n8n-nodes-base.filter",
        "typeVersion": 2.2,
        "position": [
          1536,
          -96
        ],
        "id": "c4fd6ffe-9768-4025-99c5-24df699af3d6",
        "name": "Filter3"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "https://hook.eu1.make.com/jd97r0rx4p7thjz4x68lxc52w1b50l41",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "bodyParameters": {
            "parameters": [
              {
                "name": "text",
                "value": "={{ $('Get Airtable Record').item.json[\"Instagram Post\"] }}"
              },
              {
                "name": "image",
                "value": "={{ $('Get Airtable Record').item.json[\"Featured Image\"][0].url }}"
              },
              {
                "name": "link",
                "value": "={{ $('Get Airtable Record').item.json[\"Article Link\"] }}"
              },
              {
                "name": "platform",
                "value": "instagram"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          1776,
          -96
        ],
        "id": "41f0d932-c7ed-4e49-bf74-ba082f7db931",
        "name": "LinkedIn Post",
        "disabled": true
      },
      {
        "parameters": {
          "content": "# Social Media",
          "height": 1020,
          "width": 1680,
          "color": 5
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          464,
          -704
        ],
        "id": "f9d32853-da79-480d-a28a-f6215d4a4703",
        "name": "Sticky Note1"
      },
      {
        "parameters": {
          "conditions": {
            "options": {
              "caseSensitive": true,
              "leftValue": "",
              "typeValidation": "strict",
              "version": 2
            },
            "conditions": [
              {
                "id": "bb4510c0-772e-4e32-b9e4-3929e6e39639",
                "leftValue": "={{ $('Outline Required?').isExecuted }}",
                "rightValue": "",
                "operator": {
                  "type": "boolean",
                  "operation": "false",
                  "singleValue": true
                }
              }
            ],
            "combinator": "and"
          },
          "options": {}
        },
        "type": "n8n-nodes-base.if",
        "typeVersion": 2.2,
        "position": [
          1616,
          -2016
        ],
        "id": "bc06bf42-5c1e-40a0-8714-4ea7dbddf2a7",
        "name": "If"
      },
      {
        "parameters": {
          "url": "={{ $('Configuration').item.json.sitemap_url }}",
          "options": {
            "response": {
              "response": {}
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          816,
          -1216
        ],
        "id": "ca4cdfd3-6fa6-4c54-b85f-7c6fc7145194",
        "name": "Get Sitemap"
      },
      {
        "parameters": {
          "options": {}
        },
        "type": "n8n-nodes-base.xml",
        "typeVersion": 1,
        "position": [
          1024,
          -1216
        ],
        "id": "1301c35b-2f32-46ee-9556-803153ccd91b",
        "name": "Convert to JSON"
      },
      {
        "parameters": {
          "content": "# Article Media (Images & Videos)",
          "height": 2160,
          "width": 1900,
          "color": 7
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          2352,
          -1856
        ],
        "id": "a09af5cb-1d1b-4b57-86ed-d124e408c909",
        "name": "Sticky Note2"
      },
      {
        "parameters": {
          "promptType": "define",
          "text": "=Du bist ein Outline-Generator für einen Blogartikel.  \nErstelle eine prägnante, klar strukturierte Gliederung (Outline) in Markdown, basierend auf den verfügbaren Paper-Inhalten (GraphRAG-Ergebnisse) und ergänzenden Deep Searches aus Jina.\n\n## Regeln\n- **Kein Fließtext**, nur nummerierte Hauptkapitel (**H2**) und Stichpunkte (**H3**).\n- **Jeder Punkt MUSS eine Quelle haben.**\n- **Quellenformat:**\n  - Aus Paper/GraphRAG (bevorzugt DOI): **Quelle:** DOI:<DOI> (GraphRAG, S.xx falls bekannt)\n  - **Fallback**, wenn keine DOI vorliegt: **Quelle:** <PDF-ID>.pdf (GraphRAG, S.xx falls bekannt)\n  - Aus Jina Search: **Quelle:** [Jina-URL] (Jina Search)\n- **Ergänzende Themen aus Jina** immer mit **„Ergänzung:“** kennzeichnen; **max. 2** Jina-Ergänzungen pro Hauptkapitel.\n- Gliederungstiefe: **H2 (nummeriert)** + **H3**-Stichpunkte.\n- Fokus: klare Struktur für einen Blogartikel, **keine Ausformulierung**.\n\n## Titel\n{{ $('Article fields').item.json.article_title }}\n\n## Instructions\n{{ $('Article fields').item.json.article_instructions }}\n\n## Kontext / Primärquelle\n- Primäres Paper DOI: {{ $('1. Get Rated Paper1').item.json.doi }}\n- Interne PDF-ID (Fallback): {{ $('1. Get Rated Paper1').item.json.pmid }}\n\n> Wenn DOI vorhanden, IMMER „DOI:<wert>“ in den Quellen nutzen.  \n> Wenn DOI fehlt, stattdessen „<PDF-ID>.pdf“ verwenden.  \n> Wenn GraphRAG Seitenzahlen liefert, „(GraphRAG, S.xx)“ anhängen.\n\n---\n\n## Zitations-Regel (für späteren Fließtext)\n- Wenn du später Fließtext schreibst, verwende ausschließlich nummerierte In-Text-Zitate im Format [n].\n- Die Nummern werden deterministisch vom System vergeben; du erfindest keine neuen Nummern.\n\n## Beispielausgabe (Schema)\n\n# Outline: <Titel>\n\n## 1. Einleitung\n- Kurze Definition & Relevanz des Themas  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821 (GraphRAG, S.1)\n- **Ergänzung:** Marktpotenzial in der Nutraceutical-Branche  \n  **Quelle:** [Jina-URL] (Jina Search)\n\n## 2. Molekulare Wirkmechanismen – wie schützt Curcumin Neuronen?\n- Antioxidation (Nrf2, SOD, CAT, GPx)  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821 (GraphRAG, S.3–4)\n- Hemmung toxischer Proteinaggregate (Aβ, α-Syn)  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n- **Ergänzung:** Metallchelierung bei Alzheimer (Cu/Fe)  \n  **Quelle:** [Jina-URL] (Jina Search)\n\n## 3. Warum ist Curcumin schwer bioverfügbar?\n- Geringe Wasserlöslichkeit, schneller Metabolismus  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821 (GraphRAG)\n- Blut-Hirn-Schranke als zusätzliche Hürde  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n\n## 4. Strategien zur Bioverfügbarkeitssteigerung – was wirkt wirklich?\n- Piperin als Bioenhancer  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n- Nano-/Lipid-Formulierungen (Liposomen, Phytosome/Longvida®, Theracurmin)  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n- **Ergänzung:** γ-Cyclodextrin-Ansätze (Kurzüberblick)  \n  **Quelle:** [Jina-URL] (Jina Search)\n\n## 5. Klinische Evidenz – was zeigen Humanstudien?\n- Alzheimer: Theracurmin (180 mg/Tag) – Gedächtnis & Bildgebungsmarker  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821 (GraphRAG)\n- AD: Unformuliertes Curcumin (2–4 g/Tag) – keine Wirksamkeit, GI-Nebenwirkungen  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n- Parkinson: Nanomicellen – gemischte Ergebnisse  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n\n## 6. Praxisleitfaden – Auswahl geeigneter Formulierungen\n- Kriterien: Evidenz, Dosis, Verträglichkeit, Kosten/Nutzen  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n- Häufige Fehler (Dosis vs. Formulierung)  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n\n## 7. FAQ\n- „Brauche ich Piperin immer?“ – Nur wenn die Formulierung es erfordert.  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n- „Welche Biomarker verbesserten sich in Studien?“  \n  **Quelle:** DOI:10.3389/fphar.2025.1625821\n",
          "hasOutputParser": true,
          "options": {
            "systemMessage": "=# Role\n\nYou are an expert writer, tasked with creating an article outline based on the provided scientific paper.  \nThe primary reference is identified by its DOI. All citations must prioritize DOI.  \nIf DOI is missing, fallback to internal PDF-ID.\n\n# Available Research Tools\n\n## 1. LightRAG query tool\nCall this tool to search our LightRAG database of scientific papers for food supplement substances.  \nLet LightRAG query tool look for the DOI of the scientific paper: {{ $('1. Get Rated Paper1').item.json.doi }}.  \nIf DOI is missing, use the fallback PDF-ID: {{ $('1. Get Rated Paper1').item.json.pmid }}.pdf  \nIMPORTANT: Do not call the \"LightRAG query tool\" more than three times.\n\n## 2. Deep Research with Perplexity (Report)\nPerplexity Deep Research excels at generating comprehensive research reports by autonomously exploring and synthesizing information from numerous sources. Only scientifically sound information is considered.  \nIMPORTANT: Do not call the Deep Research tool more than once.\n\n## 3. Deep Search with Jina.ai (Question Answering)\nDeep Search focuses on providing accurate and concise answers to complex questions through iterative web searching and reasoning.  \nIMPORTANT: Do not call the Deep Search tool more than twice.\n\n# Standard Operating Procedure\n\n## Step 1\nAnalyze the provided scientific paper and instructions, then trigger the most relevant tools to research and learn about the topics.  \nYou can call multiple tools, multiple times if necessary.\n\n## Step 2\nBased on the outputs from these tools, create the following:\n\n---\n\n### An Article Outline\n- Output in **Markdown**.\n- **No full sentences** in the outline – use numbered **H2** sections and bullet-point **H3** subpoints.\n- **Every point must have a source**:\n  - From GraphRAG/Paper (prefer DOI): **Quelle:** DOI:<DOI> (GraphRAG, S.xx)\n  - Fallback if DOI missing: **Quelle:** <PDF-ID>.pdf (GraphRAG, S.xx)\n  - From Jina Search: **Quelle:** [Jina-URL] (Jina Search)\n- **Supplementary topics** from Jina must be labeled **\"Ergänzung:\"** and limited to **max. 2 per H2 section**.\n- Focus: clear, logical structure for a blog article.\n- Depth: H2 numbered + H3 bullet points.\n\n---\n\n### Output Format for Outline (MANDATORY)\n\n# Outline: {{ $('Article fields').item.json.article_title }}\n\n## 1. Einleitung\n- <bullet point text>  \n  **Quelle:** DOI:{{ $('1. Get Rated Paper1').item.json.doi }} (GraphRAG, S.xx)\n- **Ergänzung:** <bullet point text>  \n  **Quelle:** [Jina-URL] (Jina Search)\n\n## 2. <Hauptkapitel-Titel>\n- <bullet point text>  \n  **Quelle:** DOI:{{ $('1. Get Rated Paper1').item.json.doi }} (GraphRAG, S.xx)\n- <bullet point text>  \n  **Quelle:** {{ $('1. Get Rated Paper1').item.json.pmid }}.pdf (GraphRAG, S.xx)\n- **Ergänzung:** <bullet point text>  \n  **Quelle:** [Jina-URL] (Jina Search)\n\n(Repeat for all sections)\n\n---\n\n### Article Type\nScientific blog article.\n\n{{ $('Article fields').item.json.article_tone_of_voice ? \"## Tone of Voice:\\n\\nThis article will be written in a \" + $('Article fields').item.json.article_tone_of_voice + \" tone.\\n\\n\" : \"\" }}\n\n### Article Length\nMaximum {{ $('Article fields').item.json.article_length }} sections.\n\n### Research Findings\nProvide a separate detailed report summarizing the gathered research.\n\n### Citations\nList all important sources with URLs at the end. Prioritize DOI sources.\n",
            "maxIterations": 8,
            "returnIntermediateSteps": false
          }
        },
        "type": "@n8n/n8n-nodes-langchain.agent",
        "typeVersion": 1.8,
        "position": [
          976,
          -2016
        ],
        "id": "7e7de258-de96-4a27-aef6-a80ad201da77",
        "name": "Agentic RAG",
        "alwaysOutputData": false,
        "retryOnFail": true,
        "waitBetweenTries": 5000
      },
      {
        "parameters": {},
        "type": "n8n-nodes-base.noOp",
        "typeVersion": 1,
        "position": [
          496,
          -1312
        ],
        "id": "938493ef-d66a-47a9-984f-ae2dd3108851",
        "name": "Go"
      },
      {
        "parameters": {
          "jsonSchemaExample": "{\n  \"article_outline\":\"\",\n  \"research_findings\":\"\",\n  \"citations\":[\"doi\",\"doi\",\"url\"]\n}"
        },
        "type": "@n8n/n8n-nodes-langchain.outputParserStructured",
        "typeVersion": 1.2,
        "position": [
          1776,
          -1664
        ],
        "id": "999be18b-6e18-441c-ae54-317bde4a147d",
        "name": "Output Format"
      },
      {
        "parameters": {
          "assignments": {
            "assignments": [
              {
                "name": "sources",
                "type": "string",
                "value": "={{ JSON.stringify(($('Agentic RAG').item.json.output?.sources || []).slice(0,20).map((s,idx)=>({ number: idx+1, doi: s.doi||'', pmid: s.pmid||'', title: s.title||'', year: Number(s.year)||0, journal: s.journal||'', authors: Array.isArray(s.authors)?s.authors:[], doc_id: s.doc_id||s.id||'' }))) }}"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.set",
        "typeVersion": 3.4,
        "position": [
          2208,
          -1536
        ],
        "id": "a2b9ed2a-0b9d-4b2c-9b3f-3b2c1f0a2bcd",
        "name": "Make Source List"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{ $vars.PAPER_BACKEND_URL }}/answers/format-bibliography",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendHeaders": true,
          "headerParameters": {
            "parameters": [
              { "name": "Content-Type", "value": "application/json" },
              { "name": "X-API-KEY", "value": "={{ $vars.API_SECRET_KEY || 'your-api-key' }}" }
            ]
          },
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "={{ JSON.stringify({ answer_text: $('Write Article').item.json.output?.[1]?.text || '', sources: JSON.parse($('Make Source List').item.json.sources || '[]') }) }}",
          "options": { "timeout": 30000 }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          4512,
          -720
        ],
        "id": "f3d6a2c0-8f16-4b0c-9f92-bb6a5e7f0a21",
        "name": "Format Bibliography",
        "disabled": false
      },
      {
        "parameters": {
          "model": {
            "__rl": true,
            "value": "={{ $('Configuration').item.json.model_name }}",
            "mode": "id"
          },
          "options": {
            "maxTokensToSample": 8000,
            "thinking": true,
            "thinkingBudget": 2000
          }
        },
        "type": "@n8n/n8n-nodes-langchain.lmChatAnthropic",
        "typeVersion": 1.3,
        "position": [
          832,
          -1664
        ],
        "id": "7d6206be-3293-453b-8d59-81146ca06bab",
        "name": "Anthropic Chat Model1",
        "credentials": {
          "anthropicApi": {
            "id": "kay2kK6GU12A3vZW",
            "name": "Anthropic Company Account"
          }
        }
      },
      {
        "parameters": {
          "sessionIdType": "customKey",
          "sessionKey": "={{ $('Article fields').item.json.randomSessionID }}",
          "contextWindowLength": 50
        },
        "type": "@n8n/n8n-nodes-langchain.memoryBufferWindow",
        "typeVersion": 1.3,
        "position": [
          992,
          -1664
        ],
        "id": "96ceedd9-de26-49d0-83b1-9d75a0b9a03f",
        "name": "Simple Memory"
      },
      {
        "parameters": {
          "assignments": {
            "assignments": [
              {
                "id": "49ff639a-b7f8-44b1-a6df-d7b7a71244d0",
                "name": "model_name",
                "value": "claude-3-7-sonnet-20250219",
                "type": "string"
              },
              {
                "id": "dcc07e91-9737-428b-b6a0-3cebfd58a264",
                "name": "website_root_url",
                "value": "https://wordpress-1157655-4032111.cloudwaysapps.com/",
                "type": "string"
              },
              {
                "id": "bc37d3b1-2022-432c-bdab-bcfbac6d7843",
                "name": "sitemap_url",
                "value": "https://wordpress-1157655-4032111.cloudwaysapps.com/post-sitemap.xml",
                "type": "string"
              },
              {
                "id": "2ee30a7a-d0f0-469c-b51c-720a1852546a",
                "name": "ai_image_model_url",
                "value": "https://fal.run/fal-ai/flux-pro/v1.1-ultra",
                "type": "string"
              },
              {
                "id": "8a09ef29-3649-4e29-9d7a-f1eb384d0512",
                "name": "nocodb_url",
                "value": "https://nocodb-production-9809.up.railway.app/",
                "type": "string"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.set",
        "typeVersion": 3.4,
        "position": [
          -16,
          -1088
        ],
        "id": "7e1a648e-0fc0-4aa2-8474-69feee07efba",
        "name": "Configuration"
      },
      {
        "parameters": {
          "rules": {
            "values": [
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "leftValue": "={{ $('Article fields').item.json.article_status }}",
                      "rightValue": " idee",
                      "operator": {
                        "type": "string",
                        "operation": "equals"
                      },
                      "id": "38478fa1-7c66-4a42-8cf0-d7e7cdd11e78"
                    }
                  ],
                  "combinator": "and"
                },
                "renameOutput": true,
                "outputKey": "idea to outline"
              },
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "id": "292cf33b-ae6f-4e9e-aedc-206999d30670",
                      "leftValue": "={{ $('Article fields').item.json.article_status }}",
                      "rightValue": "Ready for Article Generation",
                      "operator": {
                        "type": "string",
                        "operation": "equals",
                        "name": "filter.operator.equals"
                      }
                    }
                  ],
                  "combinator": "and"
                }
              },
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "id": "cc59117b-c7ef-43f4-bbb3-44e098eb4a1c",
                      "leftValue": "={{ $('Article fields').item.json.article_status }}",
                      "rightValue": "Push to Socials",
                      "operator": {
                        "type": "string",
                        "operation": "equals",
                        "name": "filter.operator.equals"
                      }
                    }
                  ],
                  "combinator": "and"
                }
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.switch",
        "typeVersion": 3.2,
        "position": [
          192,
          -1104
        ],
        "id": "fb5250f3-5e0b-4e79-83db-8ad1c2486ae8",
        "name": "Check Status",
        "alwaysOutputData": true
      },
      {
        "parameters": {
          "promptType": "define",
          "text": "=<topic>\n{{ $('Article fields').item.json.article_title }}\n</topic>\n\n<article_brief>\n{{ $('Merged outline and citations').item.json.article_outline }}\n</article_brief>\n\n<deep_research>\n{{ $('Merged outline and citations').item.json.deep_research }}\n</deep_research>\n\n<citations>\n{{ $('Merged outline and citations').item.json.citations }}\n</citations>\n\n<internal_links>\n{{ $('Pick Internal Links').item.json.text }}\n</internal_links>\n\n<allowed_sources_json>\n{{ $('Make Source List').item.json.sources }}\n</allowed_sources_json>\n\n<allowed_sources_human>\n{{ JSON.parse($('Make Source List').item.json.sources || '[]').map(s => `[${s.number}] ${s.title || 'Untitled'}${s.doi ? ' doi:'+s.doi : ''}${s.pmid ? ' pmid:'+s.pmid : ''}`).join('\\n') }}\n</allowed_sources_human>",
          "options": {
            "systemMessage": "=# Rolle\n\nDu bist ein exzellenter deutschsprachiger Fachautor.\n\n# Aufgabe\n\nSchreibe basierend auf <article_brief> einen klar strukturierten Blogartikel auf Deutsch. Nutze die Informationen in <deep_research> und die internen Links in <internal_links>.\n\n# Zitationsregeln (VERBINDLICH)\n- Verwende ausschließlich nummerierte In‑Text‑Zitate im Format [n].\n- Die erlaubten Quellen sind in <allowed_sources_json>/<allowed_sources_human> definiert. Du darfst nur diese Nummern verwenden.\n- Keine neuen Quellen erfinden, keine Nummern überspringen oder neu anordnen.\n- Zitiere jede konkrete Studie/Fakt/Statistik mit [n]. Mehrfachzitate als [1,3] oder Spannen als [2–4].\n- Am Ende KEINE eigene Quellenliste erzeugen – die Bibliographie wird serverseitig generiert.\n\n# Artikelumfang & Struktur\n\nArticle Type: {{ $('Get NocoDB Record').item.json['Article Type'] }}\nArticle Length: {{ $('Search NocoDB').item.json['Article Length'] }}\nTarget Total Word Count: {{ $('Article fields').item.json.article_target_wordcount }}\n\nBeginne mit einer kurzen Einleitung (2 Sätze). Danach die Hauptsektionen mit <h2>. Füge nach der ersten Sektion das Bild aus <image_tag_html> ein. Nutze Listen, wo sinnvoll, mit einleitendem Satz.\n\n# Stil\n\nSchreibe prägnant, aktiv, verständlich für Laien und Fortgeschrittene. Keine überflüssigen Floskeln.\n\n# Ausgabeformat\n\n- HTML, kein Markdown.\n- Antworte mit <p> beginnend.\n- Maximal 2 Sätze pro Absatz; mehrere Absätze pro Sektion sind erlaubt.\n- Wichtige Wörter fett (<strong>), 1–5 pro Absatz."
          }
        },
        "type": "@n8n/n8n-nodes-langchain.agent",
        "typeVersion": 1.8,
        "position": [
          4480,
          -944
        ],
        "id": "b8187287-2c82-4fb9-ba86-e551f5b0cd70",
        "name": "Write Article",
        "retryOnFail": true,
        "waitBetweenTries": 5000,
        "disabled": true
      },
      {
        "parameters": {
          "url": "={{ $json.largeImageURL }}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "file"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          3296,
          -864
        ],
        "id": "5f5c7c4c-799e-4ac1-9748-4d3d7cd79dfb",
        "name": "Get Image2"
      },
      {
        "parameters": {
          "jsCode": "// Get the 'hits' array from the first node's output\nconst hits = items[0].json.hits;\n\n// Function to shuffle the array using Fisher-Yates algorithm\nfunction shuffle(array) {\n  for (let i = array.length - 1; i > 0; i--) {\n    const j = Math.floor(Math.random() * (i + 1));\n    [array[i], array[j]] = [array[j], array[i]];\n  }\n  return array;\n}\n\n// Shuffle the hits array\nconst shuffledHits = shuffle(hits);\n\n// Extract the largeImageURL from the first item\nconst largeImageURL = shuffledHits[0]?.largeImageURL || 'No Image Found';\n\n// Return the result\nreturn [\n  {\n    json: {\n      largeImageURL: largeImageURL\n    }\n  }\n];"
        },
        "type": "n8n-nodes-base.code",
        "typeVersion": 2,
        "position": [
          3120,
          -864
        ],
        "id": "0fb725f6-449b-4779-aa44-6f5b0e0e389b",
        "name": "Pick Random"
      },
      {
        "parameters": {
          "url": "https://pixabay.com/api/",
          "sendQuery": true,
          "queryParameters": {
            "parameters": [
              {
                "name": "q",
                "value": "={{ $('Image prompt helper').item.json.output.image2 }}"
              },
              {
                "name": "image_type",
                "value": "photo"
              },
              {
                "name": "per_page",
                "value": "15"
              },
              {
                "name": "key",
                "value": "<INSERT-KEY>"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          2944,
          -864
        ],
        "id": "04bfb605-3e79-4228-b13b-763f5c93d4b5",
        "name": "Pixabay"
      },
      {
        "parameters": {
          "conditions": {
            "options": {
              "caseSensitive": true,
              "leftValue": "",
              "typeValidation": "strict",
              "version": 2
            },
            "conditions": [
              {
                "id": "19307073-3ee7-4aa8-9e9a-e7c1722a5289",
                "leftValue": "={{ $('Image prompt helper').item.json.output.image_type }}",
                "rightValue": "ai",
                "operator": {
                  "type": "string",
                  "operation": "equals",
                  "name": "filter.operator.equals"
                }
              }
            ],
            "combinator": "and"
          },
          "options": {}
        },
        "type": "n8n-nodes-base.if",
        "typeVersion": 2.2,
        "position": [
          2752,
          -1024
        ],
        "id": "a9326d54-46cc-4ee7-8588-eb3710d9c842",
        "name": "If1",
        "disabled": true
      },
      {
        "parameters": {
          "assignments": {
            "assignments": [
              {
                "id": "a0b6472b-f298-4a28-a884-9ba794784365",
                "name": "extract_youtube_urls",
                "value": "={{ $json.tasks.flatMap(task => task.result.flatMap(r => r.items.map(item => item.url))).join(\"\\n\") }}",
                "type": "string"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.set",
        "typeVersion": 3.4,
        "position": [
          3616,
          -1600
        ],
        "id": "6227e4a6-738a-48c2-919c-ebb93afb9e64",
        "name": "Extract youtube urls"
      },
      {
        "parameters": {
          "promptType": "define",
          "text": "=you are an assistant that will return the first youtube.com video URL that you find in the following <text>. Only respond with the valid URL and no other text. If there is no youtube URL then provide a blank response.\n\n<text>\n{{ $json.extract_youtube_urls }}\n</text>"
        },
        "type": "@n8n/n8n-nodes-langchain.chainLlm",
        "typeVersion": 1.5,
        "position": [
          3840,
          -1600
        ],
        "id": "a1d7f069-8842-4132-8b53-e59499d06de5",
        "name": "Choose Youtube URL",
        "retryOnFail": true,
        "notesInFlow": false,
        "waitBetweenTries": 5000
      },
      {
        "parameters": {
          "model": "={{ $('Configuration').item.json.model_name }}",
          "options": {}
        },
        "type": "@n8n/n8n-nodes-langchain.lmChatAnthropic",
        "typeVersion": 1.2,
        "position": [
          3840,
          -1376
        ],
        "id": "f8168644-3cfe-455f-ba74-8b2c84d180f8",
        "name": "Anthropic Chat Model7",
        "credentials": {
          "anthropicApi": {
            "id": "kay2kK6GU12A3vZW",
            "name": "Anthropic Company Account"
          }
        }
      },
      {
        "parameters": {
          "method": "POST",
          "url": "https://api.dataforseo.com/v3/serp/google/organic/live/advanced",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpBasicAuth",
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "=[{  \"language_code\": \"en\",   \"location_name\": \"United States\",   \"keyword\": {{ JSON.stringify($('Article fields').item.json.article_title + \" - youtube.com\") }},   \"calculate_rectangles\": false,   \"se_domain\": \"google.com\",   \"depth\": \"20\" }]",
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          3392,
          -1600
        ],
        "id": "f40e073d-fddb-4d76-a636-ce74e5ebb78b",
        "name": "Get Youtube Video",
        "credentials": {
          "httpBasicAuth": {
            "id": "Ez6sqrfFhtjtozYr",
            "name": "Basic Auth DataForSeo"
          }
        }
      },
      {
        "parameters": {
          "title": "={{ $('Article fields').item.json.article_title }}",
          "additionalFields": {
            "content": "={{ $json.output[1].text }}"
          }
        },
        "type": "n8n-nodes-base.wordpress",
        "typeVersion": 1,
        "position": [
          4832,
          -800
        ],
        "id": "64e303b2-6ffa-4e83-9186-f5487c8b34a1",
        "name": "Wordpress",
        "disabled": true
      },
      {
        "parameters": {
          "model": "={{ $('Configuration').item.json.model_name }}",
          "options": {
            "maxTokensToSample": 30000,
            "thinking": true,
            "thinkingBudget": 10000
          }
        },
        "type": "@n8n/n8n-nodes-langchain.lmChatAnthropic",
        "typeVersion": 1.2,
        "position": [
          4464,
          -560
        ],
        "id": "c83be857-fb9a-4976-93df-ea11633a99fc",
        "name": "Anthropic Chat Model5",
        "disabled": true
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{ $('Configuration').item.json.website_root_url }}wp-json/wp/v2/media",
          "authentication": "predefinedCredentialType",
          "nodeCredentialType": "wordpressApi",
          "sendHeaders": true,
          "headerParameters": {
            "parameters": [
              {
                "name": "content-disposition",
                "value": "=attachment; filename={{JSON.stringify($('Image prompt helper').item.json.output.image2)}}.{{ $binary.data.fileExtension }}"
              },
              {
                "name": "content-type",
                "value": "={{ $binary.data.mimeType }}"
              }
            ]
          },
          "sendBody": true,
          "contentType": "binaryData",
          "inputDataFieldName": "data",
          "options": {}
        },
        "id": "33326a8b-0c3f-4b86-89a2-d49d748f7ed7",
        "name": "Upload In-content image",
        "type": "n8n-nodes-base.httpRequest",
        "position": [
          3536,
          -1024
        ],
        "typeVersion": 4.1,
        "disabled": true
      },
      {
        "parameters": {
          "url": "={{ $json.images[0].url }}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "file"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          3216,
          -1104
        ],
        "id": "c521daf1-b71e-4253-816a-a8b7ebad5909",
        "name": "Get Image"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{ $('Configuration').item.json.ai_image_model_url }}",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "={\"prompt\": {{JSON.stringify($('Image prompt helper').item.json.output.image2)}}, \"num_images\": {{ \n  (!$('Article fields').item.json.featured_image || \n   $('Article fields').item.json.featured_image.trim() === \"\") \n    ? 2 \n    : 1 \n}}\n, \"aspect_ratio\": \"16:9\"}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "json"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          2992,
          -1104
        ],
        "id": "8a4f9dd4-af91-4226-bc69-9e4aefd8ab1d",
        "name": "Generate content image",
        "credentials": {
          "httpHeaderAuth": {
            "id": "C6EaRz4vxUMkBGCJ",
            "name": "LightRAG Api key"
          }
        }
      },
      {
        "parameters": {
          "model": "={{ $('Configuration').item.json.model_name }}",
          "options": {
            "thinking": false
          }
        },
        "type": "@n8n/n8n-nodes-langchain.lmChatAnthropic",
        "typeVersion": 1.2,
        "position": [
          2864,
          -1360
        ],
        "id": "54b6694b-b492-4e3d-b28f-486e67db77cc",
        "name": "Anthropic Chat Model4",
        "credentials": {
          "anthropicApi": {
            "id": "kay2kK6GU12A3vZW",
            "name": "Anthropic Company Account"
          }
        }
      },
      {
        "parameters": {
          "promptType": "define",
          "text": "=Title: {{ $('Article fields').item.json.article_title }}\n\nOutline: {{ $json.article_outline }}",
          "hasOutputParser": true,
          "messages": {
            "messageValues": [
              {
                "message": "=Analyze the following article title and outline.\n\nBased on that analysis, decide if a stock image or an AI image is most appropriate for this article.\n\nBased on that decision, output two appropriate prompts (if AI image) or search terms (if stock photo)\n\nSAMPLE OUTPUT STRUCTURE\n\n{\n\t\"image_type\": \"ai OR stock\",\n\t\"image1\": \"image prompt or search term - MUST BE UNDER 70 CHARACTERS\",\n\t\"image2\": \"image prompt or search term - MUST BE UNDER 70 CHARACTERS\"\n}"
              }
            ]
          }
        },
        "type": "@n8n/n8n-nodes-langchain.chainLlm",
        "typeVersion": 1.5,
        "position": [
          2880,
          -1600
        ],
        "id": "0a9a4849-6662-4703-92d0-4440c928530e",
        "name": "Image prompt helper",
        "retryOnFail": true,
        "notesInFlow": false,
        "waitBetweenTries": 5000
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{ $('Configuration').item.json.website_root_url }}/wp-json/wp/v2/media",
          "authentication": "predefinedCredentialType",
          "nodeCredentialType": "wordpressApi",
          "sendHeaders": true,
          "headerParameters": {
            "parameters": [
              {
                "name": "content-disposition",
                "value": "=attachment; filename={{JSON.stringify($('Image prompt helper').item.json.output.image1)}}.{{ $binary.data.fileExtension }}"
              },
              {
                "name": "content-type",
                "value": "={{ $binary.data.mimeType }}"
              }
            ]
          },
          "sendBody": true,
          "contentType": "binaryData",
          "inputDataFieldName": "data",
          "options": {}
        },
        "id": "8e78ffda-2ff0-4dab-a16c-c9c2053f0c39",
        "name": "Upload In-content image1",
        "type": "n8n-nodes-base.httpRequest",
        "position": [
          3504,
          -336
        ],
        "typeVersion": 4.1,
        "disabled": true
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{ $('Configuration').item.json.website_root_url }}wp-json/wp/v2/posts/{{ $('Wordpress').item.json.id }}",
          "authentication": "predefinedCredentialType",
          "nodeCredentialType": "wordpressApi",
          "sendBody": true,
          "bodyParameters": {
            "parameters": [
              {
                "name": "featured_media",
                "value": "={{ $json.id }}"
              }
            ]
          },
          "options": {}
        },
        "id": "8a997642-1429-454c-aad0-655459de489a",
        "name": "Set Featured Image",
        "type": "n8n-nodes-base.httpRequest",
        "position": [
          3696,
          -336
        ],
        "typeVersion": 4.1,
        "disabled": true
      },
      {
        "parameters": {
          "model": "={{ $('Configuration').item.json.model_name }}",
          "options": {}
        },
        "type": "@n8n/n8n-nodes-langchain.lmChatAnthropic",
        "typeVersion": 1.2,
        "position": [
          4496,
          -80
        ],
        "id": "e565f5eb-a917-4989-9559-2df6cee76c06",
        "name": "Anthropic Chat Model6",
        "disabled": true
      },
      {
        "parameters": {
          "jsonSchemaExample": "{\n  \"social_media\": {\n    \"Instagram\": \"\",\n    \"Facebook\": \"\",\n    \"Twitter\": \"\",\n    \"LinkedIn\": \"\"\n  }\n}\n"
        },
        "type": "@n8n/n8n-nodes-langchain.outputParserStructured",
        "typeVersion": 1.2,
        "position": [
          4656,
          -80
        ],
        "id": "181457db-4b39-4bc0-b46e-a76fe24714f7",
        "name": "Structured Output Parser"
      },
      {
        "parameters": {
          "url": "={{  || $('Generate content image').item.json.images[1].url }}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "file"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          3040,
          -544
        ],
        "id": "2b9dc97a-4c73-42ce-874d-a15acee01958",
        "name": "Get Image1"
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{ $('Configuration').item.json.ai_image_model_url }}",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "={\"prompt\": {{JSON.stringify($('Image prompt helper').item.json.output.image1)}}, \"num_images\": {{ \n  (!$('Article fields').item.json.featured_image || \n   $('Article fields').item.json.featured_image.trim() === \"\") \n    ? 2 \n    : 1 \n}}\n, \"aspect_ratio\": \"16:9\"}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "json"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          2960,
          -352
        ],
        "id": "209a503e-cf4f-4b8d-91fe-4fd273444983",
        "name": "Generate content image1",
        "disabled": true
      },
      {
        "parameters": {
          "url": "={{ $json.images[0].url }}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "file"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          3136,
          -352
        ],
        "id": "f5c84f31-3ba1-4e25-9043-6af8fd7043ba",
        "name": "Get Image3"
      },
      {
        "parameters": {
          "url": "https://pixabay.com/api/",
          "sendQuery": true,
          "queryParameters": {
            "parameters": [
              {
                "name": "q",
                "value": "={{ $('Image prompt helper').item.json.output.image1 }}"
              },
              {
                "name": "image_type",
                "value": "photo"
              },
              {
                "name": "per_page",
                "value": "15"
              },
              {
                "name": "key",
                "value": "<INSERT-KEY>"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          2896,
          -160
        ],
        "id": "9a32c0df-dc51-40ee-8a7b-fb2695cf35f2",
        "name": "Pixabay1"
      },
      {
        "parameters": {
          "jsCode": "// Get the 'hits' array from the first node's output\nconst hits = items[0].json.hits;\n\n// Function to shuffle the array using Fisher-Yates algorithm\nfunction shuffle(array) {\n  for (let i = array.length - 1; i > 0; i--) {\n    const j = Math.floor(Math.random() * (i + 1));\n    [array[i], array[j]] = [array[j], array[i]];\n  }\n  return array;\n}\n\n// Shuffle the hits array\nconst shuffledHits = shuffle(hits);\n\n// Extract the largeImageURL from the first item\nconst largeImageURL = shuffledHits[0]?.largeImageURL || 'No Image Found';\n\n// Return the result\nreturn [\n  {\n    json: {\n      largeImageURL: largeImageURL\n    }\n  }\n];"
        },
        "type": "n8n-nodes-base.code",
        "typeVersion": 2,
        "position": [
          3056,
          -160
        ],
        "id": "7af094a5-e63c-4621-9b9d-67db1200c7bb",
        "name": "Pick Random1"
      },
      {
        "parameters": {
          "url": "={{ $json.largeImageURL }}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "file"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          3216,
          -160
        ],
        "id": "a3b76967-a904-4fcc-b71c-b90085d896a9",
        "name": "Get Image4"
      },
      {
        "parameters": {
          "rules": {
            "values": [
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "leftValue": "={{ $('Article fields').item.json.featured_image}}",
                      "rightValue": "",
                      "operator": {
                        "type": "string",
                        "operation": "notEmpty",
                        "singleValue": true
                      },
                      "id": "80a8463f-5f8a-42b2-93c8-ff2e566805bd"
                    }
                  ],
                  "combinator": "and"
                },
                "renameOutput": true
              },
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "id": "706698e3-8f5f-4d0b-877a-86384a66070b",
                      "leftValue": "={{ $('Image prompt helper').item.json.output.image_type }}",
                      "rightValue": "ai",
                      "operator": {
                        "type": "string",
                        "operation": "equals",
                        "name": "filter.operator.equals"
                      }
                    }
                  ],
                  "combinator": "and"
                }
              },
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "id": "35243abe-4cb0-40af-9ade-a8da7bd9c382",
                      "leftValue": "={{ $('Image prompt helper').item.json.output.image_type }}",
                      "rightValue": "stock",
                      "operator": {
                        "type": "string",
                        "operation": "equals",
                        "name": "filter.operator.equals"
                      }
                    }
                  ],
                  "combinator": "and"
                }
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.switch",
        "typeVersion": 3.2,
        "position": [
          2656,
          -336
        ],
        "id": "ccec5319-eff3-4c8a-b021-3e86323dfb62",
        "name": "Switch"
      },
      {
        "parameters": {
          "authentication": "nocoDbApiToken",
          "operation": "update",
          "projectId": "pjgn0gmnxy68wqi",
          "table": "mzmh14sloork359",
          "fieldsUi": {
            "fieldValues": [
              {
                "fieldName": "Id",
                "fieldValue": "={{ $('Get NocoDB Record').first().json.Id }}"
              },
              {
                "fieldName": "Status",
                "fieldValue": "Article Generated"
              },
              {
                "fieldName": "Article Link",
                "fieldValue": "={{ $('Wordpress').item.json.guid.rendered }}"
              },
              {
                "fieldName": "Featured Image",
                "fieldValue": "=[\n    {\n      \"mimetype\": \"{{ $json.mimetype }}\",\n      \"size\": {{ $json.size }},\n      \"title\": \"{{ $json.title }}\",\n      \"url\": \"{{$('Configuration').item.json.nocodb_url}}{{ $json.path }}\",\n      \"icon\": \"\"\n    }\n  ]"
              },
              {
                "fieldName": "Facebook Post",
                "fieldValue": "={{ $('Write Social Media Posts').item.json.output.social_media.Facebook }}"
              },
              {
                "fieldName": "Instagram Post",
                "fieldValue": "={{ $('Write Social Media Posts').item.json.output.social_media.Instagram }}"
              },
              {
                "fieldName": "X Post",
                "fieldValue": "={{ $('Write Social Media Posts').item.json.output.social_media.Twitter }}"
              },
              {
                "fieldName": "LinkedIn Post",
                "fieldValue": "={{ $('Write Social Media Posts').item.json.output.social_media.LinkedIn }}"
              }
            ]
          }
        },
        "type": "n8n-nodes-base.nocoDb",
        "typeVersion": 3,
        "position": [
          5280,
          -304
        ],
        "id": "40046be6-b87c-4415-b1ac-3d97ec7ac8b9",
        "name": "Update Record",
        "disabled": true
      },
      {
        "parameters": {
          "jsonSchemaExample": "{\n\t\"image_type\": \"ai OR stock\",\n\t\"image1\": \"image prompt or search term\",\n\t\"image2\": \"image prompt or search term\"\n}"
        },
        "type": "@n8n/n8n-nodes-langchain.outputParserStructured",
        "typeVersion": 1.2,
        "position": [
          3056,
          -1360
        ],
        "id": "08289618-a6f3-4591-8cc2-e1f9fae1727e",
        "name": "Structured Output Parser1"
      },
      {
        "parameters": {
          "promptType": "define",
          "text": "={{ $('Write Article').item.json.output[1].text }}",
          "hasOutputParser": true,
          "messages": {
            "messageValues": [
              {
                "message": "=You will write the text for social media posts for facebook, linkedin, Instagram, and twitter for the provided article\n\nExample output\n\n{\n  \"social_media\": {\n    \"Instagram\": \"<ADD TEXT>\",\n    \"Facebook\": \"<ADD TEXT>\",\n    \"Twitter\": \"<ADD TEXT>\",    \n    \"LinkedIn\": \"<ADD TEXT>\"\n  }\n}"
              }
            ]
          }
        },
        "type": "@n8n/n8n-nodes-langchain.chainLlm",
        "typeVersion": 1.5,
        "position": [
          4496,
          -304
        ],
        "id": "fb7d5abd-44f4-4d05-9165-8474bb50a117",
        "name": "Write Social Media Posts",
        "retryOnFail": true,
        "notesInFlow": false,
        "waitBetweenTries": 5000
      },
      {
        "parameters": {
          "content": "# NocoDB Trigger",
          "width": 780,
          "color": 5
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          -1744,
          -1200
        ],
        "id": "6f2dd006-79af-4bc7-9307-1ed26bba0854",
        "name": "Sticky Note4"
      },
      {
        "parameters": {
          "content": "# Schedule Trigger",
          "width": 780,
          "color": 5
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          -1744,
          -976
        ],
        "id": "f549a1be-2513-41c1-b06d-3d4115c301af",
        "name": "Sticky Note5"
      },
      {
        "parameters": {
          "content": "# Internal Links",
          "height": 460,
          "width": 1180,
          "color": 7
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          784,
          -1312
        ],
        "id": "d4402739-6430-4db4-85b0-e3225593e1cd",
        "name": "Sticky Note6"
      },
      {
        "parameters": {},
        "type": "n8n-nodes-base.noOp",
        "typeVersion": 1,
        "position": [
          1936,
          -2080
        ],
        "id": "fa34dc1b-2cfa-4f0a-84a3-3dd429ff575f",
        "name": "End"
      },
      {
        "parameters": {
          "path": "aa02abc6-5417-4b5e-9d4b-d956bba8e6f8",
          "options": {}
        },
        "type": "n8n-nodes-base.webhook",
        "typeVersion": 2,
        "position": [
          -1184,
          -1184
        ],
        "id": "6f8a61df-11f3-4797-ba1e-51e46320aa83",
        "name": "Webhook",
        "webhookId": "aa02abc6-5417-4b5e-9d4b-d956bba8e6f8",
        "disabled": true
      },
      {
        "parameters": {
          "method": "POST",
          "url": "={{$('Configuration').item.json.nocodb_url}}api/v1/db/storage/upload",
          "authentication": "predefinedCredentialType",
          "nodeCredentialType": "nocoDbApiToken",
          "sendBody": true,
          "contentType": "multipart-form-data",
          "bodyParameters": {
            "parameters": [
              {
                "parameterType": "formBinaryData",
                "name": "file",
                "inputDataFieldName": "data"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          5056,
          -304
        ],
        "id": "f1552336-f853-4ed9-aaa6-c1091244ef62",
        "name": "Upload Image to NoCoDB Binary",
        "disabled": true
      },
      {
        "parameters": {
          "url": "={{ $('Article fields').item.json.featured_image ? $('Article fields').item.json.featured_image : ($('Generate content image1').isExecuted ? $('Generate content image1').item.json.images[0].url : $('Pick Random1').item.json.largeImageURL) }}",
          "options": {
            "response": {
              "response": {
                "responseFormat": "file"
              }
            }
          }
        },
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.2,
        "position": [
          4864,
          -304
        ],
        "id": "959a6f1d-3829-47da-819a-4a9da12bb53b",
        "name": "Download"
      },
      {
        "parameters": {
          "content": "[![The AI Automators](https://www.theaiautomators.com/wp-content/uploads/2025/03/gray-logo.png)](https://www.theaiautomators.com/)",
          "height": 140,
          "width": 300,
          "color": 7
        },
        "type": "n8n-nodes-base.stickyNote",
        "typeVersion": 1,
        "position": [
          2384,
          -2112
        ],
        "id": "9a8bc32c-61ce-46c9-bd9b-02c5cc6558eb",
        "name": "Sticky Note8"
      },
      {
        "parameters": {
          "method": "PATCH",
          "url": "http://paper-backend:4242/rated-papers/",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "={\n  \"doi\": \"{{ $('1. Get Rated Paper1').item.json.doi }}\",\n  \"outline\": \"{{ $json.output.article_outline }}\",\n  \"deep_research\":\"{{ $json.output.research_findings }}\",\n  \"citations\":\"{{ $json.output.citations }}\"\n}",
          "options": {}
        },
        "id": "233a9c64-7689-4d69-a1b4-d74a25d5c37b",
        "name": "Save outline",
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.1,
        "position": [
          1376,
          -2016
        ],
        "credentials": {
          "httpBearerAuth": {
            "id": "ijgx3lz1xx4Q9zxn",
            "name": "Bearer Auth account"
          },
          "httpHeaderAuth": {
            "id": "RTzRC0AggRABuRdo",
            "name": "Auth Header Paper Backend API KEY"
          }
        }
      },
      {
        "parameters": {
          "toolDescription": "Use this tool to search our LightRAG database for scientific research and additional background information directly relevant to the provided paper. Summarize all findings and explanations in clear, simple, and non-technical language, understandable to non-experts and laypersons. If available, locate the paper itself and ensure all explanations and additional insights are concise, context-sensitive, and accessible.\n",
          "method": "POST",
          "url": "=https://rag.clapclap.cc/query",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendHeaders": true,
          "headerParameters": {
            "parameters": [
              {
                "name": "accept",
                "value": "application/json"
              },
              {
                "name": "X-API-Key",
                "value": "buh0vitamin2GOLFER3weii-chrissie"
              }
            ]
          },
          "sendBody": true,
          "bodyParameters": {
            "parameters": [
              {
                "name": "query",
                "value": "={{ /*n8n-auto-generated-fromAI-override*/ $fromAI('parameters0_Value', ``, 'string') }}"
              },
              {}
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.httpRequestTool",
        "typeVersion": 4.2,
        "position": [
          1440,
          -1664
        ],
        "id": "d37845af-c5f6-4798-8178-51d87a2c42ac",
        "name": "LightRAG query tool",
        "credentials": {
          "httpHeaderAuth": {
            "id": "C6EaRz4vxUMkBGCJ",
            "name": "LightRAG Api key"
          }
        }
      },
      {
        "parameters": {
          "method": "PATCH",
          "url": "http://paper-backend:4242/rated-papers/",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "{\n\"content_status\":\"posted Social\"\n}",
          "options": {}
        },
        "id": "765240af-755f-4579-8cd2-6aea5b6bb92e",
        "name": "Save outline1",
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.1,
        "position": [
          1536,
          80
        ],
        "credentials": {
          "httpBearerAuth": {
            "id": "ijgx3lz1xx4Q9zxn",
            "name": "Bearer Auth account"
          },
          "httpHeaderAuth": {
            "id": "RTzRC0AggRABuRdo",
            "name": "Auth Header Paper Backend API KEY"
          }
        }
      },
      {
        "parameters": {
          "operation": "pdf",
          "options": {}
        },
        "type": "n8n-nodes-base.extractFromFile",
        "typeVersion": 1,
        "position": [
          -400,
          -1072
        ],
        "id": "3c2cf4e9-753b-4fac-b910-d09a6fd9eaa5",
        "name": "Extract from File"
      },
      {
        "parameters": {
          "bucketName": "paper-store",
          "fileKey": "={{ $json.pmid }}.pdf"
        },
        "type": "n8n-nodes-base.s3",
        "typeVersion": 1,
        "position": [
          -592,
          -1072
        ],
        "id": "846c6b62-37d1-4593-9340-3f50404ba17e",
        "name": "Download a file",
        "credentials": {
          "s3": {
            "id": "lXbGUFRjp6Yya8kj",
            "name": "Strato S3 Images"
          }
        }
      },
      {
        "parameters": {
          "method": "POST",
          "url": "http://paper-backend:4242/rated-papers/query",
          "authentication": "genericCredentialType",
          "genericAuthType": "httpHeaderAuth",
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "{\n  \"min_rating\": 6.1,\n  \"content_status\": \"idee\",\n  \"category_keywords\": [\n    \"Solide Grundlage\", \n    \"Content-Gold\", \n    \"Interessanter Ansatz\"\n  ],\n  \"limit\": 1\n}",
          "options": {}
        },
        "id": "59a7df04-6e78-4cb4-8329-7a87ae02ee1a",
        "name": "1. Get Rated Paper1",
        "type": "n8n-nodes-base.httpRequest",
        "typeVersion": 4.1,
        "position": [
          -928,
          -1072
        ],
        "credentials": {
          "httpBearerAuth": {
            "id": "ijgx3lz1xx4Q9zxn",
            "name": "Bearer Auth account"
          },
          "httpHeaderAuth": {
            "id": "RTzRC0AggRABuRdo",
            "name": "Auth Header Paper Backend API KEY"
          }
        }
      },
      {
        "parameters": {
          "rules": {
            "values": [
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "leftValue": "={{ $input.all().length }}",
                      "rightValue": 0,
                      "operator": {
                        "type": "number",
                        "operation": "gt"
                      },
                      "id": "9ca3c566-4222-4f04-8f7a-53905212265f"
                    }
                  ],
                  "combinator": "and"
                },
                "renameOutput": true,
                "outputKey": "Paper gefunden"
              },
              {
                "conditions": {
                  "options": {
                    "caseSensitive": true,
                    "leftValue": "",
                    "typeValidation": "strict",
                    "version": 2
                  },
                  "conditions": [
                    {
                      "id": "5f928ef1-de1c-4891-9681-2190b23cdfab",
                      "leftValue": "={{ $input.all().length }}",
                      "rightValue": 0,
                      "operator": {
                        "type": "number",
                        "operation": "equals"
                      }
                    }
                  ],
                  "combinator": "and"
                },
                "renameOutput": true,
                "outputKey": "Keine Papers gefunden"
              }
            ]
          },
          "options": {}
        },
        "type": "n8n-nodes-base.switch",
        "typeVersion": 3.2,
        "position": [
          -800,
          -1072
        ],
        "id": "d9ee80a1-33d4-4a6e-907f-516142fd5222",
        "name": "Switch1"
      },
      {
        "parameters": {
          "toolDescription": "Use this tool if you need to carry out a quick search on some key topics of the provided scientific paper. If the topic requires a much deeper understanding of a topic, use the Deep Research tool instead.\n\nIMPORTNAT: DO NOT CALL MORE THAN TWICE",
          "method": "POST",
          "url": "https://deepsearch.jina.ai/v1/chat/completions",
          "sendHeaders": true,
          "parametersHeaders": {
            "values": [
              {
                "name": "Authorization",
                "valueProvider": "=Bearer jina_c86f06e918b245028e58a1042558a80aKJe5_h7VlmeqE3zsenV0sNVRF3tr"
              },
              {
                "name": "Content-Type"
              }
            ]
          },
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "{\n    \"model\": \"jina-deepsearch-v1\",\n    \"messages\": [\n        {\n            \"role\": \"user\",\n            \"content\": \"{prompt}\"\n        }\n    ],\n    \"stream\": false,\n    \"reasoning_effort\": \"low\",\n    \"no_direct_answer\": true\n  }",
          "placeholderDefinitions": {
            "values": [
              {
                "name": "prompt",
                "description": "Populate this with the keywords or topic to be searched"
              }
            ]
          }
        },
        "type": "@n8n/n8n-nodes-langchain.toolHttpRequest",
        "typeVersion": 1.1,
        "position": [
          1136,
          -1456
        ],
        "id": "3a5f5627-1414-458d-a949-3b743e55f36e",
        "name": "Deep Search with Jina old",
        "disabled": true
      },
      {
        "parameters": {
          "resource": "research",
          "researchQuery": "=Research related to the scientific paper DOI {{ $('1. Get Rated Paper1').item.json.doi }} — focus on its key findings, bioactive mechanisms, challenges, and clinical applications. If DOI is missing, use the fallback PDF-ID/PMID {{ $('1. Get Rated Paper1').item.json.pmid }}.pdf.\n",
          "options": {},
          "requestOptions": {}
        },
        "type": "n8n-nodes-base.jinaAiTool",
        "typeVersion": 1,
        "position": [
          1152,
          -1664
        ],
        "id": "929e7c1e-933b-420c-816f-b8b5cf597b84",
        "name": "Deep Search with Jina",
        "credentials": {
          "jinaAiApi": {
            "id": "zOl636sEio26claF",
            "name": "Jina AI account"
          }
        }
      },
      {
        "parameters": {
          "toolDescription": "This tool is to carry out deep research using Perplexity. If you need very deep research on the key topic of the scientific paper provided, particularly based on up-to-date information, this is the tool to use.\n\nIMPORTNAT: DO NOT CALL MORE THAN ONCE",
          "method": "POST",
          "url": "https://api.perplexity.ai/chat/completions",
          "sendHeaders": true,
          "parametersHeaders": {
            "values": [
              {
                "name": "Authorization",
                "valueProvider": "=Bearer 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"
              },
              {
                "name": "Content-Type"
              }
            ]
          },
          "sendBody": true,
          "specifyBody": "json",
          "jsonBody": "={\n  \"model\": \"sonar-deep-research\",\n  \"messages\": [\n    {\n      \"role\": \"system\",\n      \"content\": \"you will create a summary of facts/figures and information to include for a blog post. Do not respond with introductory text. Do not number the headings.\"\n    },\n    {\n      \"role\": \"user\",\n      \"content\": {prompt}\n    }\n  ]\n}",
          "placeholderDefinitions": {
            "values": [
              {
                "name": "prompt",
                "description": "=Populate this with a prompt based on this structure ...\n\nCreate a summary of facts/figures and information to include for this topic <PROVIDE TOPIOC>. Be detailed. Each section should have the following:  Heading - key points, data, information: be specific and provide this information. - any main keywords to include, facts, figures. You must include the specific facts/figures/statistics/keywords that need to be included within the article.  Add elaboration on each key point with specific instructions for including data, comparisons, and explanations.  If providing lists of products, software, or other types of entities, then list out the specific items of the list.",
                "type": "string"
              }
            ]
          }
        },
        "type": "@n8n/n8n-nodes-langchain.toolHttpRequest",
        "typeVersion": 1.1,
        "position": [
          1328,
          -1472
        ],
        "id": "467cf0a9-65bc-47fb-89a5-9eb9bf6908da",
        "name": "Deep Research with Perplexity old",
        "disabled": true
      },
      {
        "parameters": {
          "descriptionType": "manual",
          "toolDescription": "=This tool is used to carry out deep research using Perplexity. If you need very deep research on the key topic of the scientific paper provided, particularly based on up-to-date information, this is the tool to use.\n\nIMPORTANT: Do not call more than once.\n",
          "model": "sonar-deep-research",
          "messages": {
            "message": [
              {
                "content": "=You will create a summary of facts, figures, and information to include for a blog post. Do not respond with introductory text. Do not number the headings. Always reference the DOI {{ $('1. Get Rated Paper1').item.json.doi }} when citing the primary paper. If DOI is missing, use the fallback PDF-ID.\n",
                "role": "system"
              },
              {
                "content": "=Create a detailed summary of facts, figures, and information for the scientific paper DOI {{ $('1. Get Rated Paper1').item.json.doi }}.  \nBe detailed. Each section should include:\n\nHeading\n- key points, data, information: be specific and provide this information\n- keywords, facts, figures to include in the article\n- specific facts, figures, statistics, and keywords that must appear in the article\n- elaboration on each point with instructions for including data, comparisons, and explanations\n- if listing products, substances or other entities, list the specific items\n\nIf DOI is missing, use the fallback PDF-ID {{ $('1. Get Rated Paper1').item.json.pmid }}.pdf.\n"
              }
            ]
          },
          "options": {},
          "requestOptions": {}
        },
        "type": "n8n-nodes-base.perplexityTool",
        "typeVersion": 1,
        "position": [
          1296,
          -1680
        ],
        "id": "96670675-ced0-4783-bce5-7ded81398c14",
        "name": "Deep Research with Perplexity",
        "credentials": {
          "perplexityApi": {
            "id": "JBDa4J8nPXuQsRDN",
            "name": "Perplexity account"
          }
        }
      }
    ],
    "connections": {
      "Extract URLs": {
        "main": [
          [
            {
              "node": "Pick Internal Links",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Anthropic Chat Model": {
        "ai_languageModel": [
          [
            {
              "node": "Pick Internal Links",
              "type": "ai_languageModel",
              "index": 0
            }
          ]
        ]
      },
      "Article fields": {
        "main": [
          [
            {
              "node": "Configuration",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Pick Internal Links": {
        "main": [
          [
            {
              "node": "Outline Required?",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Outline Required?": {
        "main": [
          [
            {
              "node": "Go",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Merged outline and citations",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Merged outline and citations": {
        "main": [
          [
            {
              "node": "Image prompt helper",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Schedule Trigger": {
        "main": [
          [
            {
              "node": "1. Get Rated Paper1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Continue": {
        "main": [
          [
            {
              "node": "Filter",
              "type": "main",
              "index": 0
            },
            {
              "node": "Filter1",
              "type": "main",
              "index": 0
            },
            {
              "node": "Filter2",
              "type": "main",
              "index": 0
            },
            {
              "node": "Filter3",
              "type": "main",
              "index": 0
            },
            {
              "node": "Save outline1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Filter": {
        "main": [
          [
            {
              "node": "Facebook post",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Filter1": {
        "main": [
          [
            {
              "node": "Twitter Post",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Filter2": {
        "main": [
          [
            {
              "node": "Instagram Post",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Filter3": {
        "main": [
          [
            {
              "node": "LinkedIn Post",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "If": {
        "main": [
          [
            {
              "node": "End",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Merged outline and citations",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Get Sitemap": {
        "main": [
          [
            {
              "node": "Convert to JSON",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Convert to JSON": {
        "main": [
          [
            {
              "node": "Extract URLs",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Agentic RAG": {
        "main": [
          [
            {
              "node": "Save outline",
              "type": "main",
              "index": 0
            },
            {
              "node": "Save outline",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Make Source List": {
        "main": [
          [
            {
              "node": "Output Format",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Go": {
        "main": [
          [
            {
              "node": "Agentic RAG",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Output Format": {
        "ai_outputParser": [
          [
            {
              "node": "Agentic RAG",
              "type": "ai_outputParser",
              "index": 0
            }
          ]
        ]
      },
      "Write Article": {
        "main": [
          [
            {
              "node": "Format Bibliography",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Anthropic Chat Model1": {
        "ai_languageModel": [
          [
            {
              "node": "Agentic RAG",
              "type": "ai_languageModel",
              "index": 0
            }
          ]
        ]
      },
      "Simple Memory": {
        "ai_memory": [
          [
            {
              "node": "Agentic RAG",
              "type": "ai_memory",
              "index": 0
            }
          ]
        ]
      },
      "Configuration": {
        "main": [
          [
            {
              "node": "Check Status",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Check Status": {
        "main": [
          [
            {
              "node": "Go",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Get Sitemap",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Continue",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Write Article": {
        "main": [
          [
            {
              "node": "Wordpress",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Format Bibliography": {
        "main": [
          [
            {
              "node": "Assemble Final HTML",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Assemble Final HTML": {
        "main": [
          [
            {
              "node": "Wordpress",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Get Image2": {
        "main": [
          [
            {
              "node": "Upload In-content image",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Pick Random": {
        "main": [
          [
            {
              "node": "Get Image2",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Pixabay": {
        "main": [
          [
            {
              "node": "Pick Random",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "If1": {
        "main": [
          [
            {
              "node": "Generate content image",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Pixabay",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Extract youtube urls": {
        "main": [
          [
            {
              "node": "Choose Youtube URL",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Choose Youtube URL": {
        "main": [
          [
            {
              "node": "If1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Anthropic Chat Model7": {
        "ai_languageModel": [
          [
            {
              "node": "Choose Youtube URL",
              "type": "ai_languageModel",
              "index": 0
            }
          ]
        ]
      },
      "Get Youtube Video": {
        "main": [
          [
            {
              "node": "Extract youtube urls",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Wordpress": {
        "main": [
          [
            {
              "node": "Switch",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Anthropic Chat Model5": {
        "ai_languageModel": [
          [
            {
              "node": "Write Article",
              "type": "ai_languageModel",
              "index": 0
            }
          ]
        ]
      },
      "Upload In-content image": {
        "main": [
          [
            {
              "node": "Write Article",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Get Image": {
        "main": [
          [
            {
              "node": "Upload In-content image",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Generate content image": {
        "main": [
          [
            {
              "node": "Get Image",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Anthropic Chat Model4": {
        "ai_languageModel": [
          [
            {
              "node": "Image prompt helper",
              "type": "ai_languageModel",
              "index": 0
            }
          ]
        ]
      },
      "Image prompt helper": {
        "main": [
          [
            {
              "node": "Get Youtube Video",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Upload In-content image1": {
        "main": [
          [
            {
              "node": "Set Featured Image",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Set Featured Image": {
        "main": [
          [
            {
              "node": "Write Social Media Posts",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Anthropic Chat Model6": {
        "ai_languageModel": [
          [
            {
              "node": "Write Social Media Posts",
              "type": "ai_languageModel",
              "index": 0
            }
          ]
        ]
      },
      "Structured Output Parser": {
        "ai_outputParser": [
          [
            {
              "node": "Write Social Media Posts",
              "type": "ai_outputParser",
              "index": 0
            }
          ]
        ]
      },
      "Get Image1": {
        "main": [
          [
            {
              "node": "Upload In-content image1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Generate content image1": {
        "main": [
          [
            {
              "node": "Get Image3",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Get Image3": {
        "main": [
          [
            {
              "node": "Upload In-content image1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Pixabay1": {
        "main": [
          [
            {
              "node": "Pick Random1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Pick Random1": {
        "main": [
          [
            {
              "node": "Get Image4",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Get Image4": {
        "main": [
          [
            {
              "node": "Upload In-content image1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Switch": {
        "main": [
          [
            {
              "node": "Get Image1",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Generate content image1",
              "type": "main",
              "index": 0
            }
          ],
          [
            {
              "node": "Pixabay1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Structured Output Parser1": {
        "ai_outputParser": [
          [
            {
              "node": "Image prompt helper",
              "type": "ai_outputParser",
              "index": 0
            }
          ]
        ]
      },
      "Write Social Media Posts": {
        "main": [
          [
            {
              "node": "Download",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Webhook": {
        "main": [
          [
            {
              "node": "1. Get Rated Paper1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Upload Image to NoCoDB Binary": {
        "main": [
          [
            {
              "node": "Update Record",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Download": {
        "main": [
          [
            {
              "node": "Upload Image to NoCoDB Binary",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Save outline": {
        "main": [
          [
            {
              "node": "If",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "LightRAG query tool": {
        "ai_tool": [
          [
            {
              "node": "Agentic RAG",
              "type": "ai_tool",
              "index": 0
            }
          ]
        ]
      },
      "Extract from File": {
        "main": [
          [
            {
              "node": "Article fields",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Download a file": {
        "main": [
          [
            {
              "node": "Extract from File",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "1. Get Rated Paper1": {
        "main": [
          [
            {
              "node": "Switch1",
              "type": "main",
              "index": 0
            }
          ]
        ]
      },
      "Switch1": {
        "main": [
          [
            {
              "node": "Download a file",
              "type": "main",
              "index": 0
            }
          ],
          []
        ]
      },
      "Deep Search with Jina old": {
        "ai_tool": [
          []
        ]
      },
      "Deep Search with Jina": {
        "ai_tool": [
          [
            {
              "node": "Agentic RAG",
              "type": "ai_tool",
              "index": 0
            }
          ]
        ]
      },
      "Deep Research with Perplexity old": {
        "ai_tool": [
          []
        ]
      },
      "Deep Research with Perplexity": {
        "ai_tool": [
          [
            {
              "node": "Agentic RAG",
              "type": "ai_tool",
              "index": 0
            }
          ]
        ]
      }
    },
    "pinData": {
      "Extract from File": [
        {
          "numpages": 22,
          "numrender": 22,
          "info": {
            "PDFFormatVersion": "1.4",
            "Language": null,
            "EncryptFilterName": null,
            "IsLinearized": false,
            "IsAcroFormPresent": false,
            "IsXFAPresent": false,
            "IsCollectionPresent": false,
            "IsSignaturesPresent": false,
            "CreationDate": "D:20250707180119+05'30'",
            "Creator": "Arbortext Advanced Print Publisher 9.1.510/W Unicode",
            "Producer": "Acrobat Distiller 7.0 (Windows)",
            "ModDate": "D:20250707180119+05'30'"
          },
          "metadata": {
            "pdf:producer": "dvips + MiKTeX GPL Ghostscript  9.0",
            "pdf:keywords": "curcumin, natural medicine, neurodegenerative disease, pharmacological activity, bioavailability",
            "dc:identifier": "",
            "dc:title": "Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases",
            "prism:doi": "",
            "prism:url": "",
            "dc:creator": [
              "Gang Wang",
              "Xueyuan Zhou",
              "Xiaoyan Pang",
              "Ke Ma",
              "Lu Li",
              "Yuexin Song",
              "Dongxia Hou",
              "Xiaohua Wang"
            ],
            "dc:description": "Wang G, Zhou X, Pang X, Ma K, Li L, Song Y, Hou D and Wang X (2025), Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases. Front. Pharmacol. 16:1625821. doi: 10.3389/fphar.2025.1625821",
            "dc:subject": [
              "curcumin",
              "natural medicine",
              "neurodegenerative disease",
              "pharmacological activity",
              "bioavailability"
            ],
            "dc:source": "",
            "dc:publisher": "",
            "dc:rights": "Copyright © 2025 Wang, Zhou, Pang, Ma, Li, Song, Hou and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.",
            "xaprights:marked": "True",
            "xaprights:webstatement": "https://www.frontiersin.org/legal/copyright-statement",
            "pur:copyright": "",
            "jav:journal_article_version": "",
            "crossmark:majorversiondate": "",
            "crossmark:crossmarkdomainexclusive": "false",
            "crossmark:doi": "",
            "crossmark:crossmarkdomains": "",
            "pdfx:doi": "",
            "pdfx:title": "",
            "pdfx:crossmarkmajorversiondate": "",
            "pdfx:crossmarkdomainexclusive": "false",
            "pdfx:crossmarkdomains": ""
          },
          "text": "Pharmacological effects,\nmolecular mechanisms and\nstrategies to improve\nbioavailability of curcumin in the\ntreatment of neurodegenerative\ndiseases\nGang Wang \n1 \n,\n2†\n*, Xueyuan Zhou \n1 \n,\n2†\n, Xiaoyan Pang \n1 \n,\n2 \n, Ke Ma \n1 \n,\n2 \n,\nLu Li \n1 \n, \n2\n, Yuexin Song \n1 \n,\n2 \n, Dongxia Hou \n1 \n,\n2 \n* and Xiaohua Wang \n1 \n,\n2 \n*\n1 \nDepartment of Genetics, Inner Mongolia Maternity and Child Health Care Hospital, Hohhot, China,\n2 \nInner Mongolia Engineering Research Center of Medical Genetics, Hohhot, China\nWith the global population aging, the incidence of neurodegenerative diseases (NDs),\nsuch as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and\namyotrophic lateral sclerosis, has been progressively increasing. However,\neffective therapeutic strategies and clinical drugs for these disorders remain\nscarce. Curcumin, a natural polyphenolic compound primarily derived from the\nherbaceous plant Curcuma longa L., has been proposed as a promising candidate for\nND treatment based on the excellent antioxidant, anti-inflammatory and\nneuroprotective properties. Its pharmacological activities encompass scavenging\nreactive oxygen species, mitigating toxic protein aggregation and cytotoxicity,\nrepairing mitochondrial dysfunction, and inhibiting excessive neuronal apoptosis.\nCompared with synthetic drugs, curcumin demonstrates a more favorable safety\nprofile with fewer side effects. Nevertheless, its clinical application is substantially\nhindered by poor bioavailability, which stems from low aqueous solubility, inefficient\nintestinal absorption, and rapid metabolism and systemic elimination. Conventional\nadministration methods often fail to achieve effective concentrations in vivo. Further\nclinical trials are also required to validate the therapeutic efficacy and potential\nadverse effects in human subjects. This article systematically reviews the\npathogenesis of NDs and the knowledge on curcumin including pharmacological\neffects, neuroprotective mechanisms, functions across specific NDs and advanced\nstrategies to enhance the bioavailability, with the aim of promoting the development\nand clinical translation of curcumin-based therapeutics for NDs.\nKEYWORDS\ncurcumin, natural medicine, neurodegenerative disease, pharmacological activity,\nbioavailability\n1 Introduction\nNeurodegenerative diseases (NDs) represent a group of disorders characterized by\nprogressive degeneration of the structure and function of the nervous system, particularly\naffecting neurons in the brain and spinal cord. These conditions often arise from a complex\ninterplay of genetic, environmental and lifestyle factors (Zhang W. et al., 2023;\nOPEN ACCESS\nEDITED BY\nPaul Chazot,\nDurham University, United Kingdom\nREVIEWED BY\nVenkata Ramireddy Narala,\nYogi Vemana University, India\nTapan A. Patel,\nUniversity of Nebraska Medical Center,\nUnited States\nMahmood Ahmed,\nUniversity of Education Lahore, Pakistan\nLimamanen Phom,\nSao Chang College, India\n*CORRESPONDENCE\nGang Wang,\nwgimplad@163.com\nDongxia Hou,\nhoudx1121@126.com\nXiaohua Wang,\nwangxiaohua2222@163.com\n†\nThese authors have contributed equally to\nthis work\nRECEIVED 09 May 2025\nACCEPTED 30 June 2025\nPUBLISHED 10 July 2025\nCITATION\nWang G, Zhou X, Pang X, Ma K, Li L, Song Y,\nHou D and Wang X (2025) Pharmacological\neffects, molecular mechanisms and strategies\nto improve bioavailability of curcumin in the\ntreatment of neurodegenerative diseases.\nFront. Pharmacol. 16:1625821.\ndoi: 10.3389/fphar.2025.1625821\nCOPYRIGHT\n© 2025 Wang, Zhou, Pang, Ma, Li, Song, Hou\nand Wang. This is an open-access article\ndistributed under the terms of the Creative\nCommons Attribution License (CC BY). The use,\ndistribution or reproduction in other forums is\npermitted, provided the original author(s) and\nthe copyright owner(s) are credited and that the\noriginal publication in this journal is cited, in\naccordance with accepted academic practice.\nNo use, distribution or reproduction is\npermitted which does not comply with these\nterms.\nFrontiers in Pharmacology frontiersin.org01\nTYPE Review\nPUBLISHED 10 July 2025\nDOI 10.3389/fphar.2025.1625821\n\nSwaddiwudhipong et al., 2023). The most prevalent NDs include\nAlzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic\nlateral sclerosis (ALS) and Huntington’s disease (HD). Typical\nsymptoms encompass memory loss, cognitive decline, motor\ndysfunction and behavioral changes, which vary depending on\nthe specific disease and affected brain regions. The pathogenesis\ninvolves multiple interconnected mechanisms, including genetic\nmutations, protein misfolding and aggregation, oxidative stress,\nmitochondrial dysfunction and chronic neuroinflammation (Zhao\net al., 2020; Song et al., 2020). NDs are closely related to age, as the\nonset risk increases and symptom severity worsens with advancing\nage (Sun et al., 2024). Consequently, the global aging of the\npopulation is expected to increase the incidence and prevalence\nof NDs, presenting a major challenge for healthcare systems\nworldwide (Pichet Binette et al., 2020; Shen et al., 2021). Current\ntherapeutic strategies predominantly focus on symptom\nmanagement and slowing disease progression. For instance,\ncholinesterase inhibitors and NMDA receptor antagonists are\nwidely used for AD, while dopamine replacement therapies\nremain the standard for PD (D’Angremont et al., 2023; Liang\net al., 2024). However, these treatments are not curative and only\nprovide temporary relief. Long-term use may lead to reduced\nFIGURE 1\nMechanism of curcumin exerting the neuroprotective effect. (1) Antioxidation: Ⅰ. Direct scavenging of ROS; Ⅱ. Enhancement of antioxidant enzyme\nactivity, such as SOD, CAT and GPx; Ⅲ. Promoting the dissociation of Nrf2 from Keap1 to bind to antioxidant response elements (ARE), inducing the\nexpression of antioxidant genes. (2) Anti-inflammation: Ⅰ. Inhibition of the activities of cyclooxygenase (COX), lipoxygenase (LOX), etc.; Ⅱ. Inhibition of the\nactivation of the inflammasome NLRP3; Ⅲ. Inhibiting the activity of the IκB kinase (IKK) complex, thereby suppressing NF-κB, and consequently\nreducing the expression of NF-κB-mediated pro-inflammatory factors such as IL-1β, IL-6, TNF-α, etc.; Ⅳ. Reduced abnormal activation of astrocytes and\nmicroglia; Ⅴ. Promoting the production of short-chain fatty acids (SCFAs) of intestinal microbes to regulate the brain-gut axis, maintaining the integrity of\nthe blood-brain barrier and indirectly protecting the nervous system. (3) Removal of toxic proteins: Ⅰ. Inhibition of the formation of toxic protein\naggregates; Ⅱ. Prevention of tau phosphorylation; Ⅲ. Activating the PI3K/AKT/mTOR pathway to promote autophagic clearance of formed toxic proteins\nand damaged cells. (4) Maintenance of metal homeostasis: Ⅰ. Chelating heavy metal ions to alleviate neurotoxicity; Ⅱ. Prevention of intracellular calcium\noverload. (5) Inhibition of excessive apoptosis: Upregulating Bcl-2 and downregulating Bax to reduce mitochondrial cytochrome C release and inhibit\ncaspase-9/6/3 activation, suppressing excessive apoptosis. (6) Promotion of regeneration and repair of neurons: Ⅰ. Increasing the expression of brain-\nderived neurotrophic factor (BDNF); Ⅱ. Upregulation of Wnt/β-catenin (WβC) pathway.\nFrontiers in Pharmacology frontiersin.org02\nWang et al. 10.3389/fphar.2025.1625821\n\nTABLE 1 Clinical trials of curcumin on the effect of central nervous system.\nNo. Object Research\ntype\nFormulation/\nDosage\nGroup Duration Outcome Side effect References\n1 40 non-\ndemented adults\nRandomized,\ndouble-blind,\nand placebo-\ncontrolled\nHighly absorptive\ncurcumin dispersed with\ncolloidal nanoparticles-\nTheracurmin, 90 mg twice\ndaily (180 mg/day)\nPlacebo-19;\nIntervention-\n21\n18 months Memory and\nattention improved\nwith Theracurmin;\nless\nneuropathological\naccumulation in\nthe amygdala and\nhypothalamus\nFour curcumin-\ntreated and two\nplacebo-treated\nsubjects\nexperienced\ngastrointestinal\nside effects\n(transient\nabdominal pain,\ngastritis, or\nnausea)\nSmall et al.\n(2018)\n2 36 patients with\nmild-to-\nmoderate AD\nRandomized,\ndouble blind,\nand placebo-\ncontrolled\nOral curcumin\nC3 complex (95%\ncurcuminoids with 70%–\n80% comprised by\ncurcumin, 15%–25%\ndemethoxycurcumin, and\n2.5%–6.5%\nbisdemethoxycurcumin),\ncapsules taken twice daily\nwith a fatty meal\nPlacebo-12\n2 g/day-12\n4 g/day-12\n24 weeks No differences\nbetween treatment\ngroups in clinical or\nbiomarker efficacy\nmeasures; low\nnative curcumin\nmeasured in\nplasma\n(7.32 ng/mL)\n5/24 subjects\nwithdrew in the\ncurcumin group\ndue to\ngastrointestinal\nsymptoms\nRingman et al.\n(2012)\n3 60 healthy adults\naged 60–85\nRandomized,\ndouble-blind,\nand placebo-\ncontrolled\n400 mg Longvida \n®\noptimized curcumin\ncontaining approximately\n80 mg curcumin in a solid\nlipid formulation, capsules\ntaken once daily\nPlacebo-30;\nIntervention-\n30\n4 weeks Improved\nperformance on\nsustained attention\nand working\nmemory tasks one\nhour after\nadministration\ncurcumin; better\nworking memory\nand mood\nfollowing chronic\ntreatment\n(4 weeks); reduced\ntotal and LDL\ncholesterol levels\nCurcumin\ntreatment was well\ntolerated and did\nnot significantly\nimpact of any of\nthe examined\nhematological\nsafety measures\nCox et al. (2015)\n4 48 AD patients\nwith moderate\ndementia\nRandomized,\ndouble-blind,\nand placebo-\ncontrolled\nUnformulated standard\ncurcumin complex\nwith >95% purity (USC);\ncurcumin-galactomannan\ncomplex (CGM);\n400 mg × 2/day\nPlacebo-16\nUSC group-\n16\nCGM\ngroup-16\n6 months Improved MMSE\nand GLFS scores,\nsignificant delay in\nthe progress of AD,\nand improved\nserum levels of\nspecific biomarkers\n(BDNF, Aβ42, tau\nprotein, IL-6 and\nTNF-α) in CGM\ngroup\nNo adverse events\nwere reported in\nthe placebo, USC\nor CGM groups\nDas et al. (2023)\n5 60 idiopathic PD\npatients aged≥30\nRandomized,\ntriple-blind,\nand placebo-\ncontrolled\nCurcumin nanomicelles in\nsoft gelatin capsules,\n80 mg/daily\nPlacebo-30;\nIntervention-\n30\n9 months No significant\ndifference between\nplacebo and\ncurcumin groups\nA total of\n12 subjects\nshowed nausea\nand vomiting,\ngastroesophageal\nreflux, and\ndyspepsia in\ncurcumin group\nwhile 8 patients\nwere reported\nwith side effects\nrelated to\ngastrointestinal\nsystem in placebo\ngroup\nGhodsia et al.\n(2022)\n6 96 primiparous\nwomen\nRandomized,\ndouble-blind,\nand placebo-\ncontrolled\n500 mg of curcumin\ncapsules, once daily\nPlacebo-48;\nIntervention-\n48\n8 weeks The mean score of\ndepression and\nanxiety were\nsignificantly lower\nFour individuals\nin the intervention\ngroup and one\nperson in the\nHamlbar et al.\n(2025)\n(Continued on following page)\nFrontiers in Pharmacology frontiersin.org03\nWang et al. 10.3389/fphar.2025.1625821\n\nefficacy and increased adverse effects (Xu et al., 2023). In recent\nyears, significant advancements has been made in drug\ndevelopment, with a growing emphasis on targeting the\nunderlying pathological mechanisms. Key targets include β-\namyloid (Aβ) and tau proteins of AD, α-synuclein (α-syn) of PD\nand huntingtin proteins of HD (Ran and Zhu, 2024; Martic, 2022).\nAdditionally, emerging approaches like gene therapy,\nimmunotherapies and stem cell-based treatments also hold great\npotential, although many are still in clinical trial stages (Sun and\nRoy, 2021). The development of more effective interventions and\nnovel drugs is urgently required to address the multifaceted\nchallenges posed by NDs.\nCurcumin, a natural polyphenolic compound, is primarily\nderived from the rhizomes of Curcuma longa L. (turmeric) which\nis a perennial herbaceous plant that has been extensively utilized in\ntraditional medicine and culinary practices (Rafiee et al., 2019). The\nsynthesis of curcumin has been also investigated to develop optimal\nprocedures for the rapid acquisition (Ahmed et al., 2017). The\nchemical structure is characterized by two aromatic rings linked\nby a seven-carbon chain with β-diketone functional groups,\nconferring the diverse biological activities (Figure 1). Curcumin\nexhibits a broad spectrum of pharmacological properties, including\nanti-inflammatory, antioxidant, anti-cancer and neuroprotective\neffects, making it a promising therapeutic candidate for NDs\n(Tandon et al., 2020). It can inhibit the aggregation of\npathological proteins, mitigate oxidative stress and suppresses\nneuroinflammation. Furthermore, curcumin enhances the\nexpression of neurotrophic factors and promotes autophagy,\naiding in the clearance of damaged cellular components (Gao\net al., 2020; Namgyal et al., 2021). Despite its prospective\npharmaceutical benefits, the clinical application of curcumin is\nhampered by poor bioavailability due to low solubility, structural\ninstability, rapid metabolism and fast systemic elimination. These\npharmacokinetic challenges prevent it from reaching an effective\nconcentration in target tissues. To overcome the limitations, some\nstrategies have been proposed such as the development of curcumin\nanalogs, nanoparticle-based delivery systems, liposomal\nencapsulation and the use of adjuvants like piperine (Olmos-Juste\net al., 2021; Liu et al., 2020; Zhang et al., 2018). It was demonstrated\nthat curcumin nano-formulations exhibited excellent solubility and\nstability, along with antioxidant and enzyme inhibition properties,\nas evidenced by molecular docking and simulation studies (Kanwal\net al., 2023). These approaches are of significant potential in\nimproving the efficacy and feasibility of curcumin in the\ntreatment of neurodegenerative disorders.\nIn light of the increasing interest in natural medicine for the\nmanagement of NDs, curcumin has garnered extensive attention as a\nhighly promising therapeutic agent. Some clinical studies have\nexplored the neuroprotective effects of curcumin, but their\noverall findings remain promising yet inconclusive (Table 1).\nMost trials were short-term and involved small sample sizes, with\nconsiderable dosage variability. Particularly noteworthy is the\nheterogeneity in therapeutic outcomes among studies targeting\nthe same neurodegenerative conditions, such as AD. Trials\nTABLE 1 (Continued) Clinical trials of curcumin on the effect of central nervous system.\nNo. Object Research\ntype\nFormulation/\nDosage\nGroup Duration Outcome Side effect References\nin the intervention\ngroup\nplacebo group\nreported\ngastrointestinal\nsymptoms, such as\nnausea and\nstomach pain\n7 80 patients with\ndiabetic\npolyneuropathy\nRandomized,\ndouble-blind,\nand placebo-\ncontrolled\nNano-curcumin capsules\n(curcumin 72%,\ndesmethoxycurcumin\n25%, and\nbisdemethoxycurcumin\n3%), one capsule daily\n(80 mg)\nPlacebo-40;\nIntervention-\n40\n8 weeks Significant\nreduction in the\nmean score of\ndepression and\nanxiety in the\nnano-curcumin\ngroup; changes in\nstress score were\nnot statistically\nsignificant\nStomachache was\nreported by two\npatients\nAsadi et al.\n(2019)\n8 42 ALS patients Double-blind Brainoil, a dietary\nsupplement containing\n600 mg of curcumin,\n100 mg of Coenzyme Q10,\n300 mg of Bacopa\nmonnieri, 250 mg of\nWithania somnifera,\n250 mg of Centella\nasiatica, and 1 mg of Piper\nnigrum, once daily\nGroup A-24:\nplacebo for\n3 months\n(T1), then\nBrainoil for\nthe following\n3 months\n(T2)\nGroup B-18:\nonly Brainoil\nfor 6 months\n6 months Group B: a stable\nscore of the ALS-\nFRS-r; reduced\nAOPPs; stable\nFRAP exercise\nvalues\nGroup A: FRAP\nexercise values at\nT1 were reduced\nand then increased\nat T2 with\nintroduction of\ntherapy\nGastralgia (N = 3),\ndiarrhea (N = 1),\nand skin rush\n(N = 1)\nChico et al.\n(2018)\nAD, Alzheimer’s disease; LDL, low density lipoprotein; MMSE, mini-mental state examination; GLFS, geriatric locomotive function scale; BDNF, brain-derived neurotrophic factor; Aβ,\namyloid β; IL, interleukin; TNF, tumor necrosis factor; PD, Parkinson’s disease; ALS, amyotrophic lateral sclerosis; ALS-FRS-r, revised ALS functional rating scale; AOPPs, advanced oxidation\nprotein products; FRAP, ferric reducing antioxidant power.\nFrontiers in Pharmacology frontiersin.org04\nWang et al. 10.3389/fphar.2025.1625821\n\nemploying unmodified prototype curcumin preparations showed\nnegligible differences from placebo controls, primarily due to the\ninherently low bioavailability and inadequate systemic absorption.\nThis review systematically synthesizes the knowledge on curcumin,\nincluding the pharmacological effects, underlying neuroprotective\nmechanisms, functions across specific NDs, and cutting-edge\nstrategies for bioavailability enhancement. Meanwhile, the\nlimitations of current research and the unresolved issues\nrequiring further investigation are critically discussed. These\ninsights will contribute to the advancement of novel drug\ndevelopment and the translation of curcumin-based therapies\ntoward clinical practice.\n2 Review methodology\nThe review and research articles were retrieved using relevant\nkeywords (involving curcumin, neurodegenerative diseases,\nAlzheimer’s disease, Parkinson’s disease, Huntington’s disease,\namyotrophic lateral sclerosis, toxic proteins, tau protein, β-\nAmyloid, alpha synuclein, brain, neuron, apoptosis, metal\nhomeostasis, chelation, ferroptosis, cuproptosis, mitochondria\ndamage, inflammation, oxidative stress, pharmacological effects,\nneuroprotection, antioxidation/antioxidant, anti-inflammation/\nanti-inflammatory, mechanism, signal pathway, bioavailability,\nclinical trial, and so on) from the website and databases\nincluding ScienceDirect, Google Scholar, Web of Science,\nResearchGate, and PubMed. For the included clinical studies of\ncurcumin in the treatment of neurological diseases, the necessary\ninformation was required to be reported, including the clinical trial\nregistration, the inclusion criteria of subjects, the basic information\nof drugs (source, composition, formulation type, dosage and\nadministration method), placebo, treatment time, measured\nindicators, outcomes, side effects, etc. More than 200 articles\npublished mainly from 2015 to 2025 were selected in this way.\nThen the useful information related to the topic of this paper was\nextracted and summarized from these collected references.\n3 Pharmacological effects of curcumin\n3.1 Antioxidation\nOxidative stress is a critical factor contributing to the onset and\nprogression of NDs. It arises from an imbalance between the\nproduction of reactive oxygen species (ROS) and the body’s\nantioxidant defenses (Keeney et al., 2024). ROS, such as\nsuperoxide anions, hydrogen peroxide and hydroxyl radicals, are\nbyproducts of normal cellular metabolism, particularly\nmitochondrial respiration. Under physiological conditions, ROS\nlevels are tightly regulated by endogenous antioxidant systems,\nincluding superoxide dismutase (SOD), catalase (CAT) and\nglutathione peroxidase (GPx) (Li et al., 2025). However, excessive\nROS and impaired antioxidant mechanisms will cause oxidative\ndamage to lipids, proteins, DNA and other cellular components\n(Dorszewska et al., 2023). In neurons, oxidative stress disrupts\nmitochondrial function, leading to reduced ATP (adenosine\ntriphosphate) and increased ROS, which forms a vicious cycle of\noxidative damage. Cell homeostasis is thus destroyed, and the\nmisfolding and aggregation of toxic proteins are exacerbated, like\nAβ in AD and α-syn in PD (Van Laar et al., 2020; Meng et al., 2011).\nOxidative stress induces lipid peroxidation, and impairs the\nstructural and functional integrity of cell membranes and\norganelles. Moreover, the damage to DNA caused by excessive\nROS activates apoptotic pathways to accelerate neuronal cell\ndeath (Al Olayan et al., 2020). The imbalance between ROS and\ncellular defense aggravates neuroinflammation by stimulating\nmicroglia and astrocytes to release pro-inflammatory cytokines\n(Wang et al., 2021a; Dash et al., 2025). The blood-brain barrier is\nalso impaired under such conditions, losing the ability to prevent\nperipheral immune cells and harmful molecules from infiltrating the\ncentral nervous system (CNS), which thereby accelerates\nneurodegeneration (Yang et al., 2024; Kim S. et al., 2024). The\ncumulative impact of these processes results in the gradual loss of\nneuronal structure and function, manifesting as cognitive decline,\nmotor impairments and other degenerative symptoms\nassociated with NDs.\nCurcumin exerts the antioxidant effects through multiple\npathways. Firstly, it can directly scavenge ROS and reactive\nnitrogen species, thereby reducing oxidative damage to cellular\ncomponents (Alisi et al., 2018). It is attributed to the well-\ncharacterized structural motifs (Ahmed et al., 2024). The\nchemical structure including two phenolic rings connected by a\nβ-diketone moiety enables curcumin to neutralize free radicals and\ninhibit lipid peroxidation. The activity of endogenous antioxidant\nenzymes such as SOD, CAT and GPx is enhanced by curcumin,\nwhich plays a crucial role in detoxifying ROS and maintaining\ncellular redox homeostasis (Santana-Martínez et al., 2019). In\naddition to the direct antioxidant effects, curcumin can also\nregulate the signaling pathways of antioxidant reactions to\nprotect neurons from damage (Duan et al., 2022). For instance,\nnuclear factor erythroid 2-related factor 2 (Nrf2) is a master\nregulator of antioxidant responses. Under normal conditions,\nNrf2 is sequestered in the cytoplasm by the inhibitor, Kelch-like\nECH-associated protein 1 (Keap1). When subjected to oxidative\nstress, Nrf2 translocates to the nucleus and binds to antioxidant\nresponse elements (ARE), inducing the expression of antioxidant\ngenes (Kang et al., 2024). Curcumin can promote the dissociation of\nNrf2 from Keap1 and enhance its activation to facilitate the\nupregulation of antioxidant enzymes and phase II detoxifying\nenzymes, which collectively reduce oxidative stress and\nstrengthen cellular resilience (Rathore et al., 2023). On the other\nhand, nuclear factor-kappa B (NF-κB) is a transcription factor that\npromotes the expression of pro-inflammatory cytokines and related\nenzymes such as cyclooxygenase, inducible nitric oxide synthase and\nnicotinamide adenine dinucleotide phosphate (NADPH) oxidase\n(Patel et al., 2017). Cysteine-alanine-glutamine-lysine peptide-\nmodified antioxidant nanoparticles were developed for co-\ndelivery of curcumin (C-PPS/C) to modulate oxidative and\nneuroinflammatory disturbances of mice with traumatic brain\ninjury. It was revealed that C-PPS/C nanoparticles accumulated\nat the injury site and broke the “ROS-neuroinflammation” cycle to\nprotect the blood-brain barrier and promote long-term neurological\nrecovery. The hydrophobic core of C-PPS/C composed of poly\n(propylene sulfide) can react with and scavenge ROS, while\ncurcumin release further suppressed ROS and inflammation.\nFrontiers in Pharmacology frontiersin.org05\nWang et al. 10.3389/fphar.2025.1625821\n\nMeanwhile, C-PPS/C nanoparticles were found to inhibit the NF-κB\npathway to reduce the expression of pro-inflammatory genes (Fu X.\net al., 2025). Additionally, curcumin’s ability to chelate metal ions\nlike iron and copper further contributes to the antioxidant effects, as\nthese metals are known to catalyze the production of highly reactive\nhydroxyl radicals through Fenton reactions (Cengiz et al., 2023). For\nexample, Cd exposure (2.5 mg/kg for 60 days) induced behavioral\nimpairments in mice through prefrontal cortex cellular\ninflammation and oxidative stress, as a result of the reduction of\nendogenous antioxidant enzyme activity, and the increase of pro-\ninflammatory markers (IL-6 and TNFα) and decrease of anti-\ninflammatory cytokine IL-10. Curcumin treatment\n(20–160 mg/kg for 30 days) could mitigate these behavioral and\nbiochemical impairments by reducing the neuroinflammation and\noxidative damage as well as increasing the number of viable\nprefrontal cortex neuronal cells (Namgyal et al., 2021).\n3.2 Anti-inflammation\nInflammation is triggered by body’s defense responses to stimuli\nsuch as injury and infection, and is usually conducive to tissue repair\nand pathogen clearance. Acute inflammation is always short-term\nand beneficial, but the chronic inflammation, caused by persistent\ntriggering or immune dysregulation, can damage tissues and lead to\nneurodegeneration (Zhang W. et al., 2023). Neuroinflammation is\ncharacterized by the activation of microglia and astrocytes, and the\nrelease of pro-inflammatory cytokines (Gulen et al., 2023). Microglia\nare resident immune cells in CNS, which perform the functions of\nsynaptic pruning, damage repair, homeostasis maintenance and cell\nphagocytosis. However, facing pathological stimuli such as protein\naggregates, microglia are activated and adopt a pro-inflammatory\nphenotype, leading to the release of cytokines involving interleukin-\n1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-alpha\n(TNF-α) to exacerbate neuronal impairment (Peruzzotti-Jametti\net al., 2024; Nikolopoulos et al., 2023). The activation of\nmicroglia is regulated by pattern recognition receptors (PRRs),\nincluding Toll-like receptors (TLRs) and nucleotide-binding and\noligomerization domain (NOD)-like receptors (NLRs), which can\nrecognize pathogen-associated molecular patterns (PAMPs) and\ndamage-associated molecular patterns (DAMPs) (Li and Wu,\n2021). Astrocytes are another type of glial cells related to\nneuroinflammation. In response to inflammatory signals,\nastrocytes undergo reactive astrogliosis, accompanied by cellular\nhypertrophy and the upregulation of glial fibrillary acidic protein\n(GFAP) (Lopez Rodriguez et al., 2021; Linard et al., 2023). Reactive\nastrocytes release cytokines and chemokines that further amplify the\ninflammatory response and disrupt the blood-brain barrier, allowing\nperipheral immune cells to infiltrate the CNS (Ghita et al., 2021;\nQian et al., 2023). The chronic activation of microglia and astrocytes\nleads to a self-perpetuating cycle of inflammation and\nneurodegeneration. Pro-inflammatory cytokines and ROS not\nonly damage neurons directly but also induce the misfolding and\naggregation of toxic proteins, a hallmark event of NDs. Additionally,\ninflammation destroys synaptic plasticity and inhibits the clearance\nof harmful substances to further aggravate neuronal dysfunction\n(Geng et al., 2020; Zhang et al., 2014). In summary, the activation of\nmicroglia and astrocytes, and the subsequent release of pro-\ninflammatory cytokines and ROS, create an unfavorable\nenvironment for neuronal damage and death.\nRegulating inflammatory signaling pathways and inhibiting\ninflammatory mediators are the main mechanisms of curcumin\nto achieve anti-inflammatory effects. By inhibiting the activity of the\ninhibitory kappa B kinase (IKK), curcumin prevents the\ntranslocation and activation of NF-κB, thereby reducing the\nexpression of chemokines and pro-inflammatory cytokines such\nas TNF-α, IL-1β and IL-6, which ultimately attenuates inflammatory\nresponses (Jobin et al., 1999). NOD-like receptor protein 3 (NLRP3)\ninflammasome is a protein complex involved in the development of\nimmune and inflammation-related diseases. Curcumin can directly\nrestrain the assembly of NLRP3 inflammasome, or inhibit its\nactivation by restricting the NF-κB pathway (Cai et al., 2025;\nRuan et al., 2022). T helper 17 cells (Th17), one of the targets of\ncurcumin, are an important pro-inflammatory cell that secretes IL-\n17, IL-22 and IL-23 to promote inflammation responses. On the\ncontrary, regulatory T cells (Tregs) possess prominent anti-\ninflammatory effects. The imbalance of Th17 and Tregs can lead\nto an abnormal immune response (Chaudhry et al., 2011).\nCurcumin suppresses Th17 differentiation and regulates Treg/\nTh17 rebalance by inhibiting IL-23/Th17 pathway to maintain\nimmune homeostasis. The expression of Th17 cells related\ncytokine profiles (IL-17A and RORγt) was dramatically decreased\nin curcumin-treated mice, indicating the inhibited differentiation\nand development of Th17 cells. Besides, it was demonstrated that\ntype 4 metabotropic glutamate receptor (mGluR4) was\nconstitutively expressed in mouse bone marrow-derived dendritic\ncells (BMDC), and mGluR4 siRNA-transfected BMDC tipped the\nbalance of T cell differentiation toward the Th17 phenotype.\nCurcumin upregulated mGluR4 expression in mouse BMDC,\nwhich likely contributed to the mechanism of inhibiting the\nTh17 cell differentiation (Zhao et al., 2017; Rahimi et al., 2019).\nMitogen-activated protein kinases (MAPKs) are an pivotal group of\nregulatory factors in cellular stress response. Inhibiting the MAPK\npathway is another way for curcumin to reduce the release of\ninflammatory mediators and cell apoptosis (Maugeri et al., 2023).\nIt was recently found that curcumin interacted with the Z1-type\nprotein tyrosine phosphatase receptor (PTPRZ1) to maintain the\nenzymatic activity, thereby regulating the phosphorylation of the\nm6A-reader YTH domain-containing family protein 2 (YTHDF2)\nand avoiding the overactivation of microglia (Zhang et al., 2025).\nThis process is beneficial to relieve neuroinflammation, alleviate\nbrain damage and promote neuronal repair. In addition to the above\nstrategies, curcumin inhibits inflammation-related transcription\nfactors by reducing the accumulation of ROS (Chen T. et al.,\n2024). Autophagy-related pathways (such as AMPK/mTOR) can\nbe also activated to promote the clearance of toxic protein aggregates\nand damaged cells, so as to avoid inflammation and neuronal\ndamage (Khayatan et al., 2025; Fu Y. et al., 2025).\n3.3 Apoptosis inhibition\nApoptosis, also called programmed cell death, is a highly\nregulated process that automatically eliminates damaged or\nunnecessary cells to maintain tissue homeostasis (Baar et al.,\n2017). Apoptotic cells are characterized by distinct morphological\nFrontiers in Pharmacology frontiersin.org06\nWang et al. 10.3389/fphar.2025.1625821\n\nchanges, including cell shrinkage, chromatin condensation, DNA\nfragmentation, and the formation of apoptotic bodies which are\nsubsequently phagocytosed by neighboring cells (Arvanitaki et al.,\n2024). However, when apoptosis is dysregulated as a result of\noxidative stress, neurotrophic factor deficiency, inflammatory\nresponses, and protein misfolding and aggregation, it can induce\nexcessive and premature cell death, thereby contributing to\nprogressive neuronal loss (Kumari et al., 2023; Norton et al.,\n2024). The principal factors of apoptosis program include Apaf-1\n(apoptotic protease-activating factor 1), Bcl-2 (B cell lymphoma-2)\nfamily proteins and caspases (cysteinyl aspartate-specific\nproteinases) (Qin et al., 1999). The Bcl-2 family, comprising both\nanti-apoptotic proteins (like Bcl-2 and Bcl-xl) and pro-apoptotic\nproteins (like Bax and Bak), governs apoptosis primarily by\nmodulating mitochondrial permeability. Under normal\nphysiological conditions, anti-apoptotic proteins, such as Bcl-2\nand Bcl-xl, form homodimers or multimers on the mitochondrial\nouter membrane to maintain its integrity and inhibit cytochrome c\nrelease. In contrast, pro-apoptotic Bax and Bak predominantly exist\nas inactive monomers (Edlich et al., 2011). Upon exposure to\napoptotic stimuli, Bax and Bak undergo conformational changes,\nbecome activated, and insert into the mitochondrial membrane,\nwhich then heightens mitochondrial permeability and facilitates the\nrelease of cytochrome c (Antonsson et al., 1997). The released\ncytochrome c subsequently binds to Apaf-1 to generate the\napoptosome that recruits and activates caspase-9 as well as\ndownstream effector caspases (like caspase-3/caspase-6),\nultimately executing cell death (Kim et al., 2005; Li et al., 1997).\nBcl-2 can interact with Bax to form heterodimers, thereby\nsuppressing Bax activity and cytochrome c release to block the\nsubsequent apoptotic cascade. Excessive accumulation of toxic\nproteins induces endoplasmic reticulum stress to disrupt calcium\nhomeostasis, activating the apoptotic pathway (Lim et al., 2023).\nAdditionally, neurofibrillary tangles formed by\nhyperphosphorylated tau proteins reduce their binding affinity\nwith neuronal tubulin, destabilizing microtubules and promoting\nneurodegeneration (Savastano et al., 2021; McMillan et al., 2023). By\nsecreting Il-1α, TNF and complement component subunit 1q, the\nactivated microglia induce the formation of neurotoxic reactive\nastrocytes which lose the ability to support neuronal survival,\noutgrowth, synaptogenesis and phagocytosis, leading to the death\nof neurons and oligodendrocytes (Zhang L. et al., 2023).\nFurthermore, reduced levels of neurotrophic factors, such as\nbrain-derived neurotrophic factor (BDNF), diminish the\ninitiation of anti-apoptotic process, rendering neurons more\nvulnerable to apoptosis (Zhang K. et al., 2023).\nCurcumin, on the one hand, scavenges ROS to improve\nneuronal microenvironment and prevent apoptosis; on the other\nhand, it promotes microglial polarization toward an M2 phenotype\nand inhibits M1 polarization, thereby suppressing inflammation-\ninduced apoptosis and fostering neuronal regeneration (Qian et al.,\n2024; Chen Z. et al., 2024). The expression of pro-apoptotic proteins\nCaspase 3/8/9, Bax and apoptotic peptidase activating factor 1 is\nreduced by curcumin while that of anti-apoptotic proteins Bcl-2 is\nincreased. Endoplasmic reticulum stress is mitigated by curcumin-\nmediated downregulation of Grp78 (glucose-regulated protein 78)\nand CHOP (C/EBP homologous protein) expression. This effect is\nlikely attributed to curcumin’s ability to upregulate CAT and\nglutathione reductase levels, thereby enhancing cellular\nantioxidant capacity. The resulting reduction in ROS\noverproduction helps preserve the functional integrity of\nmitochondrial respiratory chain complexes I and II (Wu et al.,\n2024). The combination of curcumin and vagus nerve stimulation\nwas found to significantly lower the neurological deficits, infract\nvolume, neural apoptosis and inflammatory cytokines release. The\nphosphorylation levels of AKT and ERK2 were both increased after\nthe combination therapy (Xu et al., 2018). Mitochondrial damage\nand dysfunction are key factors of neuron loss. Curcumin protects\nmitochondrial respiratory chain by maintaining the stability of\nmembrane potential. At the same time, mitochondrial\ndysfunction is ameliorated via promoting mitochondrial\nbiogenesis to inhibit abnormal neuronal apoptosis (Zheng et al.,\n2023). Excessive autophagy can lead to metabolic stress and\ndegradation of cellular components, which exacerbates the\nstructural destruction and functional decline of tissues (Aman\net al., 2021). It was indicated that curcumin significantly reduced\nthe level of H\n2 \nO \n2 \n-induced autophagy with a decreased expression of\nautophagy marker proteins LC3-II and Beclin-1. The ERK1/\n2 signaling pathway was also inactivated by inhibiting\nphosphorylation, thereby reducing autophagy responses and\nprotecting nerve cells from oxidative stress (Ruan et al., 2024).\nCurcumin (200 mg/kg) significantly ameliorated brain injury and\nneurological deficits in rats subjected to middle cerebral artery\nocclusion by upregulating autophagy-related proteins p-Akt and\np-mTOR, while downregulating autophagy-associated proteins\nLC3-II/LC3-I and inflammation-related proteins IL-1, TLR4, p-38\nand p-p38. However, these protective effects were attenuated when\neither LY294002 (a specific inhibitor of the PI3K/Akt/mTOR\npathway) or anisomycin (an activator of the TLR4/p38/MAPK\npathway) was administered. It was suggested that curcumin\nexhibited neuroprotective effects by modulating autophagic\nactivities via the PI3K/Akt/mTOR signaling pathway and\nsimultaneously suppressing inflammatory responses through\nregulation of the TLR4/p38/MAPK pathway (Huang et al., 2018).\nIn summary, the excessive loss of neurons is avoided by curcumin\nthrough multiple mechanisms to prevent progressive\nneurodegeneration.\n3.4 Metal chelation\nMetal ions are widely present in biological systems and\nparticipate in many key biochemical processes including material\ntransport, energy conversion, information transmission and\nmetabolic regulation (Chen et al., 2022; Maniscalchi et al., 2024).\nCommon ions, like zinc (Zn \n2+\n), magnesium (Mg \n2+\n), iron (Fe \n2+\n/Fe \n3+ \n)\nand copper (Cu \n2+\n), are co-factors of a variety of enzymes which play\nan important role in stabilizing enzyme conformation, transferring\nelectrons, and connecting enzymes and substrates in enzymatic\nreactions (Valdez et al., 2014). They are indispensable in human\nbodies. However, the imbalance of metal ions, whether deficiency or\nexcess, can lead to metabolic disorders, cell and tissue damage,\nweakened immunity and neurological dysfunction (Tian et al.,\n2024). The accumulation of metal ions promotes the production\nof hydrogen peroxide and hydroxyl radical through Fenton and\nHaber-Weiss reactions, resulting in lipid peroxidation of cell\nFrontiers in Pharmacology frontiersin.org07\nWang et al. 10.3389/fphar.2025.1625821\n\nmembrane (von Krusenstiern et al., 2023). Cellular integrity is\ndamaged by the oxidative damage of lipids, proteins and DNA\n(Khan et al., 2020). Metal ion imbalance and oxidative stress trigger\nthe overproduction of Aβ by activating β- or γ-secretases and\ninhibiting α-secretase, and also cause tau hyperphosphorylation\nby activating protein kinases, such as glycogen synthase kinase-\n3β (GSK-3β), cyclin-dependent protein kinase-5 and MAPKs, and\ninhibiting protein phosphatase 2A (Wang et al., 2020). It has been\nfound that both essential (Mn, Fe, Cu and Zn) and nonessential (Pb,\nAl and Cd) metals can accumulate in the brain and activate\nmicroglia and astrocytes to release pro-inflammatory factors\n(Domingo-Relloso et al., 2024). The inflammation and oxidative\nstress intensify each other, forming a vicious cycle. In addition, metal\nion imbalance interferes with the electron transport chain in\nmitochondria, leading to the loss of membrane potential and\nenergy metabolism disorders. The corresponding decrease in\nATP production eventually leads to cell apoptosis (Shen et al.,\n2023). Calcium ions (Ca\n2+\n) are indispensable to physiological\nactivities, which participate in the signal transduction,\nneurotransmitter release and hormone secretion. Excessive metal\nions impair Ca \n2+ \nchannels and calmodulin function, generating\nabnormally elevated intracellular calcium concentrations. The\nbreakdown of calcium homeostasis affects the synthesis, release\nand reuptake of neurotransmitters, followed by excitotoxicity and\nloss of neurons (Fan et al., 2020; Bharat et al., 2023).\nFerroptosis and cuproptosis are two specific modes of cell death\nthat depend on the exposure to iron and copper, respectively (Zou\net al., 2020; Li S. et al., 2022). The ferroptosis is characterized by iron\nmetabolism disorder, ROS accumulation, reduced glutathione levels\nand the inactivation of glutathione peroxidase 4 (GPX4). The\npresence of Fe\n2+ \nand lipoxygenases facilitates the lipid\nperoxidation of cell membranes and ultimately induces\nferroptosis (Qiu et al., 2024). Both exogenous and endogenous\npathways drive this process. Exogenous pathways rely on the\ninhibition of system Xc– (cystine/glutamate transporter) and the\nactivation of the transferrin and transferrin receptor 1, while the\nendogenous pathway mainly involves blocking the activation of\nGPX4 (Xue et al., 2023). As for cuproptosis, it is closely related to\nmitochondrial metabolism. The excess copper binds to lipase in the\nmitochondrial TCA cycle, which accelerates protein aggregation and\nproteotoxic stress, leading to cell death (Chen et al., 2022). It has\nbeen proved that changes of iron and copper homeostasis is directly\nlinked to the progression of multiple NDs, including AD, HD and\nALS (Maniscalchi et al., 2024).\nThe metal chelation of curcumin is mainly attributed to the unique\nchemical structure, including two adjacent phenolic hydroxyl groups\nand a β-diketone moiety, which enable it to form stable complexes with\nvarious metal ions through coordination covalent bonds (Mari et al.,\n2022). The oxygen atoms in phenolic hydroxyl groups provide lone pair\nelectrons to interact with positively charged metal ions, and the\ncarbonyl oxygen atoms in the β-diketone structure further enhance\nthe stability of metal-curcumin complexes by providing additional\ncoordination sites for metal ions (Moradi et al., 2020). The metal-\nchelating ability is affected by many factors, especially the pH. Under\nacidic conditions, the phenol hydroxyl groups are more readily\nprotonated, thereby increasing the affinity to metal ions (Wahyudi\net al., 2022; Rasouli and Ghavami, 2021). Neuroprotective effects are\nexerted by modulating the activity of metal-dependent enzymes,\nreducing the production of ROS, and inhibiting the aggregation of\nabnormal proteins. The chelating effect of curcumin reduces the levels\nof free metal ions and inhibits their participation in the reactions of free\nradical generation, which helps protect neurons from oxidative stress-\ninduced cell death (Namgyal et al., 2021). Additionally, the aggregation\nof toxic proteins is also reduced, slowing the progression of\nneurodegeneration. The binding of cadmium or arsenic to SOD\ndiminishes its enzymatic activity, whereas curcumin forms hydrogen\nbonds with histidine residues, thereby reducing SOD’s affinity for\narsenic and cadmium and restoring its activity (Cengiz et al., 2023).\nCerebral cortex acetylcholinesterase (AChE) and adenosine deaminase\n(ADA) activities were elevated in rats exposed to Cd (2.5 mg/kg). Co-\ntreatment with curcumin reversed these enzyme activities back to\ncontrol levels. Furthermore, Cd exposure induced an increase in\nlipid peroxidation in the cerebral cortex, accompanied by a\nreduction in functional sulfhydryl (-SH) groups and nitric oxide\n(NO), a critical neurotransmitter and neuromodulatory agent. Co-\nadministration of curcumin (12.5 or 25 mg/kg) enhanced the non-\nenzymatic antioxidant status and NO levels while simultaneously\nreducing malondialdehyde levels. Therefore, the inhibition of AChE\nand ADA activities, along with the enhancement of the antioxidant\nstatus mediated by curcumin, may provide potential mechanisms\nunderlying its cognitive-enhancing effects in Cd-induced memory\ndysfunction (Akinyemi et al., 2017). Curcumin can also improve the\ncell apoptosis caused by metal toxicity. Excessive accumulation of heavy\nmetals promoted the cleavage of poly (ADP-ribose) polymerase-1 and\ncaspase-3, suppressed Bcl-2 expression, and induced the release of\ncytochrome c and second mitochondria-derived activator of caspases\nfrom the mitochondria into the cytosol. Curcumin inhibited both early\nand late apoptosis induced by heavy metals and reversed the alterations\nin apoptotic markers. Metallothionein (MT), a cysteine-rich protein,\nplays a pivotal role in metal detoxification. Curcumin increased the level\nof MT2A mRNA and enhanced the expression of MT2. The\nantiapoptotic effects of curcumin were attenuated under MT2A\nknockdown conditions, suggesting that MT2A may be a critical\ntarget of curcumin (Wahyudi et al., 2022). Aluminum is known as a\nneurotoxic metal, which may show negative effects on the nervous\nsystem, particularly at higher concentrations (Bishop et al., 1997). The\nsymptoms include movement disorders, seizures, memory loss, learning\ndisabilities and depressive tendencies. Curcumin has the potential of\nreducing the bonding affinity of Al\n3+ \nto DNA and preventing the Al\n3+\n-\ninduced cognitive impairment (Sood et al., 2012). It can be concluded\nthe metal-chelating ability of curcumin, driven by its unique chemical\nstructure, plays a crucial role in neuroprotection by modulating enzyme\nactivity, reducing oxidative stress and inflammation, inhibiting toxic\nprotein aggregation, and alleviating metal-induced apoptosis, thereby\noffering a promising therapeutic strategy for NDs.\n4 Function of curcumin in the\ntreatment of specific NDs\n4.1 Alzheimer’s disease\n4.1.1 Pathogenesis of AD\nAlzheimer’s disease (AD) is a progressive neurodegenerative\ndisorder that accounts for 60%–80% of all dementia cases\nworldwide. The main manifestations are behavioral changes and\nFrontiers in Pharmacology frontiersin.org08\nWang et al. 10.3389/fphar.2025.1625821\n\ngradual decline of cognitive functions, which seriously affect daily\nlife (Self and Holtzman, 2023). It is estimated that over 50 million\npeople are currently living with AD, and this number is projected to\nrise to 152 million by 2050 (Long and Holtzman, 2019). The\nprevalence of AD increases with age. Approximately 5%–10% of\nindividuals over 65 years old and more than 20% of those over\n85 years old are affected. With the aging of global population, AD\nhas become a major public health challenge (Pichet Binette et al.,\n2020). Hallmark pathological features of AD are the accumulation of\nAβ plaques and neurofibrillary tangles composed of\nhyperphosphorylated tau proteins (Islam et al., 2025). Aβ plaques\nare formed due to the abnormal cleavage of amyloid precursor\nprotein by β- and γ-secretases that leads to the production and\naggregation of toxic peptides in brain. The plaques disrupt neuronal\ncommunication and trigger inflammatory responses (Pang et al.,\n2022). Tau, on the other hand, is a structural protein mainly\ndistributed in CNS, which is responsible for maintaining the\nstability of microtubules, like the “skeleton of neurons”. It\nfacilitates the efficient transport of nutrients to support the\noptimal exercise of physiological functions (Roemer-Cassiano\net al., 2025). However, in AD, tau becomes hyperphosphorylated\nto detach from microtubules and form toxic neurofibrillary tangles\nthat impair cellular transport and accelerate neuronal death (Berlind\net al., 2025). The upregulation of histone deacetylase 7 (HDAC7)\ninduces AD-like tau pathologies by deacetylating the transcriptional\nfactor EB (TFEB) and inhibiting lysosomal biogenesis in astrocytes.\nSuppressing HDAC7-TFEB signaling is promising for alleviating\nAD and other neurodegenerative disorders (Ye et al., 2025). The\nrecent findings also suggested that Aβ promoted tau spreading in\nAD by eliciting neuronal hyperactivity and hyperconnectivity\n(Roemer-Cassiano et al., 2025). These pathological changes\nprimarily affect the hippocampus and cerebral cortex, which are\ncritical regions for memory and cognitive functions.\nOxidative stress, neuroinflammation driven by activated\nmicroglia and astrocytes, mitochondrial dysfunction and genetic\nvariation are all key factors in the development of AD (Long and\nHoltzman, 2019). It has been found that mutations in the amyloid\nprotein precursor (APP), presenilin-1 (PSEN1), and presenilin-2\n(PSEN2) genes are associated with autosomal dominant early-onset\nfamilial AD, while apolipoprotein E4 (APOE4) represents the most\nsignificant genetic risk factor for late-onset sporadic AD,\ncontributing to the deposition of Aβ peptides and\nhyperphosphorylated tau proteins (Giau et al., 2019; Rao et al.,\n2025). Accumulating evidence has unveiled the bidirectional\ncommunication between gut microbiome and CNS, referred to as\nthe “microbiota-gut-brain axis” (Forner et al., 2021; Wang X. et al.,\n2019; Boehme et al., 2021). The gut microbiome regulates microglial\nmaturation and activation via short-chain fatty acids (SCFAs)\nrelease. The depletion of SCFAs stimulates the transition of cells\ntowards a pro-inflammatory state. The elevated immune activation\nis coupled with impaired hippocampal synaptic transmission, and\ncholinergic gamma oscillations (Loh et al., 2024). Akkermansia\nmuciniphila, a mucin- and SCFA-yielding intestinal\nmicroorganism, is essential for the regulation of metabolic\nhomeostasis and immune system, and propionic acid is one of\nthe main metabolites. It was revealed that propionate reduced\nmitochondrial over-division by downregulating mitochondrial\nfission protein (DRP1) via G-protein coupled receptor 41, and\nactivated PINK1/PARKIN-mediated mitophagy via GPR43 to\nmaintain mitochondrial homeostasis and improve the\npathological injury of AD (Wang Z. et al., 2025).\n4.1.2 Function of curcumin in AD\nThe strategies of curcumin to address AD mainly include the\ninhibition of Aβ aggregation and tau hyperphosphorylation, anti-\noxidation, anti-inflammation and brain-gut axis regulation (Pei\net al., 2024; Ruan et al., 2024). Curcumin directly binds to small\nAβ peptides to block the aggregation and fibril formation, which\nattenuates their destructive effect on cell membranes, thereby\nreducing cytotoxicity and improving cell survival (Chen Z. et al.,\n2024; Zhang et al., 2010). Moreover, curcumin facilitates the\nclearance of Aβ by enhancing microglial phagocytic activity and\nup-regulating Aβ-degrading enzymes. Neprilysin (NEP) is the most\nimportant Aβ-degrading enzyme. Its expression decreases with age\nand is negatively correlated with Aβ accumulation (Iwata et al., 2001;\nKim et al., 2023). The investigation of 25 curcumin analogs\nsurprisingly showed that dihydroxylated curcumin,\nmonohydroxylated demethoxycurcumin, and mono- and di-\nhydroxylated bisdemethoxycurcumin, increased NEP activity, but\ncurcumin did not. Thus, it was proposed that\npolyhydroxycurcuminoids might be better candidates than\ncurcumin as a dietary supplement in the prevention and therapy\nof AD (Chen et al., 2016). Exposing organotypic hippocampal\ncultures to Aβ, curcumin and/or LY294002, it was found that\ncurcumin treatment mitigated the Aβ-induced decline in\nsynaptophysin expression, and significantly reduced cell death.\nAβ resulted in the increase of phosphorylated (Ser45) β-catenin\nand the decrease of β-catenin immunocontent, but curcumin\nprevented this destabilization. Additionally, the neuroprotective\neffects of curcumin was inhibited by LY294002, and the\nphosphorylation/activation of Akt and the phosphorylation/\ninactivation of GSK-3β were activated, which revealed that the\nneuroprotection may involve the PI3-K pathway and β-catenin\nsignaling, a key transduction factor of Wnt signaling pathway\n(Hoppe et al., 2011). Metabolomic studies of other natural\ncompounds, have similarly identified hippocampal and cortical\nmetabolic pathways critical for counteracting Aβ-induced\nneurotoxicity, reinforcing the potential of phytochemicals in\nmulti-target AD therapies (Li H. et al, 2022). On the other hand,\ncurcumin inhibits the activation of NLRP3 inflammasomes in\nneurons and microglia to relieve neuroinflammation and reduce\nthe amyloid plaque burden in AD (Guglielmo et al., 2017; Ruan\net al., 2022). Molecular docking indicated that there were putative\nbinding sites with curcumin in microtubule-binding regions of tau.\nIt could not only inhibit the oligomerization of tau, but also\ndisintegrate preformed tau filaments (Rane et al., 2017). The\ncurcumin-primed exosomes effi\nciently penetrate blood-brain\nbarrier through receptor-mediated transcytosis to access brain\ntissues, and inhibit tau phosphorylation by activating the AKT/\nGSK-3β pathway, which holds great potential in improving targeted\ndrug delivery and restoring neuronal function (Wang H. et al.,\n2019). In the initial stage of AD, copper accumulation triggers a self-\nassembly of both Aβ40 and Aβ42 (Tian et al., 2024). Under\ninflammatory conditions, high levels of copper in serum can also\ninduce oxidative stress and promote inflammatory response. The\ndifluoroboron curcumin derivative (DF-Cur) showed highly specific\nFrontiers in Pharmacology frontiersin.org09\nWang et al. 10.3389/fphar.2025.1625821\n\nand selective recognition of Cu \n2+\n, which could serve as a diagnostic\nagent for the copper detection. Additionally, DF-Cur promoted the\nexcretion of Cu \n2+ \nand reduced its accumulation in vivo, alleviating\nthe damage to nervous system (Wang M. et al., 2021). It was\ndemonstrated that curcumin functioned as prebiotics, which\nadjusted the gut microbiota community, improved intestinal\nbarrier integrity, and prevented the release of detrimental\nmetabolites and pro-inflammatory factors. Considering the link\nbetween gut health and neurodegeneration, the treatments\ntargeting gut microbiota may be a promising strategy to address\nneuroinflammation and delay AD (Kim Y. et al., 2024; Su\nJ. et al., 2021).\nAlthough curcumin has demonstrated promising anti-AD\nactivity in cellular and murine models, consistent clinical\nevidence remains lacking. In a clinical trial involving 36 patients\nwith mild-to-moderate AD, no significant differences were observed\nbetween oral curcumin (2 or 4 g/day) and placebo after 24 weeks of\ntreatment (Ringman et al., 2012). Pretty low native curcumin\n(7.32 ng/mL) was measured in the plasma. Gastrointestinal\nadverse effects were reported in five participants from the\nintervention group. Conversely, a separate six-month randomized\ncontrolled trial revealed that a curcumin-galactomannan complex\n(400 mg twice daily) significantly improved Mini-Mental State\nExamination (MMSE) and Geriatric Locomotive Function Scale\n(GLFS) scores of AD patients compared to both placebo and\nunformulated standard curcumin, suggesting a potential delay in\ndisease progression (Das et al., 2023). This formulation positively\nmodulated serum levels of AD-specific biomarkers, including\nBDNF, Aβ42, tau protein, IL-6 and TNF-α. Notably, no adverse\neffects were reported in either the curcumin or placebo groups in\nthis trial. These findings highlight that the clinical efficacy of\ncurcumin may depend on formulation type, dosage and\nbioavailability. Further large-scale, long-term studies are\nwarranted to conclusively establish its therapeutic effects and\nsafety profile in AD populations.\n4.2 Parkinson’s disease\n4.2.1 Pathogenesis of PD\nParkinson’s disease (PD) is the second most prevalent\nneurodegenerative disorder after AD, mainly manifested as motor\ndysfunction and cognitive decline. Globally, more than 10 million\nindividuals currently suffer from PD, with a prevalence rate of 1%–\n2% among those over 65 years old (Bloem et al., 2021; Ben-Shlomo\net al., 2024). PD can be categorized into two distinct subtypes,\nfamilial (genetic) PD and sporadic PD, based on the etiological\norigins. Familial PD results from well-defined pathogenic mutations\nin associated genes (like SNCA, LRRK2, PRKN, PINK1 and DJ-1).\nThese mutations exhibit autosomal dominant or recessive\ninheritance patterns and can be transmitted across generations,\noften leading to multiple affected individuals within families. As\nfor sporadic PD which accounts for approximately 90% of cases, it\nlacks clear familial aggregation. The pathogenesis involves complex\ninteractions between environmental exposure, lifestyle and age. The\nprimary pathogenesis of PD involves the degeneration and death of\ndopaminergic neurons in midbrain substantia nigra, as well as the\npresence of abundant filamentous inclusions of α-syn in the form of\nLewy bodies and Lewy neurites (Yang et al., 2022; Mahul-Mellier\net al., 2020). As a widely expressed protein in CNS, α-syn normally\nplays a role in neuronal signal transduction and synaptic function.\nHowever, in PD, α-syn monomers undergo misfolding and\naggregate into fibrous structures that transfer between neurons\nand rapidly spread throughout brain regions, causing functional\ndamage and neuronal death (Hallacli et al., 2022). Toxic proteins\ninfiltrating the midbrain substantia nigra can trigger the demise of\ndopaminergic neurons, leading to motor symptoms such as\nbradykinesia, resting tremor, and muscle rigidity. When they\ndisseminate to the cerebral cortex, cognitive deficits like memory\ndecline, anxiety and somnipathy may emerge (Park et al., 2025).\nFAM171A2 is a key regulatory gene of progranulin, a secreted\npleiotropic glycoprotein associated with NDs (Xu W. et al., 2020).\nThe expression of FAM171A2 was found to be significantly elevated\nin PD and positively correlated with the aggregation of α-syn. The\ndomain 1 of FAM171A2 protein is tightly bound to the C-terminal\nregion of α-syn by electrostatic interaction, and the binding degree\nof FAM171A2 to pathological α-syn fibers is much stronger than\nthat of monomeric α-syn. Their combination enhances the\nendocytosis of neurons, encouraging toxic proteins to enter the\ncells (Wu et al., 2025). The endosomal sorting complex required for\ntransport (ESCRT) system is responsible for the sorting, trafficking\nand degradation of proteins and other cellular components. It is\ncritical in facilitating the degradation of ubiquitinated α-syn through\nthe endosome pathway (Nim et al., 2023). The E3 ubiquitin ligase\nListerin promotes K27-linked polyubiquitination of α-syn, directing\nit to the endosome for the subsequent degradation. It has been\nrevealed that the deletion of the Listerin gene exacerbates α\n-syn-\ninduced olfactory dysfunction and motor deficits in a mouse model\nof PD (Qin et al., 2025). Parthanatos-associated apoptosis-inducing\nfactor nuclease (PAAN), also known as macrophage migration\ninhibitory factor (MIF), is a critical member of the PD-D/E(X)K\nnuclease family that serves as a terminal executor in the parthanatos\npathway (Wang et al., 2016). Neurodegeneration is triggered by\npathological α-syn through the nuclease activity of PAAN/MIF.\nBoth genetic ablation of PAAN/MIF and the nuclease-deficient\nmutant have been demonstrated to protect against dopaminergic\nneuron loss and mitigate behavioral impairments in the α-syn\npreformed fibril mouse model of sporadic PD (Park et al., 2022).\nEpigenetic mechanisms, including DNA methylation, histone\nmodifications and non-coding RNA regulation, play significant roles\nin modulating dopamine transporter (DAT) endocytosis, a process\nimplicated in PD pathogenesis (Liang et al., 2025). While no direct\nepigenetic regulator of DAT endocytosis has been identified, DNA\nmethyltransferases can indirectly affect this process by altering the\nexpression of genes involved in key signaling pathways, such as\nprotein kinase C and D2 receptor systems (Cremona et al., 2011; Su\nand Liu, 2017). Similarly, RNA-modifying enzymes, particularly\nm6A methyltransferases, influence DAT endocytosis by regulating\nthe synthesis and functionality of associated proteins (Jiang et al.,\n2021). Histone-modifying enzymes contribute to this regulatory\nnetwork by controlling chromatin accessibility, thereby affecting\nthe expression of genes critical for endocytosis, endosome formation\nand recycling process (Wang H. et al., 2021). Collectively, these\nepigenetic modifications establish a sophisticated regulatory\nnetwork that indirectly controls the dynamics of DAT\nFrontiers in Pharmacology frontiersin.org10\nWang et al. 10.3389/fphar.2025.1625821\n\nendocytosis and recycling, representing a crucial regulatory node in\nneurotransmitter transport and PD progression.\nGenetic variation, including single nucleotide variants, small\nindels, structural variants, copy number variants and short tandem\nrepeats, is another important cause of PD, which is associated with\nabout 10% of cases (Wang C. et al., 2024; Hop et al., 2024). For\nexample, the variant of LRRK2 is a risk factor for PD in Chinese and\nKorean populations, corresponding to SNCA and MAPT genes in\nEuropeans and GBA1 in Africans (Rizig et al., 2023). SNCA is\nresponsible for encoding α-syn. Its mutation can cause the\noverexpression and aggregation of α-syn, resulting in the\nformation of Lewy bodies. The leucine-rich repeat kinase 2\n(LRRK2) is a multifunctional protein that coordinates a variety\nof cellular processes, including vesicle transport, autophagy,\nlysosomal degradation, neurotransmission and mitochondrial\nactivity (Zhu et al., 2023; Deniston et al., 2020). Gain-of-function\nmutations of LRRK2 gene trigger lysosomal dysfunction and\nabnormal cellular response to membrane damage, leading to\nvesicular transport dysfunction, neuroinflammation, accumulation\nof alpha-synuclein, mitochondrial dysfunction and ciliary loss,\nultimately leading to PD (Gustavsson et al., 2024; Simuni et al.,\n2020). In addition to the above factors, the identified mechanisms of\nPD also include oxidative stress, ferroptosis, gut dysbiosis and so on.\nTheir interaction complicates the disease and poses great challenges\nto clinical treatment and drug development (Dong-Chen et al., 2023;\nKotsiliti, 2023).\n4.2.2 Function of curcumin in PD\nUp to now, the research on curcumin in the treatment of PD has\nbeen mainly conducted at the molecular level and in mouse models.\nThere is still a lack of large-scale human experiments and convincing\nclinical evidence. Curcumin mitigates neuronal degeneration by\nblocking the histone deacetylase 6 (HDAC6)-NLRP3 signaling\npathway to suppress NLRP3 inflammasome-mediated\ninflammatory responses and counteracts α-syn-induced\nneurotoxicity (Cai et al., 2025). At the molecular level, curcumin\ndose-dependently reduces intracellular ROS, inhibits mitochondrial\nmembrane potential collapse and cytochrome c release, and\nsuppresses caspase-9/caspase-3 activation, thereby interrupting\nmitochondria-dependent apoptosis (Liu et al., 2011).\nAdditionally, by inhibiting the hyperphosphorylation of c-Jun\nN-terminal kinase, curcumin prevents the mitochondrial\ntranslocation of the pro-apoptotic factor Bax, subsequently\nreducing dopaminergic neuronal death and striatal axonal\ndegeneration (Pan et al., 2012). The coordination polymers,\ncomposed of ferric ions and curcumin at an ultrasmall nanoscale,\nexhibit blood-brain barrier permeability, which can effectively\nscavenge free radicals, inhibit neuroinflammation and restore\nmitochondrial function. These polymers significantly alleviate\noxidative stress and inflammatory states in the midbrain and\nstriatum (Cheng et al., 2022). In animal models, curcumin\ntreatment (80 mg/kg) reversed rotenone (2.5 mg/kg)-induced\nmotor coordination deficits while restoring antioxidant capacity\nand mitochondrial function. The rotenone-induced PD model\ndisplayed compromised autophagy, characterized by reduced\np62 and LC3-II expression levels which led to excessive\naccumulation of misfolded α-syn. In contrast, curcumin\npromoted the autophagic clearance of pathological α-syn by\nupregulating LC3-II expression and inhibiting the apoptotic\ncascade. Furthermore, curcumin administration upregulated\nNrf2 expression and normalized the Nrf2-Keap1 pathway,\nthereby enhancing antioxidant activity (Rathore et al., 2023). The\ncurcumin analogue-derived nanoscavenger (NanoCA) with a\ncontrolled-release property was designed to facilitate the nuclear\ntranslocation of TFEB, which activated both autophagy and\ncalcium-dependent exosome secretion to clear α-syn. Pre-\ntreatment with NanoCA has been shown to shield cell lines and\nprimary neurons from MPP \n+\n-induced neurotoxicity. Significantly, a\nnovel rapid arousal intranasal delivery system (RA-IDDS) was\ndeveloped to ensure targeted delivery of NanoCA to the brain,\nwhich provided substantial neuroprotection to alleviate behavioral\ndeficits and enhance the clearance of monomers, oligomers and\naggregates of α-syn in the midbrain (Liu et al., 2020). Emerging\nevidence suggests that the activation of the gut-brain axis through\nintestinal inflammation may contribute to PD pathogenesis, with\ngastrointestinal dysfunction representing the most common non-\nmotor symptom (Kotsiliti, 2023). In the N-methyl-4-phenyl-1,2,3,6-\ntetrahydropyridine (MPTP)-induced PD mouse model, curcumin\nintervention attenuated the reduction of tyrosine hydroxylase levels\nin both substantia nigra pars compacta and striatum, inhibited\nAIM2-mediated pyroptosis and caspase-1 activation, and\ndecreased pro-inflammatory factors and inflammatory responses\nin the intestinal tract. The gastrointestinal disorders and barrier\nfunction were improved, and motor dysfunction and dopaminergic\nneuron loss were reversed (Zhong et al., 2022; Cai et al., 2023). These\nfindings highlight curcumin’s potential as a multi-target therapeutic\nagent in PD, addressing both central and peripheral mechanisms of\nthe disease.\n4.3 Amyotrophic lateral sclerosis\n4.3.1 Pathogenesis of ALS\nAmyotrophic lateral sclerosis (ALS) is pathologically defined by\nthe degeneration of both upper and lower motor neurons followed\nby muscle denervation, atrophy and ultimately profound motor\ndisability. The annual incidence is 1.5–2.7 per 100,000 individuals,\nwith a corresponding prevalence of 3-5 per 100,000 (Xu L. et al.,\n2020). The peak period of disease onset is between 55 and 65 years\nold. Approximately 10% of ALS patients are hereditary, called\nfamilial ALS (fALS), while the remaining 90% (sALS) occur\nsporadically without apparent genetic predisposition (Van Daele\net al., 2023). Notably, the mean onset age of fALS tends to be earlier\nthan that of sALS. Cognitive impairments occur in 20%–50% of\ncases, with a subset (5%–15%) progressing to full-blown\nfrontotemporal dementia. The average survival time ranges from\n2 to 5 years post-diagnosis, and respiratory failure is the primary\ncause of mortality. About 5%–10% of individuals exhibit\nsignificantly prolonged survival exceeding 10 years (Su W. et al.,\n2021). The exact pathogenic mechanisms of ALS have not been fully\nelucidated. Potential risk factors include genetic predisposition,\nneurotoxicant exposure (organic solvents, pesticides and heavy\nmetals), chronic nutritional deficiencies, metabolic disorders,\nimmune dysregulation, viral infections and neuroinflammation\n(Newell et al., 2022; Xue et al., 2022). The widely accepted\nhypothesis proposes that motor neuron degeneration arises from\nFrontiers in Pharmacology frontiersin.org11\nWang et al. 10.3389/fphar.2025.1625821\n\nthe interaction between genetic susceptibility and environmental\nfactors, primarily through mitochondrial dysfunction and\ncytoskeletal disruption mediated by oxidative stress and\nexcitotoxicity (Zhou et al., 2023). The neurodegenerative cascade\ntypically originates at the neuromuscular junction and distal axons,\ncharacterized by early synaptic dysfunction and axonal degeneration\nthat progresses to neuronal death, ultimately causing neural\ntransmission failure and motor impairment (Berth and Lloyd,\n2023). Axonal lesions are the earliest clinical symptom and\ncrucial cause of ALS (Luan et al., 2024). Among the ALS-\nassociated genes, multiple mutations have been demonstrated to\nbe strongly correlated with axonal dysfunction (Mizielinska et al.,\n2025). The highly efficient transport system within neuronal axons is\nessential for maintaining material and energy supply, and transport\ndefects constitutes a major contributor to ALS. Kinesin, a motor\nprotein responsible for anterograde transport of organelles, vesicles,\nand protein complexes from the cell body to synaptic terminals,\ncauses transport disruption when mutated. Conversely, the dynein\nmediates retrograde transport of various cargoes, and ALS-related\nmutations lead to transport abnormalities, axonal swelling and\nultimately motor neuron degeneration (Cristofani et al., 2017).\nAdditionally, the change of tubulin can destabilize microtubule\nnetworks, which also impairs axonal transport (Fumagalli\net al., 2021).\nThe abnormal accumulation of proteins in motor neurons is a\nhallmark pathological feature of ALS, mainly including transactive\nresponse DNA-binding protein 43 (TDP-43), fused in sarcoma (FUS),\nSOD1 and sequestosome 1 (SQSTM1). RNA-binding proteins,\nparticularly TDP-43, play a key role in protein aggregation. TDP-\n43 aggregates are found in over 90% of ALS cases (Lepine et al., 2022).\nMost disease-causing mutations in these proteins occur in low-\ncomplexity domains mediating liquid-liquid phase separation to\nalter protein conformation, which promotes the aggregation and\ndisrupts RNA regulation while also generating additional toxicity.\nNotably, many protein aggregates also present in neuronal axons,\nsuch as mutated TDP-43 and FUS, resulting in abnormal RNA\ntransport and dysregulated protein synthesis (Marrone et al.,\n2019). SOD1 was the first identified ALS-associated gene, and\nmutations alter the protein conformation to expose hydrophobic\nsurfaces and facilitate the aggregation (Wang L. et al., 2024).\nC9ORF72 (chromosome 9 open reading frame 72) is another core\ngenetic contributor to ALS. The expansion of a G4C2 (GGGGCC)\nhexanucleotide repeat in the non-coding region leads to the\nproduction and accumulation of dipeptide repeat proteins in\nneurons (Maor-Nof et al., 2021). In addition, SOD1, C9ORF72,\nTDP-43 and FUS are also crucial molecular players associated with\nmitochondrial defects in ALS. The SOD1 G93A mutation results in its\naccumulation within axons and significantly impedes mitochondrial\ntrafficking. Furthermore, SOD1 G93A may form pathogenic\ncomplexes with Bcl-2 to potentiate cytochrome c release and\nsubsequent activation of apoptotic pathways (Pedrini et al., 2010).\nOther SOD1 mutants, including A4V, H46R, D90A and R115G, have\nbeen also found to disrupt proteostasis, diminish mitochondrial\nmembrane potential and compromise ATP generation (Rasouli\net al., 2018). The poly-dipeptides derived from\nC9ORF72 hexanucleotide expansions exhibit high affinity for\nmitochondrial proteins, thereby impairing mitochondrial structural\nintegrity and intracellular transport dynamics, as well as Ca\n2+ \nuptake\nand ATP synthesis (Fumagalli et al., 2021). Pathogenic mutations in\nTDP-43, like Q331K and M337V, interfere with the microtubule-\ndependent mitochondrial transport system, leading to profound\nmitochondrial dysfunction. Excessive TDP-43 can also induce\nmitochondrial DNA leakage into the cytosol, which activates NF-\nκB and type I interferon pathways that drive neuroinflammatory\nresponses (Yu et al., 2020). In summary, aberrant protein changes are\ncrucial of ALS. Nevertheless, the distinct aggregation behaviors\nunderscore the multifaceted nature of the pathology and present\nformidable challenges for therapeutic development.\n4.3.2 Function of curcumin in ALS\nCurcumin is recommended as a dietary supplement to reduce\nthe risk of ALS (D’Antona et al., 2021). However, to date, research\non its therapeutic potential in ALS remains limited (de Oliveira et al.,\n2016). Both mutant and wild-type TDP-43 elevate neuronal\nexcitability, with mutant TDP-43 exhibiting greater toxicity. The\nhyperexcitability is accompanied by oxidative stress and\nmitochondrial dysfunction. Treatment with dimethoxy curcumin\n(DMC) significantly normalizes aberrant action potentials and\nvoltage-gated sodium (Nav) channel activity, indicating a\ndropping-excitability state. The rescue involves DMC-mediated\nmitigation of oxidative stress and restoration of mitochondrial\nfunction (Dong et al., 2014). Men and postmenopausal women\nshow a higher incidence and more severe progression of ALS and\nFTLD (frontotemporal lobar degeneration) compared to younger\nwomen, pointing to a key role for sex hormones in disease\ndevelopment (McCombe and Henderson, 2010). In Prp-TDP-\n43 \nA315T \nmice, dysregulated expression of estrogen-related enzymes\n(CYP19A1 and CYP3A4) was observed relative to wild-type\ncontrols, which suggested that toxic phosphorylated TDP-43\noligomers may disrupt the balance between CYP19A1 and\nCYP3A4 expression, resulting in reduced estrogen biosynthesis\nand accelerated degradation. Remarkably, oral administration of\nsolid lipid curcumin particles (SLCP) improved survival in female\nPrp-TDP-43 \nA315T \nmice and diminished pathological TDP-43\ndeposits. The treatment also mitigated TDP-43-driven\nneurodegeneration by regulating estrogen production and\nCYP450 enzyme activity. These findings highlight SLCP as a\npotential estrogen replacement therapy for ALS and FTLD\n(Majumder et al., 2025). Curcumin shows enhanced binding\naffinity for mutant proteins compared to the native form,\nprimarily through increased hydrophobic interactions (Srinivasan\nand Rajasekaran, 2016). By targeting amyloidogenic regions,\ncurcumin blocks SOD1 fibrillation and promotes the formation\nof smaller and disordered aggregates. While pre-fibrillar and fibrillar\nSOD1 aggregates exhibit significant toxicity, this effect is absent in\ncurcumin-treated samples, suggesting its ability to neutralize\nharmful intermediates (Bhatia et al., 2015). Additionally,\ncurcumin potently inhibits FUS liquid-liquid phase separation by\nsuppresses droplet formation and stress granule assembly. Based on\nhydrophobic interactions, it reduces FUS β-sheet content, mitigates\naberrant aggregation, and rescues cellular metabolic dysfunction by\nreversing FUS-induced sequestration of pyruvate kinase and\nrestoring ATP production. (Shi et al., 2023). These properties\nposition curcumin as a promising candidate for ALS, but further\ninvestigation is still warranted to fully elucidate its efficacy and\nmechanism of action.\nFrontiers in Pharmacology frontiersin.org12\nWang et al. 10.3389/fphar.2025.1625821\n\n4.4 Huntington’s disease\n4.4.1 Pathogenesis of HD\nHuntington’s disease (HD) is an autosomal dominant\nneurodegenerative disorder characterized by progressive motor\ndysfunction, cognitive decline and psychiatric disturbances, which\ntypically manifests in mid-adulthood with an average age of\n30–50 years old (Ling et al., 2025; Eddy et al., 2016). It has been\nreported across diverse ethnic populations, with the highest\nprevalence observed in Caucasian populations (10.6–13.7/\n100,000). In contrast, Asian populations including those in Japan,\nTaiwan (China) and Hong Kong (China) demonstrate substantially\nlower prevalence (0.1–0.7/100,000), suggesting potential genetic\nand/or environmental modifying factors (Wise, 2010; Buchanan\net al., 2023). The disease is invariably fatal, with a life expectancy of\n15–20 years after symptom onset. The neuropathological features of\nHD are selective and massive degeneration of medium spiny\nneurons (MSNs) in the striatum, and mild degeneration of\ncortical pyramidal neurons, accompanied by astrocyte\nproliferation (Wright et al., 2020). It arises from an abnormally\nexpanded CAG trinucleotide repeat encoding the elongated\npolyglutamine (polyQ) within exon 1 of Huntingtin (HTT) gene,\nwhich results in the production of toxic mutant huntingtin proteins\n(mHTT) that accumulate in neurons, particularly in the striatum\nand cortex (Genetic Modifiers of Huntington’s Disease Consortium,\n2019). In healthy individuals, the HTT gene normally contains 10 to\n35 CAG trinucleotide repeats, while HD patients exhibit more than\n36 repeats. Emerging evidence indicates that pronounced neurotoxic\neffects manifest only when CAG repeats exceed 150 copies. These\nexceptionally large repeat expansions demonstrate striking cellular\nspecificity, being predominantly localized to MSNs (Matlik et al.,\n2024). Upon exceeding 150 CAG repeats, MSNs undergo\nprogressive loss of neuronal characteristics while concurrently\nupregulating senescence-related and pro-apoptotic gene\nprograms, culminating in neuronal degeneration. Notably, MSNs\nmaintain stable gene expression profiles when CAG repeat lengths\nremain below the critical threshold (Handsaker et al., 2025). Longer\nCAG repeats are correlated significantly with earlier onset age and\nmore severe clinical manifestations (Genetic Modifiers of\nHuntington’s Disease Consortium, 2019).\nGenome-wide association studies have identified potential\ngenetic modifiers, including mismatch-repair (MMR) genes\n(MSH3, MLH1, PMS1 and PMS2) and other DNA repair genes\n(FAN1 and LIG1) (Aldous et al., 2024). The MMR system comprises\nspecialized protein complexes with distinct functions: MutSβ\n(MSH2-MSH3 heterodimer) primarily recognizes large insertion-\ndeletion loops (IDLs) and repetitive sequence extrusions, whereas\nMutSα (MSH2-MSH6 heterodimer) detects smaller 1-2 bp IDLs\n(Ferguson et al., 2024). Following mismatch recognition, MutS\ncomplexes recruit specific MutL heterodimers including MutLα\n(MLH1-PMS2), MutLβ (MLH1-PMS1) and MutLγ (MLH1-\nMLH3) (Dai et al., 2021; Ortega et al., 2021). While MutLα and\nMutLγ possess critical endonuclease activities essential for MMR\ninitiation, the biological role of MutLβ remains enigmatic due to\nthe lack of demonstrated nuclease activity. The knockout of MMR\ngenes (MSH3, PMS1, MSH2 and MLH1) ameliorates both early-\nonset phenotypes in MSNs and late-onset manifestations in\ncortical neurons, including somatic CAG-repeat expansion,\ntranscriptionopathy and mHTT aggregation (Moss et al., 2017).\nMSH3 deficiency specifically improves open-chromatin\ndysregulation in neurons. The rapid linear expansion rate of\nCAG repeats in MSNs is sharply reduced or terminated by MMR\nmutants. The deficiencies in either MSH3 or PMS1 effectively\nprevent mHTT aggregation by maintaining somatic CAG repeat\nlengths below the critical threshold of 150 repeats (Wang N. et al.,\n2025). Moreover, MSH3 deficiency demonstrates comprehensive\ntherapeutic potential by correcting synaptic dysfunction, astrocytic\nabnormalities and locomotor deficits in HD mice (Bunting et al.,\n2025). These findings establish that MSH3 and PMS1 play pivotal\nroles in driving accelerated somatic mHTT CAG expansion rates\nspecifically in HD-vulnerable neurons, underlying the repeat length-\ndependent, threshold-sensitive, selective and progressive\npathogenesis in vivo.\nTDP-43 is a DNA/RNA-binding protein essential for splicing\nregulation. TDP-43 and the N6-methyladenosine (m6A) writer\nprotein METTL3 are upstream regulators of exon skipping in\nHD (Mendel et al., 2018). TDP-43 exhibits disrupted nuclear\nlocalization and accumulates in the cytoplasm in a\nphosphorylated form in HD mouse and human brains. Notably,\nTDP-43 co-localizes with mHTT nuclear aggregates, suggesting a\npotential interaction within pathological inclusion bodies (Sanchez\net al., 2021). The binding of TDP-43 to RNAs encoding HD-\nassociated genes, many of which are differentially expressed and\naberrantly spliced, is significantly reduced. Concurrently, m6A RNA\nmodifications are diminished on RNAs that are abnormally\nexpressed in the striatum, particularly at clustered sites near\nTDP-43 binding regions (Yu et al., 2018). The spatial and\nfunctional overlap between reduced m6A marks and impaired\nTDP-43-RNA interactions suggests a synergistic mechanism: the\nloss of METTL3-mediated m6A modifi\ncation may destabilize RNA-\nprotein complexes, exacerbating the inability of TDP-43 to regulate\nsplicing fidelity (Tollervey et al., 2011). These findings support TDP-\n43 dysfunction and altered m6A modification converge to drive\nalternative splicing defects in HD (Nguyen et al., 2025). It has been\nalso unveiled that the adenosine can be methylated to N \n1 \n-\nmethyladenosine (m1A) by the enzyme TRMT61A, while m1A\ncan be demethylated by ALKBH3. The m1A/adenosine ratio in\nCAG repeat RNA exhibits a positive correlation with repeat length, a\nphenomenon attributed to the reduced expression of\nALKBH3 elicited by the repeat RNA. TDP-43 binds directly and\nwith high affinity to m1A in RNA, which promotes the cytoplasmic\nmis-localization and subsequent formation of gel-like aggregates\n(Sun et al., 2023).\n4.4.2 Function of curcumin in HD\nAlthough multiple cellular events, including oxidative stress,\nmitochondrial dysfunction, neuroinflammation and transcriptional\ndysregulation, have been identified in HD, the development of\neffective therapies with favorable safety profiles remains an\nunmet medical need (Elifani et al., 2016). Curcumin\ndemonstrated potent anti-aggregation effects in yeast,\nsignificantly inhibiting the formation of both htt72Q-GFP (a\npolyglutamine-rich protein) and Het-s-GFP (a non-polyglutamine\nprotein) aggregates. It was found that curcumin prevented htt72Q-\nGFP aggregation through the downregulation of Vps36, a crucial\ncomponent of the ESCRT-II complex. On the other hand, it also\nFrontiers in Pharmacology frontiersin.org13\nWang et al. 10.3389/fphar.2025.1625821\n\nexhibited disaggregation activity, effectively disrupting pre-formed\nhtt72Q-GFP aggregates (Verma et al., 2012). Curcumin treatment\nenhances mitochondrial function by upregulating the activity of\nelectron transport chain complexes and elevating cytochrome levels.\nThis restoration is accompanied by increased glutathione content\nand SOD activity, indicating improved redox homeostasis.\nFurthermore, curcumin administration significantly attenuates\nmitochondrial swelling, reduces lipid peroxidation and protein\ncarbonyl formation, and decreases ROS production in HD rats\n(Sandhir et al., 2014). These protective effects are mediated partly\nthrough the activation of Nrf2 antioxidant pathway, leading to\nmarked improvements in neuromotor coordination (Santana-\nMartínez et al., 2019). The CAG140 knock-in (KI) mouse model\nexhibits abnormal mHTT aggregates, striatal transcriptional deficits,\nand early-onset motor, cognitive and affective impairments.\nCurcumin-supplemented KI mice showed reduced mHTT\naggregation and upregulated mRNA expression of striatal\nDARPP-32 and dopamine receptor D1, which were accompanied\nby behavioral recovery, particularly in rearing deficits (Hickey et al.,\n2012). Curcumin enhanced the phagocytic activity by upregulating\nthe expression of key phagocytic receptors in HD flies, while\nsimultaneously suppressing the transcriptional expression of pro-\ninflammatory cytokines and anti-microbial peptides (Dhankhar\net al., 2023). It was found that curcumin normalized body weight\nand restored lipid and carbohydrate homeostasis. The treatment also\nreduced elevated ROS levels in adipose tissue and significantly\nimproved both survival rates and locomotor function, even at\nadvanced disease stages (Aditi et al., 2022). A recent study\nelucidated the mechanism of curcumin modulating the\naggregation of huntingtin exon 1. Under substoichiometric\namounts, curcumin was found to perturb primary and/or\nsecondary nucleation events, thereby extending the lag phase\npreceding aggregation. Notably, this disruption of the aggregation\nkinetics not only altered the structural properties of the resulting\naggregates but also their cellular metabolic profiles. When applied to\nneuronal cells, the “break-through” aggregates, formed in the\npresence of curcumin, induced markedly lower cellular stress\ncompared to those generated without the inhibitor. It was\nbelieved that the differential effect was attributed to structural\nmodifications, particularly the presence or absence of the\npolyglutamine (polyQ) β-hairpin conformation in the aggregates\n(Jain et al., 2025).\n5 Strategies to enhance the\nbioavailability and pharmacological\nefficacy of curcumin\n5.1 Poor bioavailability of curcumin\nAlthough curcumin has demonstrated excellent\npharmacological activities, the extremely low bioavailability\nsignificantly restricts its clinical application in disease prevention\nand treatment. After a single oral dose of 10 or 12 g of curcumin for\n0.25–72 h, almost no free form is detectable in human plasma\n(Vareed et al., 2008). Achieving health-promoting effects often\nrequires long-term intake of high doses of curcumin, which may\nlead to adverse reactions and poor compliance. The low\nbioavailability is attributed to multiple factors, including poor\nsolubility, low stability, inefficient absorption and rapid\nmetabolism and excretion (Sabet et al., 2021). Curcumin exhibits\npoor stability in aqueous solutions and degrades rapidly in a pH-\ndependent manner. Its half-life ranges from approximately\n100–200 min at pH 3–6.5, but sharply decreases to 1–9 min at\npH 7.2–8.0. Notably, the biological activity of the hydrolysis\nproducts is generally lower or negligible. The primary absorption\nsite of curcumin in the gastrointestinal tract (GIT) is the small\nintestine (Luo et al., 2022). As a lipophilic polyphenolic compound,\ncurcumin is difficult to be absorbed by small intestinal epithelial\ncells. Even when absorbed, its hydrophobic nature often leads to\nefflux back into the intestinal lumen via the P-glycoprotein\ntransporter, which is highly expressed in the intestine\n(Culbertson and Liao, 2025). This process significantly reduces\ncurcumin’s entry into the bloodstream. Following oral\nadministration, curcumin undergoes rapid metabolism, including\nreduction (Phase I metabolism) and conjugation (Phase II\nmetabolism) in GIT and liver. Enzymes like NADPH reductase\nmetabolize curcumin into various products, including\ndihydrocurcumin, tetrahydrocurcumin, hexahydrocurcumin and\noctahydrocurcumin (Metzler et al., 2013). Additionally, gut\nbacteria, like Escherichia coli, can catalyze curcumin reduction\nthrough a unique bacterial enzyme, CurA (NADPH-dependent\ncurcumin/dihydrocurcumin reductase), resulting in the\nproduction of dihydrocurcumin and tetrahydrocurcumin\n(Hassaninasab et al., 2011). The two phenolic groups of\ncurcumin also make it susceptible to Phase II detoxifying\nenzymes, such as glucuronosyltransferases and sulfotransferases,\nleading to the formation of glucuronide and sulfate conjugates\n(Pan et al., 1999). These metabolites possess significantly reduced\nbiological activity compared to curcumin itself. Conventional tablet\nor powder formulations release curcumin quickly in the GIT but fail\nto address the poor solubility and metabolic challenges. Non-oral\nroutes, such as intravenous injection, can bypass some of these\nissues; however, curcumin tends to aggregate or precipitate in the\nbloodstream, raising safety concerns. Therefore, improving\ncurcumin’s bioavailability remains a critical challenge for its\ntherapeutic potential.\n5.2 Nano-delivery systems\nTo overcome the above limitations, several strategies have been\ndeveloped to enhance the utilization efficiency and pharmacological\nefficacy of curcumin, focusing on nanoparticle formulations,\nchemical modification, novel delivery systems and drug\ncombination. Particle size is closely related to drug solubility.\nNanoparticle-based formulations, including nanoemulsions,\nmicelles, liposomes and solid dispersions, are widely used to\nimprove curcumin’s solubility and bioavailability (Xu et al., 2024;\nOlmos-Juste et al., 2021). Through non-covalent interactions,\ncurcumin (Cur) and poly (−)-epigallocatechin-3-gallate (pEGCG)\nwere co-encapsulated within hyaluronic acid (HA) to form HA-\nCurNPs nanoparticles that exhibited sustained-release properties\n(Chen T. et al., 2024). The released drugs synergistically scavenged\nROS and inhibited apoptosis while modulating CD74 to promote\nmicroglial polarization toward the M2 phenotype, thereby\nFrontiers in Pharmacology frontiersin.org14\nWang et al. 10.3389/fphar.2025.1625821\n\nalleviating neuroinflammation and enhancing neurogenesis.\nAdditionally, these nanoparticles effectively maintained neuronal\nintegrity, reduced glial scarring, and ultimately restored electrical\nsignaling and motor functions at injury sites. To overcome the\nblood-brain barrier, curcumin-loaded polysorbate 80-modified\ncerasome nanoparticles (CPC NPs, ~110 nm) were developed,\ncoupled with ultrasound-targeted microbubble destruction\n(UTMD) to enhance brain targeting (Zhang et al., 2018). The\nnanohybrid cerasomes demonstrated superior stability against\nsurfactant solubilization and extended circulation time. The\ncombined CPC NPs-UTMD approach achieved 1.7-fold greater\nbrain permeation compared to CPC alone at 6 h post-\nadministration. In MPTP-induced PD models, this strategy\neffectively delivered curcumin to the striatum, clearing α-syn\naggregates and restoring normal motor function, dopamine levels\nand tyrosine hydroxylase expression. This novel delivery system\nwith higher therapeutic relevance and fewer unwanted\ncomplications could be a promising choice for PD treatment.\nLiposomes, composed of phospholipid bilayers, can encapsulate\ncurcumin, enhancing its hydrophilicity and mimicking cell\nmembranes to promote transmembrane absorption (Fernandes\net al., 2021). PEGylation of liposomes further reduces the\nclearance of the reticuloendothelial system and prolongs systemic\ncirculation. Solid dispersions, such as those prepared with\npolyvinylpyrrolidone or poloxamer, increased curcumin’s\nsolubility and stability by converting crystalline forms into\namorphous structures (Yang et al., 2023). However, low\nencapsulation efficiency, complex preparation processes and\ninstability persist as challenges in nanoparticle-based systems.\n5.3 Chemical structure modification\nChemical structure modification, including synthesizing analogs\nand designing prodrugs, is another effective approach. Curcumin\npredominantly exists in the bis-keto form in acidic to neutral\nconditions (pH 3–7), stabilized by an acidic proton on the\nactivated interaromatic carbon. Conversely, under alkaline\nconditions (pH > 8), the enolic form becomes predominant,\nconferring electron-donating properties (Genchi et al., 2024). The\nβ-diketone moiety, responsible for keto-enol tautomerism, can be\nmodified to enhance its antioxidant activity. 3,5-bis(2-\nfluorobenzylidene)piperidin-4-one (EF24) demonstrated potent\nNF-κB suppression by directly inhibiting IKK (Kasinski et al.,\n2008). EF24 blocked TNF-α-induced IκB phosphorylation and\ndegradation, with in vitro studies confirming the inhibition of\nIKK catalytic activity. These findings identified IKK as the\nmolecular target of EF24 and elucidated its superior efficacy\ncompared to curcumin prototype. Prodrugs are\npharmacologically inactive derivatives that are metabolized into\nactive forms within the body. Common modifications involve\nesterification, etherification, hydrazone and disulfide bond\nformation. For example, curcumin linked to glutaric acid via an\nester bond showed improved water solubility, while curcumin\nconjugated with poly (lactic-co-glycolic acid) enabled controlled\nrelease, enhancing cellular uptake (Muangnoi et al., 2018; Sampath\net al., 2014). In addition, co-loading curcumin with doxorubicin in\npH-sensitive nanoparticles has demonstrated enhanced\nbioavailability and reduced systemic toxicity (Zhang et al., 2016).\nSome prodrugs require specific enzymes or endogenous compounds\nfor hydrolysis, such as the carboxylesterases including\nacetylcholinesterase, butyrylcholinesterase and arylesterase that\nare critically involved in the bioconversion of ester-based\nprodrugs into pharmacologically active forms (Liederer and\nBorchardt, 2006). Due to the substrate specificity of different\nesterases, the enzymatic consideration should be systematically\nincorporated into the early design stage.\n5.4 Combination drug therapy\nCombination therapies aim to improve curcumin bioavailability\nby inhibiting its inactivation and metabolism. Curcumin is primarily\nmetabolized by UDP-glucuronosyltransferases and\nsulfotransferases. Natural compounds such as piperine, quercetin\nand silymarin have been shown to inhibit curcumin\nglucuronidation, thereby increasing its plasma levels and oral\nbioavailability (Grill et al., 2014; Rinwa and Kumar, 2013).\nSynergistic effects have also been observed when curcumin is\ncombined with other bioactive compounds-naringenin, genistein\nand epigallocatechin gallate (Ghobadi and Asoodeh, 2023). For the\nrats administered either curcumin (25 or 50 mg/kg) or a\ncombination of curcumin (25 mg/kg) with piperine (2.5 mg/kg)\nonce daily for 21 consecutive days prior to 3-Nitropropionic acid\nadministration (3-NP, a neurotoxin inducing symptoms of\nHuntington’s disease), it was found that both curcumin\nmonotherapy and the curcumin-piperine combination\ndemonstrated protective effects against 3-NP-induced motor\ndeficit, biochemical alterations and neurochemical abnormalities.\nThe combination treatment showed greater neuroprotection\ncompared to curcumin alone, suggesting piperine as a\nbioavailability enhancer of curcumin (Singh et al., 2015). In the\nclinical trial involving 48 AD patients, there was no remarkable\ndifferences between the unformulated standard curcumin treatment\nand the placebo group. However, the curcumin-galactomannan\ncomplex significantly improved the MMSE and GLFS scores of\nthe participants as well as the serum levels of specific biomarkers\n(Das et al., 2023).\n6 Conclusion and prospect\n6.1 Conclusion\nNeurodegenerative diseases represent a significant threat to\npublic health, exacerbated by the global aging population. The\npathogenesis of NDs, such as AD, PD, HD and ALS, is complex\nand multifactorial, involving oxidative stress, neuroinflammation,\nmitochondrial dysfunction and protein misfolding/aggregation.\nThese pathological processes lead to progressive neuronal loss\nand subsequent neurological dysfunction. Curcumin, a natural\npolyphenolic compound, has emerged as a promising therapeutic\ncandidate for NDs due to its excellent biological properties,\nincluding potent antioxidant, anti-inflammatory, anti-apoptotic\nand neuroprotective effects. It has been shown to scavenge ROS,\ninhibit pro-inflammatory pathways, reduce the accumulation and\nFrontiers in Pharmacology frontiersin.org15\nWang et al. 10.3389/fphar.2025.1625821\n\ntoxicity of misfolded proteins, and promote neuronal survival and\nregeneration. To overcome the limitations of curcumin’s low\nbioavailability in clinical applications, various strategies have also\nbeen developed to enhance the utilization efficiency and\npharmacological efficacy, including nano-delivery systems,\nchemical modifications and combination therapies. In vitro\nexperiments and a small number of clinical studies have\nconfirmed the role of curcumin-related preparations in alleviating\nneurodegeneration and delaying disease progression. This approach\nis considered an additional option for managing the health issues\narising from the global demographic shift toward an aging\npopulation.\n6.2 Future prospect\nAlthough curcumin has demonstrated potential neuroprotective\neffects, it is important to highlight that the clinical transformation\nstill encounters numerous challenges and requires further\ninvestigation: (1) Most curcumin formulations used in current\nstudies are complex mixtures primarily consisting of curcumin,\ndemethoxycurcumin and bisdemethoxycurcumin. Moreover,\nsignificant variations exist across studies regarding the source,\npurity, and formulation of curcumin, complicating the\ncomparison of clinical outcomes. To address this issue,\nstandardized quality control protocols for curcumin preparations\nshould be established to minimize batch-to-batch inconsistencies.\n(2) Clinical evidence remains inconsistent, with some trials\nreporting limited efficacy, potentially due to inadequate dosing,\nsuboptimal trial design (e.g., insufficient sample size or duration),\nor patient heterogeneity. Additionally, high doses may induce\ngastrointestinal discomfort, and the potential hepatorenal toxicity\nnecessitates further evaluation. Large-scale and long-term clinical\ntrials are essential to resolve these concerns. (3) While curcumin\nexhibits a broad spectrum of molecular targets, its pleiotropic effects\ncomplicate the elucidation of precise mechanisms of action, thereby\nhindering targeted therapeutic applications. (4) Despite various\nstrategies proposed to enhance curcumin’s bioavailability and\ntherapeutic efficacy, the in vitro-in vivo correlation of cell\ncytotoxicity and bioavailability remains poorly understood,\nwarranting additional human studies. (5) A comprehensive\nassessment of the safety, stability and long-term effects of\nexcipients and polymers utilized in novel delivery systems is\nrequired. Current in vitro and animal models inadequately\nreplicate the complexity of human gastrointestinal absorption,\nlimiting their predictive value for drug behavior in humans.\nFurther research into pharmacokinetics, pharmacodynamics and\noptimal delivery strategies is necessary for successful clinical\napplication. (6) Integrating curcumin with complementary\ntherapies, such as lifestyle modifications, dietary interventions\nand physical activity, holds promise for improving outcomes in\nNDs. Incorporating curcumin into comprehensive treatment\nregimens could potentially slow ND progression and enhance life\nquality, addressing the growing global health challenge.\nAuthor contributions\nGW: Resources, Writing – original draft, Investigation,\nMethodology. XZ: Investigation, Writing – review and editing,\nResources. XP: Resources, Writing – review and editing. KM:\nResources, Writing – review and editing. LL: Writing – review\nand editing, Resources. YS: Writing – review and editing,\nResources. DH: Resources, Conceptualization,\nWriting – review and editing. XW: Funding acquisition,\nSupervision, Project administration, Writing – review and\nediting, Conceptualization.\nFunding\nThe author(s) declare that financial support was received for the\nresearch and/or publication of this article. This work was supported\nby the Science and Technology Plan Project of Inner Mongolia\nAutonomous Region, China (2021GG0130), and Natural Science\nFoundation of Inner Mongolia Autonomous Region of China\n(2024MS08051).\nConflict of interest\nThe authors declare that the research was conducted in the\nabsence of any commercial or financial relationships that could be\nconstrued as a potential conflict of interest.\nGenerative AI statement\nThe author(s) declare that no Generative AI was used in the\ncreation of this manuscript.\nPublisher’s note\nAll claims expressed in this article are solely those of the authors\nand do not necessarily represent those of their affiliated\norganizations, or those of the publisher, the editors and the\nreviewers. Any product that may be evaluated in this article, or\nclaim that may be made by its manufacturer, is not guaranteed or\nendorsed by the publisher.\nReferences\nAditi, K., Singh, A., Shakarad, M. N., and Agrawal, N. (2022). Management of altered\nmetabolic activity in drosophila model of huntington’s disease by curcumin. Exp. Biol.\nMed. 247 (2), 152–164. doi:10.1177/15353702211046927\nAhmed, M., Abdul Qadir, M., Imtiaz Shafiq, M., Muddassar, M., Hameed, A.,\nNadeem Arshad, M., et al. (2017). Curcumin: synthesis optimization and in silico\ninteraction with cyclin dependent kinase. Acta Pharm. 67 (3), 385–395. doi:10.1515/\nacph-2017-0023\nAhmed, M., Basheer, S., AL Mughram, M. H., Iqbal, D. N., Qamar, S., Saeed,\nA., et al. (2024). Structural development of curcumin: a natural product arsenal\nfor diverse therapeutic targets-seizing opportunities through serendipity and\nFrontiers in Pharmacology frontiersin.org16\nWang et al. 10.3389/fphar.2025.1625821\n\nrational design. J. Mol. Struct. 1324, 140815. doi:10.1016/j.molstruc.2024.\n140815\nAkinyemi, A. J., Okonkwo, P. K., Faboya, O. A., Onikanni, S. A., Fadaka, A., Olayide,\nI., et al. (2017). Curcumin improves episodic memory in cadmium induced memory\nimpairment through inhibition of acetylcholinesterase and adenosine deaminase\nactivities in a rat model. Metab. Brain Dis. 32 (1), 87–95. doi:10.1007/s11011-016-\n9887-x\nAldous, S. G., Smith, E. J., Landles, C., Osborne, G. F., Cañibano-Pico, M., Nita, I. M.,\net al. (2024). A CAG repeat threshold for therapeutics targeting somatic instability in\nhuntington’s disease. Brain 147 (5), 1784–1798. doi:10.1093/brain/awae063\nAlisi, I. O., Uzairu, A., Abechi, S. E., and Idris, S. O. (2018). Evaluation of the\nantioxidant properties of curcumin derivatives by genetic function algorithm. J. Adv.\nRes. 12, 47–54. doi:10.1016/j.jare.2018.03.003\nAl Olayan, E. M., Aloufi, A. S., Alamri, O. D., El-Habit, O. H., and Abdel Moneim, A.\nE. (2020). Protocatechuic acid mitigates cadmium-induced neurotoxicity in rats: role of\noxidative stress, inflammation and apoptosis. Sci. Total Environ. 723, 137969. doi:10.\n1016/j.scitotenv.2020.137969\nAman, Y., Schmauck-Medina, T., Hansen, M., Morimoto, R. I., Simon, A. K., Bjedov,\nI., et al. (2021). Autophagy in healthy aging and disease. Nat. Aging 1 (8), 634–650.\ndoi:10.1038/s43587-021-00098-4\nAntonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., et al.\n(1997). Inhibition of bax channel-forming activity by Bcl-2. Science 277 (5324),\n370–372. doi:10.1126/science.277.5324.370\nArvanitaki, E. S., Goulielmaki, E., Gkirtzimanaki, K., Niotis, G., Tsakani, E., Nenedaki,\nE., et al. (2024). Microglia-derived extracellular vesicles trigger age-related\nneurodegeneration upon DNA damage. Proc. Natl. Acad. Sci. 121 (17),\ne2317402121. doi:10.1073/pnas.2317402121\nAsadi, S., Gholami, M. S., Siassi, F., Qorbani, M., and Sotoudeh, G. (2019). Beneficial\neffects of nano-curcumin supplement on depression and anxiety in diabetic patients\nwith peripheral neuropathy: a randomized, double-blind, placebo-controlled clinical\ntrial. Phytother. Res. 34 (4), 896–903. doi:10.1002/ptr.6571\nBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois,\nB. R. M., et al. (2017). Targeted apoptosis of senescent cells restores tissue homeostasis\nin response to chemotoxicity and aging. Cell 169 (1), 132–147.e16. doi:10.1016/j.cell.\n2017.02.031\nBen-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., Marras, C., San Luciano, M., and\nTanner, C. (2024). The epidemiology of parkinson’s disease. Lancet 403 (10423),\n283–292. doi:10.1016/S0140-6736(23)01419-8\nBerlind, J. E., Lai, J. D., Lie, C., Vicente, J., Lam, K., Guo, S., et al. (2025).\nKCTD20 suppression mitigates excitotoxicity in tauopathy patient organoids.\nNeuron 113 (8), 1169–1189.e7. doi:10.1016/j.neuron.2025.02.001\nBerth, S. H., and Lloyd, T. E. (2023). Disruption of axonal transport in\nneurodegeneration. J. Clin. Invest 133 (11), e168554. doi:10.1172/JCI168554\nBharat, V., Durairaj, A. S., Vanhauwaert, R., Li, L., Muir, C. M., Chandra, S., et al.\n(2023). A mitochondrial inside-out iron-calcium signal reveals drug targets for\nparkinson’s disease. Cell Rep. 42 (12), 113544. doi:10.1016/j.celrep.2023.113544\nBhatia, N. K., Srivastava, A., Katyal, N., Jain, N., Khan, M. A. I., Kundu, B., et al.\n(2015). Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase\n(SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim.\nBiophys. Acta 1854 (5), 426–436. doi:10.1016/j.bbapap.2015.01.014\nBishop, N. J., Morley, R., Day, J. P., and Lucas, A. (1997). Aluminum neurotoxicity in\npreterm infants receiving intravenous-feeding solutions. N. Engl. J. Med. 336 (22),\n1557–1561. doi:10.1056/NEJM199705293362203\nBloem, B. R., Okun, M. S., and Klein, C. (2021). Parkinson’s disease. Lancet 397\n(10291), 2284–2303. doi:10.1016/S0140-6736(21)00218-X\nBoehme, M., Guzzetta, K. E., Bastiaanssen, T. F. S., van de Wouw, M., Moloney, G. M.,\nGual-Grau, A., et al. (2021). Microbiota from young mice counteracts selective age-\nassociated behavioral deficits. Nat. Aging 1 (8), 666–676. doi:10.1038/s43587-021-\n00093-9\nBuchanan, D. A., Brown, A. E., Osigwe, E. C., Pfalzer, A. C., Mann, L. G., Yan, Y., et al.\n(2023). Racial differences in the presentation and progression of huntington’s disease.\nMov. Disord. 38 (10), 1945–1949. doi:10.1002/mds.29536\nBunting, E. L., Donaldson, J., Cumming, S. A., Olive, J., Broom, E., Miclăuș, M., et al.\n(2025). Antisense oligonucleotide-mediated MSH3 suppression reduces somatic CAG\nrepeat expansion in huntington’s disease iPSC-derived striatal neurons. Sci. Transl.\nMed. 17 (785), eadn4600. doi:10.1126/scitranslmed.adn4600\nCai, B., Zhong, L., Wang, Q., Xu, W., Li, X., and Chen, T. (2023). Curcumin alleviates\n1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinson’s disease in mice via\nmodulating gut microbiota and short-chain fatty acids. Front. Pharmacol. 14, 1198335.\ndoi:10.3389/fphar.2023.1198335\nCai, Z., Liang, C., Huang, K., Luo, J., Lu, R., Lai, Y., et al. (2025). Curcumin prevents\nneurodegeneration by blocking HDAC6-NLRP3 pathway-dependent\nneuroinflammation in parkinson’s disease. Int. Immunopharmacol. 146, 113928.\ndoi:10.1016/j.intimp.2024.113928\nCengiz, M., Gur, B., Sezer, C. V., Cengiz, B. P., Gür, F., Bayrakdar, A., et al. (2023).\nAlternations in interleukin-1β and nuclear factor kappa beta activity (NF-kB) in rat liver\ndue to the co-exposure of cadmium and arsenic: protective role of curcumin. Environ.\nToxicol. Pharmacol. 102, 104218. doi:10.1016/j.etap.2023.104218\nChaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J. M., et al.\n(2011). Interleukin-10 signaling in regulatory T cells is required for suppression of\nTh17 cell-mediated inflammation. Immunity 34 (4), 566–578. doi:10.1016/j.immuni.\n2011.03.018\nChen, L., Min, J., and Wang, F. (2022). Copper homeostasis and cuproptosis in health\nand disease. Signal Transduct. Target Ther. 7 (1), 378. doi:10.1038/s41392-022-01229-y\nChen, P., Chen, Z., Hou, W., Yu, L. C., and Chen, R. P. Y. (2016).\nPolyhydroxycurcuminoids but not curcumin upregulate neprilysin and can be\napplied to the prevention of alzheimer’s disease. \nSci. Rep. 6, 29760. doi:10.1038/\nsrep29760\nChen, T., Wan, L., Xiao, Y., Wang, K., Wu, P., Li, C., et al. (2024). Curcumin/PEGCG-\nencapsulated nanoparticles enhance spinal cord injury recovery by regulating CD74 to\nalleviate oxidative stress and inflammation. J. Nanobiotechnology 22 (1), 653. doi:10.\n1186/s12951-024-02916-4\nChen, Z., Xia, D., Liang, X., Liu, Q., Li, J., Li, Q., et al. (2024). Curcumin mitigates\nAβ33-42 fibril-induced neuronal injury in the hippocampus. Mater Today Phys. 44,\n101436. doi:10.1016/j.mtphys.2024.101436\nCheng, G., Liu, X., Liu, Y., Liu, Y., Ma, R., Luo, J., et al. (2022). Ultrasmall coordination\npolymers for alleviating ROS-mediated inflammatory and realizing neuroprotection\nagainst parkinson’s disease. Res. 2022, 9781323. doi:10.34133/2022/9781323\nChico, L., Ienco, E. C., Bisordi, C., Lo Gerfo, A., Petrozzi, L., Petrucci, A., et al. (2018).\nAmyotrophic lateral sclerosis and oxidative stress: a double-blind therapeutic trial after\ncurcumin supplementation. CNS Neurol. Disord. Drug Targets 17 (10), 767–779. doi:10.\n2174/1871527317666180720162029\nCox, K., Pipingas, A., and Scholey, A. B. (2015). Investigation of the effects of solid\nlipidcurcumin on cognition and mood in a healthyolder population.\nJ. Psychopharmacol. 29 (5), 642–651. doi:10.1177/0269881114552744\nCremona, M. L., Matthies, H. J. G., Pau, K., Bowton, E., Speed, N., Lute, B. J., et al.\n(2011). Flotillin-1 is essential for PKC-Triggered endocytosis and membrane\nmicrodomain localization of DAT. Nat. Neurosci. 14 (4), 469–477. doi:10.1038/nn.2781\nCristofani, R., Crippa, V., Rusmini, P., Cicardi, M. E., Meroni, M., Licata, N. V., et al.\n(2017). Inhibition of retrograde transport modulates misfolded protein accumulation\nand clearance in motoneuron diseases. Autophagy 13 (8), 1280–1303. doi:10.1080/\n15548627.2017.1308985\nCulbertson, A. T., and Liao, M. (2025). Cryo-EM of human P-glycoprotein reveals an\nintermediate occluded conformation during active drug transport. Nat. Commun. 16\n(1), 3619. doi:10.1038/s41467-025-58561-4\nDai, J., Sanchez, A., Adam, C., Ranjha, L., Reginato, G., Chervy, P., et al. (2021).\nMolecular basis of the dual role of the Mlh1-Mlh3 endonuclease in MMR and in meiotic\ncrossover formation. Proc. Natl. Acad. Sci. 118 (23), e2022704118. doi:10.1073/pnas.\n2022704118\nD’Angremont, E., Begemann, M. J. H., Van Laar, T., and Sommer, I. E. C. (2023).\nCholinesterase inhibitors for treatment of psychotic symptoms in alzheimer disease and\nparkinson disease: a meta-analysis. JAMA Neurol. 80 (8), 813–823. doi:10.1001/\njamaneurol.2023.1835\nD’Antona, S., Caramenti, M., Porro, D., Castiglioni, I., and Cava, C. (2021).\nAmyotrophic lateral sclerosis: a diet review. Foods 10 (12), 3128. doi:10.3390/\nfoods10123128\nDas, S. S., Gopal, P. M., Thomas, J. V., Mohan, M. C., Thomas, S. C., Maliakel, B. P.,\net al. (2023). Influence of CurQfen\n® \n-curcuminon cognitive impairment:\narandomized,double-blindedplacebo-controlled, 3-arm3-sequence comparative study.\nFront. Dement. 2, 1222708. doi:10.3389/frdem.2023.1222708\nDash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., et al. (2025).\nOxidative stress and inflammation in the pathogenesis of neurological disorders:\nmechanisms and implications. Acta Pharm. Sin. B 15 (1), 15–34. doi:10.1016/j.apsb.\n2024.10.004\nDeniston, C. K., Salogiannis, J., Mathea, S., Snead, D. M., Lahiri, I., Matyszewski, M.,\net al. (2020). Structure of LRRK2 in parkinson’s disease and model for microtubule\ninteraction. Nature 588 (7837), 344–349. doi:10.1038/s41586-020-2673-2\nDe Oliveira, M. R., Jardim, F. R., Setzer, W. N., Nabavi, S. M., and Nabavi, S. F. (2016).\nCurcumin, mitochondrial biogenesis, and mitophagy: exploring recent data and\nindicating future needs. Biotechnol. Adv. 34 (5), 813–826. doi:10.1016/j.biotechadv.\n2016.04.004\nDhankhar, J., Shrivastava, A., and Agrawal, N. (2023). Amendment of altered\nimmune response by curcumin in drosophila model of huntington’s disease.\nJ. Huntingt. Dis. 12 (4), 335–354. doi:10.3233/JHD-230595\nDomingo-Relloso, A., Mcgraw, K. E., Heckbert, S. R., Luchsinger, J. A., Schilling, K.,\nGlabonjat, R. A., et al. (2024). Urinary metal levels, cognitive test performance, and\ndementia in the multi-ethnic study of atherosclerosis. JAMA Netw. Open 7 (12),\ne2448286. doi:10.1001/jamanetworkopen.2024.48286\nFrontiers in Pharmacology frontiersin.org17\nWang et al. 10.3389/fphar.2025.1625821\n\nDong, H., Xu, L., Wu, L., Wang, X., Duan, W., Li, H., et al. (2014). Curcumin abolishes\nmutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS.\nNeuroscience 272, 141–153. doi:10.1016/j.neuroscience.2014.04.032\nDong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., and Li-Hua, P. (2023). Signaling\npathways in parkinson’s disease: molecular mechanisms and therapeutic interventions.\nSignal Transduct. Target Ther. 8 (1), 73. doi:10.1038/s41392-023-01353-3\nDorszewska, J., Florczak Wyspianska, J., Zasada, A., Korczowska-Łącka, I.,\nSzymanowicz, O., and Kozubski, W. (2023). Analysis of genetic variants related to\noxidative stress in patients with Alzheimer’s disease. Alzheimers Dement. 19 (S1),\ne062766. doi:10.1002/alz.062766\nDuan, C., Wang, H., Jiao, D., Geng, Y., Wu, Q., Yan, H., et al. (2022). Curcumin\nrestrains oxidative stress of after intracerebral hemorrhage in rat by activating the Nrf2/\nHO-1 pathway. Front. Pharmacol. 13, 889226. doi:10.3389/fphar.2022.889226\nEddy, C. M., Parkinson, E. G., and Rickards, H. E. (2016). Changes in mental state and\nbehaviour in huntington’s disease. Lancet Psychiatry 3 (11), 1079–1086. doi:10.1016/\nS2215-0366(16)30144-4\nEdlich, F., Banerjee, S., Suzuki, M., Cleland, M. M., Arnoult, D., Wang, C., et al.\n(2011). Bcl-x(L) retrotranslocates bax from the mitochondria into the cytosol. Cell 145\n(1), 104–116. doi:10.1016/j.cell.2011.02.034\nElifani, F., Crispi, S., Filosa, S., Castaldo, S., Capocci, L., Madonna, M., et al. (2016).\nCurcumin: a natural compound to counteract the pathology of huntington’s disease?\nJ. Neurol. Neurosurg. Psychiatry 87 (S1), A93. doi:10.1136/jnnp-2016-314597.264\nFan, M., Zhang, J., Tsai, C., Orlando, B. J., Rodriguez, M., Xu, Y., et al. (2020).\nStructure and mechanism of the mitochondrial Ca\n2+ \nuniporter holocomplex. Nature\n582 (7810), 129–133. doi:10.1038/s41586-020-2309-6\nFerguson, R., Goold, R., Coupland, L., Flower, M., and Tabrizi, S. J. (2024).\nTherapeutic validation of MMR-associated genetic modifiers in a human ex vivo\nmodel of huntington disease. Am. J. Hum. Genet. 111 (6), 1165–1183. doi:10.1016/j.\najhg.2024.04.015\nFernandes, M., Lopes, I., Magalhães, L., Sárria, M. P., Machado, R., Sousa, J. C., et al.\n(2021). Novel concept of exosome-like liposomes for the treatment of alzheimer’s\ndisease. J. Control Release 336, 130–143. doi:10.1016/j.jconrel.2021.06.018\nForner, S., Kawauchi, S., Balderrama-Gutierrez, G., Kramár, E. A., Matheos, D. P.,\nPhan, J., et al. (2021). Systematic phenotyping and characterization of the 5xFAD\nmouse model of alzheimer’s disease. Sci. Data 8 (1), 270. doi:10.1038/s41597-021-\n01054-y\nFu, X., Zhang, Y., Chen, G., Mao, G., Tang, J., Xu, J., et al. (2025). Responsive\nnanoparticles synergize with curcumin to break the reactive oxygen species-\nneuroinflammation vicious cycle, enhancing traumatic brain injury outcomes.\nJ. Nanobiotechnology 23 (1), 172. doi:10.1186/s12951-025-03251-y\nFu, Y., Zhang, J., Qin, R., Ren, Y., Zhou, T., Han, B., et al. (2025). Activating autophagy\nto eliminate toxic protein aggregates with small molecules in neurodegenerative\ndiseases. Pharmacol. Rev. 77 (3), 100053. doi:10.1016/j.pharmr.2025.100053\nFumagalli, L., Young, F. L., Boeynaems, S., De Decker, M., Mehta, A. R., Swijsen, A.,\net al. (2021). C9orf72 -derived arginine-containing dipeptide repeats associate with\naxonal transport machinery and impede microtubule-based motility. Sci. Adv. 7 (15),\neabg3013. doi:10.1126/sciadv.abg3013\nGao, C., Wang, Y., Sun, J., Han, Y., Gong, W., Li, Y., et al. (2020). Neuronal\nmitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems\nin alzheimer’s disease mice. Acta Biomater. 108, 285–299. doi:10.1016/j.actbio.2020.\n03.029\nGenchi, G., Lauria, G., Catalano, A., Carocci, A., and Sinicropi, M. S. (2024).\nNeuroprotective effects of curcumin in neurodegenerative diseases. Foods 13 (11),\n1774. doi:10.3390/foods13111774\nGenetic Modifiers of Huntington’s Disease Consortium, Genetic Modifiers of\nHuntington’s Disease GeM-HD Consortium (2019). CAG repeat not polyglutamine\nlength determines timing of huntington’s disease onset. Cell 178 (4), 887–900.e14.\ndoi:10.1016/j.cell.2019.06.036\nGeng, L., Fan, L. M., Liu, F., Smith, C., and Li, J. M. (2020). Nox2 dependent redox-\nregulation of microglial response to amyloid-β stimulation and microgliosis in aging.\nSci. Rep. 10 (1), 1582. doi:10.1038/s41598-020-58422-8\nGhita, L., Spanier, J., Chhatbar, C., Mulenge, F., Pavlou, A., Larsen, P. K., et al. (2021).\nMyD88 signaling by neurons induces chemokines that recruit protective leukocytes to\nthe virus-infected CNS. Sci. Immunol. 6 (60), eabc9165. doi:10.1126/sciimmunol.\nabc9165\nGhobadi, N., and Asoodeh, A. (2023). Co-administration of curcumin with other\nphytochemicals improves anticancer activity by regulating multiple molecular targets.\nPhytother. Res. 37 (4), 1688\n–1702. doi:10.1002/ptr.7794\nGhodsia, H., Rahimib, H. R., Aghili, S. M., Saberi, A., and Shoeibi, A. (2022).\nEvaluation of curcumin as add-on therapy in patients with parkinson’s disease: a\npilot randomized, triple-blind, placebo-controlled trial. Clin. Neurol. Neurosurg. 218,\n107300. doi:10.1016/j.clineuro.2022.107300\nGiau, V. V., Bagyinszky, E., Youn, Y. C., and Kim, S. (2019). APP, PSEN1, and PSEN2\nmutations in Asian patients with early-onset alzheimer disease. Int. J. Mol. Sci. 20 (19),\n4757. doi:10.3390/ijms20194757\nGrill, A. E., Koniar, B., and Panyam, J. (2014). Co-delivery of natural metabolic\ninhibitors in a self-microemulsifying drug delivery system for improved oral\nbioavailability of curcumin. Drug Deliv Transl Res. 4 (4), 344–352. doi:10.1007/\ns13346-014-0199-6\nGuglielmo, A., Sabra, A., Elbery, M., Cerveira, M. M., Ghenov, F., Sunasee, R., et al.\n(2017). A mechanistic insight into curcumin modulation of the IL-1β secretion and\nNLRP3 S-glutathionylation induced by needle-like cationic cellulose nanocrystals in\nmyeloid cells. Chem. Biol. Interact. 274, 1–12. doi:10.1016/j.cbi.2017.06.028\nGulen, M. F., Samson, N., Keller, A., Schwabenland, M., Liu, C., Glück, S., et al. (2023).\ncGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620\n(7973), 374–380. doi:10.1038/s41586-023-06373-1\nGustavsson, E. K., Follett, J., Trinh, J., Barodia, S. K., Real, R., Liu, Z., et al. (2024).\nRAB32 Ser71Arg in autosomal dominant parkinson’s disease: linkage, association, and\nfunctional analyses. Lancet Neurol. 23 (6), 603–614. doi:10.1016/S1474-4422(24)\n00121-2\nHallacli, E., Kayatekin, C., Nazeen, S., Wang, X. H., Sheinkopf, Z., Sathyakumar, S.,\net al. (2022). The parkinson’s disease protein alpha-synuclein is a modulator of\nprocessing bodies and mRNA stability. Cell 185 (12), 2035–2056.e33. doi:10.1016/j.\ncell.2022.05.008\nHamlbar, E. P., Mirghafourvand, M., Shaseb, E., and Kamalifard, M. (2025). The effect\nof curcumin on postpartum depression and anxiety in primiparous women: a double-\nblind randomized placebocontrolled clinical trial. BMC Complement. Med. Ther. 25 (1),\n157. doi:10.1186/s12906-025-04798-x\nHandsaker, R. E., Kashin, S., Reed, N. M., Tan, S., Lee, W. S., McDonald, T. M., et al.\n(2025). Long somatic DNA-repeat expansion drives neurodegeneration in huntington’s\ndisease. Cell 188 (3), 623–639.e19. doi:10.1016/j.cell.2024.11.038\nHassaninasab, A., Hashimoto, Y., Tomita-Yokotani, K., and Kobayashi, M. (2011).\nDiscovery of the curcumin metabolic pathway involving a unique enzyme in an\nintestinal microorganism. Proc. Natl. Acad. Sci. 108 (16), 6615–6620. doi:10.1073/\npnas.1016217108\nHickey, M. A., Zhu, C., Medvedeva, V., Lerner, R. P., Patassini, S., Franich, N. R., et al.\n(2012). Improvement of neuropathology and transcriptional deficits in CAG 140 knock-\nin mice supports a beneficial effect of dietary curcumin in huntington’s disease. Mol.\nNeurodegener. 7, 12. doi:10.1186/1750-1326-7-12\nHop, P. J., Lai, D., Keagle, P. J., Baron, D. M., Kenna, B. J., Kooyman, M., et al. (2024).\nSystematic rare variant analyses identify RAB32 as a susceptibility gene for familial\nparkinson’s disease. Nat. Genet. 56 (7), 1371–1376. doi:10.1038/s41588-024-01787-7\nHoppe, J. B., Frozza, R., Meneghetti, A., Bernardi, A., da Silva, T., Gerhardt, D., et al.\n(2011). P2-216: involvement of PI3-K pathway and β-catenin signaling in curcumin\nprotecting against Aβ1-42-induced neurotoxicity. Alzheimers Dement. 7 (4S),\nS381–S382. doi:10.1016/j.jalz.2011.05.1099\nHuang, L., Chen, C., Zhang, X., Li, X., Chen, Z., Yang, C., et al. (2018).\nNeuroprotective effect of curcumin against cerebral ischemia-reperfusion via\nmediating autophagy and inflammation. J. Mol. Neurosci. 64 (1), 129–139. doi:10.\n1007/s12031-017-1006-x\nIslam, T., Hill, E., Abrahamson, E. E., Servaes, S., Smirnov, D. S., Zeng, X., et al. (2025).\nPhospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau\nassemblies in alzheimer’s disease. Nat. Med. 31 (2), 574–588. doi:10.1038/s41591-\n024-03400-0\nIwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., et al. (2001).\nMetabolic regulation of brain abeta by neprilysin. Science 292 (5521), 1550–1552. doi:10.\n1126/science.1059946\nJain, G., Trombetta-Lima, M., Matlahov, I., Ribas, H. T., Chen, T., Parlato, R., et al.\n(2025). Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates\nfibril-induced cellular stress. Nat. Commun. 16, 3588. doi:10.1038/s41467-025-58691-9\nJiang, X., Liu, B., Nie, Z., Duan, L., Xiong, Q., Jin, Z., et al. (2021). The role of m6A\nmodification in the biological functions and diseases. Signal Transduct. Target Ther. 6\n(1), 74. doi:10.1038/s41392-020-00450-x\nJobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., et al.\n(1999). Curcumin blocks cytokine-mediated NF-kappa B activation and\nproinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase\nactivity. J. Immunol. 163 (6), 3474–3483. doi:10.4049/jimmunol.163.6.3474\nKang, Y. J., Hyeon, S. J., Mcquade, A., Lim, J., Baek, S. H., Diep, Y. N., et al. (2024).\nNeurotoxic microglial activation via IFNγ-induced Nrf2 reduction exacerbating\nalzheimer’s disease. Adv. Sci. 11 (20), e2304357. doi:10.1002/advs.202304357\nKanwal, Q., Ahmed, M., Hamza, M., Ahmad, M., Atiq-Ur-Rehman, Yousaf, N., et al.\n(2023). Curcumin nanoparticles: physicochemical fabrication, characterization,\nantioxidant, enzyme inhibition, molecular docking and simulation studies. RSC Adv.\n13, 22268–22280. doi:10.1039/d3ra01432k\nKasinski, A. L., Du, Y., Thomas, S. L., Zhao, J., Sun, S. Y., Khuri, F. R., et al. (2008).\nInhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-\nflurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin.\nMol. Pharmacol. 74 (3), 654–661. doi:10.1124/mol.108.046201\nKeeney, M. T., Rocha, E. M., Hoffman, E. K., Farmer, K., Di Maio, R., Weir, J., et al.\n(2024). LRRK2 regulates production of reactive oxygen species in cell and animal\nFrontiers in Pharmacology frontiersin.org18\nWang et al. 10.3389/fphar.2025.1625821\n\nmodels of parkinson’s disease. Sci. Transl. Med. 16 (767), eadl3438. doi:10.1126/\nscitranslmed.adl3438\nKhan, S., Zafar, A., and Naseem, I. (2020). Redox cycling of copper by coumarin-di(2-\npicolyl)amine hybrid molecule leads to ROS-Mediated modulation of redox scavengers,\nDNA damage and cell death in diethylnitrosamine induced hepatocellular carcinoma.\nBioorg Chem. 99, 103818. doi:10.1016/j.bioorg.2020.103818\nKhayatan, D., Razavi, S. M., Arab, Z. N., Nasoori, H., Fouladi, A., Pasha, A. V. K., et al.\n(2025). Targeting mTOR with curcumin: therapeutic implications for complex diseases.\nInflammopharmacology 33 (4), 1583–1616. doi:10.1007/s10787-025-01643-y\nKim, E., Kim, H., Jedrychowski, M. P., Bakiasi, G., Park, J., Kruskop, J., et al. (2023).\nIrisin reduces amyloid-beta by inducing the release of neprilysin from astrocytes\nfollowing downregulation of ERK-STAT3 signaling. Neuron 111 (22), 3619–3633.e8.\ndoi:10.1016/j.neuron.2023.08.012\nKim, H., Du, F., Fang, M., and Wang, X. (2005). Formation of apoptosome is initiated\nby cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on\nApaf-1. Proc. Natl. Acad. Sci. 102 (49), 17545–17550. doi:10.1073/pnas.0507900102\nKim, S., Jung, U. J., and Kim, S. R. (2024). Role of oxidative stress in blood-brain\nbarrier disruption and neurodegenerative diseases. Antioxidants 13 (12), 1462. doi:10.\n3390/antiox13121462\nKim, Y., Lim, J., and Oh, J. (2024). Taming neuroinflammation in alzheimer’s disease:\nthe protective role of phytochemicals through the gut-brain axis. Biomed.\nPharmacother. 178, 117277. doi:10.1016/j.biopha.2024.117277\nKotsiliti, E. (2023). Gut syndromes and parkinson disease prediction. Nat. Rev.\nGastroenterol. Hepatol. 20 (11), 694. doi:10.1038/s41575-023-00851-7\nKumari, S., Dhapola, R., and Reddy, D. H. (2023). Apoptosis in alzheimer’s disease:\ninsight into the signaling pathways and therapeutic avenues. Apoptosis 28 (7-8),\n943–957. doi:10.1007/s10495-023-01848-y\nLepine, S., Castellanos-Montiel, M. J., and Durcan, T. M. (2022). TDP-43\ndysregulation and neuromuscular junction disruption in amyotrophic lateral\nsclerosis. Transl. Neurodegener. 11 (1), 56. doi:10.1186/s40035-022-00331-z\nLi, B., Ming, H., Qin, S., Nice, E. C., Dong, J., Du, Z., et al. (2025). Redox regulation:\nmechanisms, biology and therapeutic targets in diseases. Signal Transduct. Target Ther.\n10 (1), 72. doi:10.1038/s41392-024-02095-6\nLi, D., and Wu, M. (2021). Pattern recognition receptors in health and diseases. Signal\nTransduct. Target Ther. 6 (1), 291. doi:10.1038/s41392-021-00687-0\nLi, H., Tan, Y., Cheng, X., Zhang, Z., Huang, J., Hui, S., et al. (2022). Untargeted\nmetabolomics analysis of the hippocampus and cerebral cortex identified the\nneuroprotective mechanisms of bushen tiansui formula in an aβ\n25-35\n-induced rat model\nof alzheimer’s disease. Front. Pharmacol. 13, 990307. doi:10.3389/fphar.2022.990307\nLi, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., et al.\n(1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex\ninitiates an apoptotic protease cascade. Cell 91 (4), 479–489. doi:10.1016/s0092-\n8674(00)80434-1\nLi, S., Bu, L., and Cai, L. (2022). Cuproptosis: lipoylated TCA cycle proteins-mediated\nnovel cell death pathway. Signal Transduct. Target Ther. 7 (1), 158. doi:10.1038/s41392-\n022-01014-x\nLiang, K., Yang, L., Kang, J., Liu, B., Zhang, D., Wang, L., et al. (2024). Improving\ntreatment for parkinson’s disease: harnessing photothermal and phagocytosis-driven\ndelivery of levodopa nanocarriers across the blood-brain barrier. Asian J. Pharm. Sci. 19\n(6), 100963. doi:10.1016/j.ajps.2024.100963\nLiang, Z., Liu, W., Cao, M., Cui, J., Lan, J., Ding, Y., et al. (2025). Epigenetic\nregulation-mediated disorders in dopamine transporter endocytosis: a novel\nmechanism for the pathogenesis of parkinson’s disease. Theranostics 15 (6),\n2250–2278. doi:10.7150/thno.107436\nLiederer, B. M., and Borchardt, R. T. (2006). Enzymes involved in the bioconversion\nof ester-based prodrugs. J. Pharm. Sci. 95 (6), 1177–1195. doi:10.1002/jps.20542\nLim, D., Tapella, L., Dematteis, G., Genazzani, A. A., Corazzari, M., and Verkhratsky,\nA. (2023). The endoplasmic reticulum stress and unfolded protein response in\nAlzheimer’s disease: a calcium dyshomeostasis perspective. Ageing Res. Rev. 87,\n101914. doi:10.1016/j.arr.2023.101914\nLinard, M., Martinuzzi, M., Samieri, C., Dartigues, J., Glaichenhaus, N., Féart, C., et al.\n(2023). High plasma glial fibrillary acidic protein levels are associated with an increased\nrisk of dementia and Alzheimer’s disease over a 13-year follow-up period: results from a\nprospective population-based cohort. Alzheimers Dement. 19 (S2), e065653. doi:10.\n1002/alz.065653\nLing, S., Zhang, X., Dai, Y., Jiang, Z., Zhou, X., Lu, S., et al. (2025). Customizable virus-\nlike particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular\nand huntington’s disease gene therapy. Nat. Nanotechnol. 20, 543–553. doi:10.1038/\ns41565-024-01851-7\nLiu, J., Liu, C., Zhang, J., Zhang, Y., Liu, K., Song, J. X., et al. (2020). A self-assembled\nα-synuclein nanoscavenger for Parkinson’s disease. ACS Nano 14 (2), 1533–1549.\ndoi:10.1021/acsnano.9b06453\nLiu, Z., Yu, Y., Li, X., Ross, C. A., and Smith, W. W. (2011). Curcumin protects against\nA53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for\nparkinsonism. Pharmacol. Res. 63 (5), 439–444. doi:10.1016/j.phrs.2011.01.004\nLoh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., et al. (2024).\nMicrobiota-gut-brain axis and its therapeutic applications in neurodegenerative\ndiseases. Signal Transduct. Target Ther. 9 (1), 37. doi:10.1038/s41392-024-01743-1\nLong, J. M., and Holtzman, D. M. (2019). Alzheimer disease: an update on\npathobiology and treatment strategies. Cell 179 (2), 312–339. doi:10.1016/j.cell.2019.\n09.001\nLopez Rodriguez, A. B., Hennessy, E., Murray, C. L., Nazmi, A., Delaney, H. J., Healy,\nD., et al. (2021). Acute systemic inflammation exacerbates neuroinflammation in\nalzheimer’s disease: IL-1β drives amplified responses in primed astrocytes and\nneuronal network dysfunction. Alzheimers Dement. 17 (10), 1735–1755. doi:10.1002/\nalz.12341\nLuan, T., Li, Q., Huang, Z., Feng, Y., Xu, D., Zhou, Y., et al. (2024). Axonopathy\nunderlying amyotrophic lateral sclerosis: unraveling complex pathways and therapeutic\ninsights. Neurosci. Bull. 40 (11), 1789–1810. doi:10.1007/s12264-024-01267-2\nLuo, H., Li, Z., Yao, M., McClements, D. J., and Xiao, H. (2022). Impact of excipient\nemulsions made from different types of oils on the bioavailability and metabolism of\ncurcumin in gastrointestinal tract. Food Chem. 370, 130980. doi:10.1016/j.foodchem.\n2021.130980\nMahul-Mellier, A., Burtscher, J., Maharjan, N., Weerens, L., Croisier, M., Kuttler, F.,\net al. (2020). The process of lewy body formation, rather than simply alpha-synuclein\nfibrillization, is one of the major drivers of neurodegeneration. Proc. Natl. Acad. Sci. 117\n(9), 4971–4982. doi:10.1073/pnas.1913904117\nMajumder, P., Hsu, T., Hu, C., Huang, J. K., Lee, Y. C., Hsieh, Y. C., et al. (2025).\nPotential role of solid lipid curcumin particle (SLCP) as estrogen replacement therapy in\nmitigating TDP-43-related neuropathy in the mouse model of ALS disease. Exp. Neurol.\n383, 114999. doi:10.1016/j.expneurol.2024.114999\nManiscalchi, A., Benzi Juncos, O. N., Conde, M. A., Funk, M. I., Fermento, M. E.,\nFacchinetti, M. M., et al. (2024). New insights on neurodegeneration triggered by iron\naccumulation: intersections with neutral lipid metabolism, ferroptosis, and motor\nimpairment. Redox Biol. 71, 103074. doi:10.1016/j.redox.2024.103074\nMaor-Nof, M., Shipony, Z., Lopez-Gonzalez, R., Nakayama, L., Zhang, Y. J.,\nCouthouis, J., et al. (2021). p53 is a central regulator driving neurodegeneration\ncaused by C9orf72 poly(PR). Cell 184 (3), 689–708.e20. doi:10.1016/j.cell.2020.12.025\nMari, M., Carrozza, D., Malavasi, G., Venturi, E., Avino, G., Capponi, P. C., et al.\n(2022). Curcumin-based β-diketo ligands for Ga \n3+ \n: thermodynamic investigation of\npotential metal-based drugs. Pharmaceuticals 15 (7), 854. doi:10.3390/ph15070854\nMarrone, L., Drexler, H. C. A., Wang, J., Tripathi, P., Distler, T., Heisterkamp, P., et al.\n(2019). FUS pathology in ALS is linked to alterations in multiple ALS-associated\nproteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 138 (1), 67–84.\ndoi:10.1007/s00401-019-01998-x\nMartic, S. (2022). Inhibition of tau protein aggregation using small molecule\ninhibitors and immunotherapies. Alzheimers Dement. 18 (S10), e065627. doi:10.\n1002/alz.065627\nMatlik, K., Baffuto, M., Kus, L., Deshmukh, A. L., Davis, D. A., Paul, M. R., et al.\n(2024). Cell-type-specific CAG repeat expansions and toxicity of mutant huntingtin in\nhuman striatum and cerebellum. Nat. Genet. 56 (3), 383–394. doi:10.1038/s41588-024-\n01653-6\nMaugeri, A., Russo, C., Patanè, G. T., Barreca, D., Mandalari, G., and Navarra, M.\n(2023). The inhibition of mitogen-activated protein kinases (MAPKs) and NF-κB\nunderlies the neuroprotective capacity of a cinnamon/curcumin/turmeric spice blend in\nAβ-exposed THP-1 cells. Molecules 28 (24), 7949. doi:10.3390/molecules28247949\nMcCombe, P. A., and Henderson, R. D. (2010). Effects of gender in amyotrophic\nlateral sclerosis. Gend. Med. 7 (6), 557–570. doi:10.1016/j.genm.2010.11.010\nMcmillan, P. J., Benbow, S. J., Uhrich, R., Saxton, A., Baum, M., Strovas, T., et al.\n(2023). Tau-RNA complexes inhibit microtubule polymerization and drive disease-\nrelevant conformation change. Brain 146 (8), 3206–3220. doi:10.1093/brain/awad032\nMendel, M., Chen, K., Homolka, D., Gos, P., Pandey, R. R., McCarthy, A. A., et al.\n(2018). Methylation of structured RNA by the m(6)A writer METTL16 is essential for\nmouse embryonic development. Mol. Cell 71 (6), 986–1000.e11. doi:10.1016/j.molcel.\n2018.08.004\nMeng, F., Yao, D., Shi, Y., Kabakoff, J., Wu, W., Reicher, J., et al. (2011). Oxidation of\nthe cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to\nprotein aggregation. Mol. Neurodegener. 6 (1), 34. doi:10.1186/1750-1326-6-34\nMetzler, M., Pfeiffer, E., Schulz, S. I., and Dempe, J. S. (2013). Curcumin uptake and\nmetabolism. BioFactors 39 (1), 14–20. doi:10.1002/biof.1042\nMizielinska, S., Hautbergue, G. M., Gendron, T. F., van Blitterswijk, M., Hardiman,\nO., Ravits, J., et al. (2025). Amyotrophic lateral sclerosis caused by hexanucleotide repeat\nexpansions in C9orf72: from genetics to therapeutics. Lancet Neurol. 24 (3), 261–274.\ndoi:10.1016/S1474-4422(25)00026-2\nMoradi, G., Zinadini, S., Rajabi, L., and Ashraf Derakhshan, A. (2020). Removal of\nheavy metal ions using a new high performance nanofiltration membrane modified with\ncurcumin boehmite nanoparticles. Chem. Eng. J. 390, 124546. doi:10.1016/j.cej.2020.\n124546\nMoss, D. J. H., Pardinas, A. F., Langbehn, D., Lo, K., Leavitt, B. R., Roos, R., et al.\n(2017). Identification of genetic variants associated with huntington’s disease\nFrontiers in Pharmacology frontiersin.org19\nWang et al. 10.3389/fphar.2025.1625821\n\nprogression: a genome-wide association study. Lancet Neurol. 16 (9), 701–711. doi:10.\n1016/S1474-4422(17)30161-8\nMuangnoi, C., Jithavech, P., Ratnatilaka Na Bhuket, P., Supasena, W., Wichitnithad,\nW., Towiwat, P., et al. (2018). A curcumin-diglutaric acid conjugated prodrug with\nimproved water solubility and antinociceptive properties compared to curcumin. Biosci.\nBiotechnol. Biochem. 82 (8), 1301–1308. doi:10.1080/09168451.2018.1462694\nNamgyal, D., Ali, S., Hussain, M. D., Kazi, M., Ahmad, A., and Sarwat, M. (2021).\nCurcumin ameliorates the Cd-induced anxiety-like behavior in mice by regulating\noxidative stress and neuro-inflammatory proteins in the prefrontal cortex region of the\nbrain. Antioxidants 10 (11), 1710. doi:10.3390/antiox10111710\nNewell, M. E., Adhikari, S., and Halden, R. U. (2022). Systematic and state-of the\nscience review of the role of environmental factors in amyotrophic lateral sclerosis\n(ALS) or Lou gehrig’s disease. Sci. Total Environ. 817, 152504. doi:10.1016/j.scitotenv.\n2021.152504\nNguyen, T. B., Miramontes, R., Chillon-Marinas, C., Maimon, R., Vazquez-Sanchez,\nS., Lau, A. L., et al. (2025). Aberrant splicing in huntington’s disease accompanies\ndisrupted TDP-43 activity and altered m6A RNA modification. Nat. Neurosci. 28 (2),\n280–292. doi:10.1038/s41593-024-01850-w\nNikolopoulos, D., Manolakou, T., Polissidis, A., Filia, A., Bertsias, G., Koutmani, Y.,\net al. (2023). Microglia activation in the presence of intact blood–brain barrier and\ndisruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse\nneuropsychiatric lupus. Ann. Rheum. Dis. 82 (5), 646–657. doi:10.1136/ard-2022-\n223506\nNim, S., O’Hara, D. M., Corbi-Verge, C., Perez-Riba, A., Fujisawa, K., Kapadia, M.,\net al. (2023). Disrupting the alpha-synuclein-ESCRT interaction with a peptide inhibitor\nmitigates neurodegeneration in preclinical models of parkinson’s disease. Nat.\nCommun. 14 (1), 2150. doi:10.1038/s41467-023-37464-2\nNorton, C. E., Shaw, R. L., Domeier, T. L., Segal, S. S., and Dockery, B. (2024).\nAdvanced age and female sex protect cerebral arteries from mitochondrial\ndepolarization and apoptosis during acute oxidative stress. Aging Cell 23 (5),\ne14110. doi:10.1111/acel.14110\nOlmos-Juste, R., Alonso-Lerma, B., Pérez-Jiménez, R., Gabilondo, N., and Eceiza, A.\n(2021). 3D printed alginate-cellulose nanofibers based patches for local curcumin\nadministration. Carbohydr. Polym. 264, 118026. doi:10.1016/j.carbpol.2021.118026\nOrtega, J., Lee, G. S., Gu, L., Yang, W., and Li, G. M. (2021). Mispair-bound human\nMutS-MutL complex triggers DNA incisions and activates mismatch repair. Cell Res. 31\n(5), 542–553. doi:10.1038/s41422-021-00468-y\nPan, J., Li, H., Ma, J., Tan, Y. Y., Xiao, Q., Ding, J. Q., et al. (2012). Curcumin\ninhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of\nparkinson’s disease through suppressing mitochondria dysfunction. Transl.\nNeurodegener. 1 (1), 16. doi:10.1186/2047-9158-1-16\nPan, M., Huang, T., and Lin, J. (1999). Biotransformation of curcumin through\nreduction and glucuronidation in mice. Drug Metab. Dispos. 27 (4), 486–494. doi:10.\n1016/s0090-9556(24)15211-7\nPang, K., Jiang, R., Zhang, W., Yang, Z., Li, L. L., Shimozawa, M., et al. (2022). An app\nknock-in rat model for alzheimer’s disease exhibiting A\nβ and tau pathologies, neuronal\ndeath and cognitive impairments. Cell Res. 32 (2), 157–175. doi:10.1038/s41422-021-\n00582-x\nPark, H., Kam, T., Dawson, V. L., and Dawson, T. M. (2025). α-Synuclein pathology as\na target in neurodegenerative diseases. Nat. Rev. Neurol. 21 (1), 32–47. doi:10.1038/\ns41582-024-01043-w\nPark, H., Kam, T., Peng, H., Chou, S. C., Mehrabani-Tabari, A. A., Song, J. J., et al.\n(2022). PAAN/MIF nuclease inhibition prevents neurodegeneration in parkinson’s\ndisease. Cell 185 (11), 1943–1959.e21. doi:10.1016/j.cell.2022.04.020\nPatel, H., Mcintire, J., Ryan, S., Dunah, A., and Loring, R. (2017). Anti-inflammatory\neffects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the\nNF-κB pathway and activation of the Nrf2 pathway. J. Neuroinflammation 14 (1), 192.\ndoi:10.1186/s12974-017-0967-6\nPedrini, S., Sau, D., Guareschi, S., Bogush, M., Brown, R. H., Jr, Naniche, N., et al.\n(2010). ALS-Linked mutant SOD1 damages mitochondria by promoting\nconformational changes in Bcl-2. Hum. Mol. Genet. 19 (15), 2974–2986. doi:10.\n1093/hmg/ddq202\nPei, J., Palanisamy, C. P., Natarajan, P. M., Umapathy, V. R., Roy, J. R., Srinivasan, G.\nP., et al. (2024). Curcumin-loaded polymeric nanomaterials as a novel therapeutic\nstrategy for alzheimer’s disease: a comprehensive review. Ageing Res. Rev. 99, 102393.\ndoi:10.1016/j.arr.2024.102393\nPeruzzotti-Jametti, L., Willis, C. M., Krzak, G., Hamel, R., Pirvan, L., Ionescu, R. B.,\net al. (2024). Mitochondrial complex I activity in microglia sustains neuroinflammation.\nNature 628 (8006), 195–203. doi:10.1038/s41586-024-07167-9\nPichet Binette, A., Gonneaud, J., Vogel, J. W., La Joie, R., Rosa-Neto, P., Collins, D. L.,\net al. (2020). Morphometric network differences in ageing versus alzheimer’s disease\ndementia. Brain 143 (2), 635–649. doi:10.1093/brain/awz414\nQian, D., Xu, J., Zhang, X., Hu, F., Cao, S., Dong, Y., et al. (2024). Microenvironment\nself-adaptive nanomedicine promotes spinal cord repair by suppressing inflammation\nCascade and neural apoptosis. Adv. Mater 36 (50), e2307624. doi:10.1002/adma.\n202307624\nQian, K., Jiang, X., Liu, Z., Zhang, J., Fu, P., Su, Y., et al. (2023). Revisiting the critical\nroles of reactive astrocytes in neurodegeneration. Mol. Psychiatry 28 (7), 2697–2706.\ndoi:10.1038/s41380-023-02061-8\nQin, F., Cao, R., Cui, W., Bai, X., Yuan, J., Zhang, Y., et al. (2025). Listerin promotes\nalpha-synuclein degradation to alleviate parkinson’s disease through the ESCRT\npathway. Sci. Adv. 11 (7), eadp3672. doi:10.1126/sciadv.adp3672\nQin, H., Srinivasula, S. M., Wu, G., Fernandes-Alnemri, T., Alnemri, E. S., and Shi, Y.\n(1999). Structural basis of procaspase-9 recruitment by the apoptotic protease-\nactivating factor 1. Nature 399 (6736), 549–\n557. doi:10.1038/21124\nQiu, B., Zandkarimi, F., Bezjian, C. T., Reznik, E., Soni, R. K., Gu, W., et al. (2024).\nPhospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell 187\n(5), 1177–1190.e18. doi:10.1016/j.cell.2024.01.030\nRafiee, Z., Nejatian, M., Daeihamed, M., and Jafari, S. M. (2019). Application of\ncurcumin-loaded nanocarriers for food, drug and cosmetic purposes. Trends Food Sci.\nTech. 88, 445–458. doi:10.1016/j.tifs.2019.04.017\nRahimi, K., Ahmadi, A., Hassanzadeh, K., Soleimani, Z., Sathyapalan, T.,\nMohammadi, A., et al. (2019). Targeting the balance of T helper cell responses by\ncurcumin in inflammatory and autoimmune states. Autoimmun. Rev. 18 (7), 738–748.\ndoi:10.1016/j.autrev.2019.05.012\nRan, C., and Zhu, B. (2024). Molecular chemiluminescence imaging of misfolded\nproteins with a versatile and highly sensitive probe in neurodegenerative disease models.\nAlzheimers Dement. 20 (S6), e090061. doi:10.1002/alz.090061\nRane, J. S., Bhaumik, P., and Panda, D. (2017). Curcumin inhibits tau aggregation and\ndisintegrates preformed tau filaments in vitro. J. Alzheimers Dis. 60 (3), 999–1014.\ndoi:10.3233/JAD-170351\nRao, A., Chen, N., Kim, M. J., Blumenfeld, J., Yip, O., Liang, Z., et al. (2025). Microglia\ndepletion reduces human neuronal APOE4-related pathologies in a chimeric\nalzheimer’s disease model. Cell Stem Cell 32 (1), 86–104.e7. doi:10.1016/j.stem.2024.\n10.005\nRasouli, S., Abdolvahabi, A., Croom, C. M., Plewman, D. L., Shi, Y., and Shaw, B. F.\n(2018). Glycerolipid headgroups control rate and mechanism of superoxide dismutase-\n1 aggregation and accelerate fibrillization of slowly aggregating amyotrophic lateral\nsclerosis mutants. ACS Chem. Neurosci. 9 (7), 1743–1756. doi:10.1021/acschemneuro.\n8b00086\nRasouli, Z., and Ghavami, R. (2021). A 3×3 visible-light cross-reactive sensor array\nbased on the nanoaggregation of curcumin in different pH and buffers for the\nmultivariate identification and quantification of metal ions. Talanta 226, 122131.\ndoi:10.1016/j.talanta.2021.122131\nRathore, A. S., Singh, S. S., Birla, H., Zahra, W., Keshri, P. K., Dilnashin, H., et al.\n(2023). Curcumin modulates p62-Keap1-Nrf2-mediated autophagy in rotenone-\ninduced parkinson’s disease mouse models. ACS Chem. Neurosci. 14 (8). doi:10.\n1021/acschemneuro.2c00706\nRingman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., Beigi, M., et al.\n(2012). Oral curcumin for alzheimer’s disease: tolerability and efficacy in a 24-week\nrandomized, double blind, placebo-controlled study. Alzheimers Res. Ther. 4 (5), 43.\ndoi:10.1186/alzrt146\nRinwa, P., and Kumar, A. (2013). P1–013: piperine enhances the neuroprotective\neffects of curcumin against mild traumatic brain injury–induced cognitive deficits:\nbehavioral, biochemical, mitochondrial and molecular correlates. Alzheimers Dement. 9\n(4), 158. doi:10.1016/j.jalz.2013.05.233\nRizig, M., Bandres-Ciga, S., Makarious, M. B., Ojo, O. O., Crea, P. W., Abiodun, O. V.,\net al. (2023). Identification of genetic risk loci and causal insights associated with\nparkinson’s disease in African and African admixed populations: a genome-wide\nassociation study. Lancet Neurol. 22 (11), 1015–1025. doi:10.1016/S1474-4422(23)\n00283-1\nRoemer-Cassiano, S. N., Wagner, F., Evangelista, L., Rauchmann, B. S., Dehsarvi, A.,\nSteward, A., et al. (2025). Amyloid-associated hyperconnectivity drives tau spread\nacross connected brain regions in alzheimer’s disease. Sci. Transl. Med. 17 (782),\neadp2564. doi:10.1126/scitranslmed.adp2564\nRuan, Y., Luo, H., Tang, J., Ji, M., Yu, D., Yu, Q., et al. (2024). Curcumin inhibits\noxidative stress and autophagy in C17.2 neural stem cell through ERK1/2 signaling\npathways. Aging Med. 7 (5), 559–570. doi:10.1002/agm2.12361\nRuan, Y., Xiong, Y., Fang, W., Yu, Q., Mai, Y., Cao, Z., et al. (2022). Highly sensitive\ncurcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by\nmagnetic resonance imaging and reversing cognitive deficits of alzheimer’s disease via\nNLRP3-inhibition. J. Nanobiotechnology 20 (1), 322. doi:10.1186/s12951-022-01524-4\nSabet, S., Rashidinejad, A., Melton, L. D., and McGillivray, D. J. (2021). Recent\nadvances to improve curcumin oral bioavailability. Trends Food Sci. Tech. 110, 253–266.\ndoi:10.1016/j.tifs.2021.02.006\nSampath, M., Lakra, R., Korrapati, P., and Sengottuvelan, B. (2014). Curcumin loaded\npoly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. Colloids Surf. B,\nBiointerfaces 117, 128–134. doi:10.1016/j.colsurfb.2014.02.020\nSanchez, I. I., Nguyen, T. B., England, W. E., Lim, R. G., Vu, A. Q., Miramontes, R.,\net al. (2021). Huntington’s disease mice and human brain tissue exhibit increased\nG3BP1 granules and TDP43 mislocalization. J. Clin. Invest 131 (12), e140723. doi:10.\n1172/JCI140723\nFrontiers in Pharmacology frontiersin.org20\nWang et al. 10.3389/fphar.2025.1625821\n\nSandhir, R., Yadav, A., Mehrotra, A., Sunkaria, A., Singh, A., and Sharma, S. (2014).\nCurcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in\nexperimental model of huntington’s disease. Neuromolecular Med. 16 (1), 106–118.\ndoi:10.1007/s12017-013-8261-y\nSantana-Martínez, R. A., Silva-Islas, C. A., Fernández-Orihuela, Y. Y., Barrera-\nOviedo, D., Pedraza-Chaverri, J., Hernández-Pando, R., et al. (2019). The\ntherapeutic effect of curcumin in quinolinic acid-induced neurotoxicity in rats is\nassociated with BDNF, ERK1/2, Nrf2, and antioxidant enzymes. Antioxidants 8 (9),\n388. doi:10.3390/antiox8090388\nSavastano, A., Flores, D., Kadavath, H., Biernat, J., Mandelkow, E., and Zweckstetter,\nM. (2021). Disease-associated tau phosphorylation hinders tubulin assembly within tau\ncondensates. Angew. Chem. Int. Ed. 60 (2), 726–730. doi:10.1002/anie.202011157\nSelf, W. K., and Holtzman, D. M. (2023). Emerging diagnostics and therapeutics for\nalzheimer disease. Nat. Med. 29 (9), 2187–2199. doi:10.1038/s41591-023-02505-2\nShen, C., Sheng, Z., Shao, J., Tang, M., Mao, L., Huang, C. H., et al. (2023).\nMechanistic investigation of the differential synergistic neurotoxicity between\npesticide metam sodium and copper or zinc. Chemosphere 328, 138430. doi:10.1016/\nj.chemosphere.2023.138430\nShen, J., Lu, Z., Wang, J., Hao, Q., Ji, W., Wu, Y., et al. (2021). Traceable nano-\nbiohybrid complexes by one-step synthesis as CRISPR-chem vectors for\nneurodegenerative diseases synergistic treatment. Adv. Mater 33 (27), e2101993.\ndoi:10.1002/adma.202101993\nShi, W., Lin, W., Ge, W., Chen, L. L., Zhang, T. D., Guo, W. H., et al. (2023). Curcumin\ninhibits liquid-liquid phase separation of fused in sarcoma and attenuates the\nsequestration of pyruvate kinase to restore cellular metabolism. Food Funct. 14 (1),\n4621–4631. doi:10.1039/d2fo03224d\nSimuni, T., Uribe, L., Cho, H. R., Caspell-Garcia, C., Coffey, C. S., Siderowf, A., et al.\n(2020). Clinical and dopamine transporter imaging characteristics of non-manifest\nLRRK2 and GBA mutation carriers in the Parkinson’s progression markers initiative\n(PPMI): a cross-sectional study. Lancet Neurol. 19 (1), 71–80. doi:10.1016/S1474-\n4422(19)30319-9\nSingh, S., Jamwal, S., and Kumar, P. (2015). Piperine enhances the protective effect of\ncurcumin against 3-NP induced neurotoxicity: possible neurotransmitters modulation\nmechanism. Neurochem. Res. 40 (8), 1758–1766. doi:10.1007/s11064-015-1658-2\nSmall, G. W., Siddarth, P., Li, Z., Miller, K. J., Ercoli, L., Emerson, N. D., et al. (2018).\nMemory and brain amyloid and tau effects of a bioavailable form of curcumin in non-\ndemented adults: a double-blind, placebo-controlled 18-month trial. Am. J. Geriatr.\nPsychiatry 26 (3), 266–277. doi:10.1016/j.jagp.2017.10.010\nSong, H., Sieurin, J., Wirdefeldt, K., Pedersen, N. L., Almqvist, C., Larsson, H., et al.\n(2020). Association of stress-related disorders with subsequent neurodegenerative\ndiseases. JAMA Neurol. 77 (6), 700–709. doi:10.1001/jamaneurol.2020.0117\nSood, P. K., Nahar, U., and Nehru, B. (2012). Stress proteins and glial cell functions\nduring chronic aluminium exposures: protective role of curcumin. Neurochem. Res. 37\n(3), 639–646. doi:10.1007/s11064-011-0655-3\nSrinivasan, E., and Rajasekaran, R. (2016). Computational investigation of curcumin,\na natural polyphenol that inhibits the destabilization and the aggregation of human\nSOD1 mutant (Ala4Val). RSC Adv. 6 (14), 102744–102753. doi:10.1039/c6ra21927f\nSu, J., Cai, Y., Zhi, Z., Guo, Q., Mao, L., Gao, Y., et al. (2021). Assembly of propylene\nglycol alginate/β-lactoglobulin composite hydrogels induced by ethanol for co-delivery\nof probiotics and curcumin. \nCarbohydr. Polym. 254, 117446. doi:10.1016/j.carbpol.2020.\n117446\nSu, P., and Liu, F. (2017). A peptide disrupting the D2R-DAT interaction protects\nagainst dopamine neurotoxicity. Exp. Neurol. 295, 176–183. doi:10.1016/j.expneurol.\n2017.05.010\nSu, W., Cheng, Y., Jiang, Z., Duan, Q. Q., Yang, T. M., Shang, H. F., et al. (2021).\nPredictors of survival in patients with amyotrophic lateral sclerosis: a large meta-\nanalysis. EBioMedicine 74, 103732. doi:10.1016/j.ebiom.2021.103732\nSun, E. D., Zhou, O. Y., Hauptschein, M., Rappoport, N., Xu, L., Navarro Negredo, P.,\net al. (2024). Spatial transcriptomic clocks reveal cell proximity effects in brain ageing.\nNature 638 (8049), 160–171. doi:10.1038/s41586-024-08334-8\nSun, J., and Roy, S. (2021). Gene-based therapies for neurodegenerative diseases. Nat.\nNeurosci. 24 (3), 297–311. doi:10.1038/s41593-020-00778-1\nSun, Y., Dai, H., Dai, X., Yin, J., Cui, Y., Liu, X., et al. (2023). m(1)A in CAG repeat\nRNA binds to TDP-43 and induces neurodegeneration. Nature 623 (7987), 580–587.\ndoi:10.1038/s41586-023-06701-5\nSwaddiwudhipong, N., Whiteside, D. J., Hezemans, F. H., Street, D., Rowe, J. B., and\nRittman, T. (2023). Pre-diagnostic cognitive and functional impairment in multiple\nsporadic neurodegenerative diseases. Alzheimers Dement. 19 (5), 1752–1763. doi:10.\n1002/alz.12802\nTandon, A., Singh, S. J., Gupta, M., Singh, N., Shankar, J., Arjaria, N., et al. (2020).\nNotch pathway up-regulation via curcumin mitigates bisphenol-A (BPA) induced\nalterations in hippocampal oligodendrogenesis. J. Hazard Mater. 392, 122052.\ndoi:10.1016/j.jhazmat.2020.122052\nTian, Y., Shang, Q., Liang, R., and Viles, J. H. (2024). Copper(II) can kinetically trap\narctic and Italian amyloid-β40 as toxic oligomers, mimicking Cu(II) binding to wild-\ntype amyloid-β42: implications for familial Alzheimer’s disease. JACS Au 4 (2),\n578–591. doi:10.1021/jacsau.3c00687\nTollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., et al. (2011).\nCharacterizing the RNA targets and position-dependent splicing regulation by TDP-43.\nNat. Neurosci. 14 (4), 452–458. doi:10.1038/nn.2778\nValdez, C. E., Smith, Q. A., Nechay, M. R., and Alexandrova, A. N. (2014). Mysteries\nof metals in metalloenzymes. Acc. Chem. Res. 47 (10), 3110–3117. doi:10.1021/\nar500227u\nVan Daele, S. H., Moisse, M., Van Vugt, J. J. F. A., Zwamborn, R. A. J., van der Spek,\nR., van Rheenen, W., et al. (2023). Genetic variability in sporadic amyotrophic lateral\nsclerosis. Brain 146 (9), 3760–3769. doi:10.1093/brain/awad120\nVan Laar, V. S., Chen, J., Zharikov, A. D., Bai, Q., Di Maio, R., Dukes, A. A., et al.\n(2020). α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked\nby mitochondrial inhibitors in CNS dopaminergic neurons in vivo. Redox Biol. 37,\n101695. doi:10.1016/j.redox.2020.101695\nVareed, S. K., Kakarala, M., Ruffin, M. T., Crowell, J. A., Normolle, D. P., Djuric, Z.,\net al. (2008). Pharmacokinetics of curcumin conjugate metabolites in healthy human\nsubjects. Cancer Epidemiol. Biomarkers Prev. \n17 (6), 1411–1417. doi:10.1158/1055-\n9965.EPI-07-2693\nVerma, M., Sharma, A., Naidu, S., Bhadra, A. K., Kukreti, R., and Taneja, V. (2012).\nCurcumin prevents formation of polyglutamine aggregates by inhibiting Vps36, a\ncomponent of the ESCRT-II complex. PLoS One 7 (8), e42923. doi:10.1371/journal.\npone.0042923\nvon Krusenstiern, A. N., Robson, R. N., Qian, N., Qiu, B., Hu, F., Reznik, E., et al.\n(2023). Identification of essential sites of lipid peroxidation in ferroptosis. Nat. Chem.\nBiol. 19 (6), 719–730. doi:10.1038/s41589-022-01249-3\nWahyudi, L. D., Yu, S. H., and Cho, M. K. (2022). The effect of curcumin on the\ncadmium-induced mitochondrial apoptosis pathway by metallothionein 2A regulation.\nLife Sci. 310, 121076. doi:10.1016/j.lfs.2022.121076\nWang, C., Liu, H., Li, X., Ma, J., Gu, Z., Feng, X., et al. (2024). High-depth whole-\ngenome sequencing identifies structure variants, copy number variants and short\ntandem repeats associated with parkinson’s disease. NPJ Park. Dis. 10 (1), 134.\ndoi:10.1038/s41531-024-00722-1\nWang, H., Shan, X., Ren, M., Shang, M., and Zhou, C. (2021). Nucleosomes enter cells\nby clathrin- and caveolin-dependent endocytosis. Nucleic Acids Res. 49 (21),\n12306–12319. doi:10.1093/nar/gkab1121\nWang, H., Sui, H., Zheng, Y., Jiang, Y., Shi, Y., Liang, J., et al. (2019). Curcumin-\nprimed exosomes potently ameliorate cognitive function in AD mice by inhibiting\nhyperphosphorylation of the tau protein through the AKT/GSK-3β pathway. Nanoscale\n11 (15), 7481–7496. doi:10.1039/c9nr01255a\nWang, L., Ma, Y., Zhang, M., Yuan, H. Y., Li, X. N., Xia, W., et al. (2024). Amyloid\nfibril structures and ferroptosis activation induced by ALS-Causing SOD1 mutations.\nSci. Adv. 10 (44), eado8499. doi:10.1126/sciadv.ado8499\nWang, L., Yin, Y., Liu, X., Shen, P., Zheng, Y. G., Lan, X. R., et al. (2020). Current\nunderstanding of metal ions in the pathogenesis of alzheimer’s disease. Transl.\nNeurodegener. 9, 10. doi:10.1186/s40035-020-00189-z\nWang, M., Zhang, R., Dehaen, W., Fang, Y., Qian, S., Ren, Y., et al. (2021). Specific\nrecognition, intracellular assay and detoxification of fluorescent curcumin derivative for\ncopper ions. J. Hazard Mater 420, 126490. doi:10.1016/j.jhazmat.2021.126490\nWang, N., Zhang, S., Langfelder, P., Ramanathan, L., Gao, F., Plascencia, M., et al.\n(2025). Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion\nrate to drive selective pathogenesis in HD mice. Cell 188 (6), 1524–1544.e22. doi:10.\n1016/j.cell.2025.01.031\nWang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., et al. (2019). Sodium\noligomannate therapeutically remodels gut microbiota and suppresses gut bacterial\namino acids-shaped neuroinflammation to inhibit alzheimer’s disease progression. Cell\nRes. 29 (10), 787–803. doi:10.1038/s41422-019-0216-x\nWang, Y., An, R., Umanah, G. K., Park, H., Nambiar, K., Eacker, S. M., et al. (2016). A\nnuclease that mediates cell death induced by DNA damage and poly(ADP-ribose)\npolymerase-1. Science 354 (6308), aad6872. doi:10.1126/science.aad6872\nWang, Z., Wang, C., Yuan, B., Liu, L., Zhang, H., Zhu, M., et al. (2025).\nAkkermansia muciniphila and its metabolite propionic acid maintains neuronal\nmitochondrial division and autophagy homeostasis during alzheimer\n’s disease\npathologic process via GPR41 and GPR43. Microbiome 13 (1), 16. doi:10.1186/\ns40168-024-02001-w\nWang, G., Yin, W., Shin, H., Tian, Q., Lu, W., and Hou, S. X. (2021). Neuronal\naccumulation of peroxidated lipids promotes demyelination and neurodegeneration\nthrough the activation of the microglial NLRP3 inflammasome. Nat. aging 1 (11),\n1024–1037. doi:10.1038/s43587-021-00130-7\nWise, J. (2010). Prevalence of Huntington’s disease is underestimated in UK. BMJ 340,\nc3516. doi:10.1136/bmj.c3516\nWright, G. E. B., Black, H. F., Collins, J. A., Gall-Duncan, T., Caron, N. S., Pearson, C.\nE., et al. (2020). Interrupting sequence variants and age of onset in huntington’s disease:\nclinical implications and emerging therapies. Lancet Neurol. 19 (11), 930–939. doi:10.\n1016/S1474-4422(20)30343-4\nFrontiers in Pharmacology frontiersin.org21\nWang et al. 10.3389/fphar.2025.1625821\n\nWu, K., Xu, Q., Liu, Y., Feng, Y. W., Han, S. D., Zhang, Y. R., et al. (2025). Neuronal\nFAM171A2 mediates alpha-synuclein fibril uptake and drives parkinson’s disease.\nScience 387 (6736), 892–900. doi:10.1126/science.adp3645\nWu, L., Zhao, P., Wu, P., Jiang, W., Liu, Y., Ren, H., et al. (2024). Curcumin attenuates\nochratoxin A and hypoxia co-induced liver injury in grass carp (Ctenopharyngodon\nidella) by dual targeting endoplasmic reticulum stress and apoptosis via reducing ROS\ncontent. J. Anim. Sci. Biotechnol. 15 (1), 131. doi:10.1186/s40104-024-01089-2\nXu, H., Garcia-Ptacek, S., Bruchfeld, A., Fu, E. L., Shori, T. D., Lindholm, B., et al.\n(2023). Association between cholinesterase inhibitors and kidney function decline in\npatients with Alzheimer’s dementia. Kidney Int. 103 (1), 166–176. doi:10.1016/j.kint.\n2022.09.022\nXu, H., Ma, Q., Qiu, C., Wang, J., Jin, Z., and Hu, Y. (2024). Encapsulation and\ncontrolled delivery of curcumin by self-assembled cyclodextrin succinate/chitosan\nnanoparticles. Food Hydrocoll. 157, 110465. doi:10.1016/j.foodhyd.2024.110465\nXu, J., Kong, X., Xiu, H., Dou, Y., Wu, Z., and Sun, P. (2018). Combination of\ncurcumin and vagus nerve stimulation attenuates cerebral ischemia/reperfusion injury-\ninduced behavioral deficits. Biomed. Pharmacother. 103, 614–620. doi:10.1016/j.biopha.\n2018.04.069\nXu, L., Chen, L., Wang, S., Feng, J., Liu, L., Liu, G., et al. (2020). Incidence and\nprevalence of amyotrophic lateral sclerosis in urban China: a national population-based\nstudy. J. Neurol. Neurosurg. Psychiatry 91 (5), 520–525. doi:10.1136/jnnp-2019-322317\nXu, W., Han, S., Zhang, C., Li, J. Q., Wang, Y. J., Tan, C. C., et al. (2020). The\nFAM171A2 gene is a key regulator of progranulin expression and modifies the risk of\nmultiple neurodegenerative diseases. Sci. Adv. 6 (43), eabb3063. doi:10.1126/sciadv.\nabb3063\nXue, Q., Yan, D., Chen, X., Li, X., Kang, R., Klionsky, D. J., et al. (2023). Copper-\ndependent autophagic degradation of GPX4 drives ferroptosis. Autophagy 19 (7),\n1982–1996. doi:10.1080/15548627.2023.2165323\nXue, Y. C., Liu, H., Mohamud, Y., Bahreyni, A., Zhang, J., Cashman, N. R., et al.\n(2022). Sublethal enteroviral infection exacerbates disease progression in an ALS mouse\nmodel. J. Neuroinflammation 19 (1), 16. doi:10.1186/s12974-022-02380-7\nYang, Q., Cai, W., Wang, Z., Li, Y., Zhang, Y., Lin, X., et al. (2023). Structural\ncharacteristics, binding behaviors, and stability of ternary nanocomplexes of lecithin,\npolyvinylpyrrolidone, and curcumin. LWT 175, 114489. doi:10.1016/j.lwt.2023.114489\nYang, Q., Li, R., Hong, Y., Liu, H., Jian, C., and Zhao, S. (2024). Curcumin-loaded\ngelatin nanoparticles cross the blood-brain barrier to treat ischemic stroke by\nattenuating oxidative stress and neuroinflammation. Int. J. Nanomedicine 19,\n11633–11649. doi:10.2147/IJN.S487628\nYang, Y., Shi, Y., Schweighauser, M., Zhang, X., Kotecha, A., Murzin, A. G., et al.\n(2022). Structures of alpha-synuclein filaments from human brains with lewy pathology.\nNature 610 (7933), 791–795. doi:10.1038/s41586-022-05319-3\nYe, J., Zhong, S., Wan, H., Guo, X., Yao, X., Liu, Q., et al. (2025). Upregulated astrocyte\nHDAC7 induces alzheimer-like tau pathologies via deacetylating transcription factor-\nEB and inhibiting lysosome biogenesis. Mol. Neurodegener. 20 (1), 5. doi:10.1186/\ns13024-025-00796-2\nYu, C., Davidson, S., Harapas, C. R., Hilton, J. B., Mlodzianoski, M. J.,\nLaohamonthonkul, P., et al. (2020). TDP-43 triggers mitochondrial DNA release via\nmPTP to activate cGAS/STING in ALS. Cell 183 (3), 636–649.e18. doi:10.1016/j.cell.\n2020.09.020\nYu, J., Chen, M., Huang, H., Zhu, J., Song, H., Zhu, J., et al. (2018). Dynamic m6A\nmodification regulates local translation of mRNA in axons. Nucleic Acids Res. 46 (3),\n1412–1423. doi:10.1093/nar/gkx1182\nZhang, C., Browne, A., Child, D., and Tanzi, R. E. (2010). Curcumin decreases\namyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor\nprotein. J. Biol. Chem. 285 (37), 28472–28480. doi:10.1074/jbc.M110.133520\nZhang, J., Malik, A., Choi, H. B., Ko, R. W. Y., Dissing-Olesen, L., and MacVicar, B. A.\n(2014). Microglial CR3 activation triggers long-term synaptic depression in the\nhippocampus via NADPH oxidase. Neuron 82 (1), 195–207. doi:10.1016/j.neuron.\n2014.01.043\nZhang K., K., Wang, F., Zhai, M., He, M., Hu, Y., Feng, L., et al. (2023). Hyperactive\nneuronal autophagy depletes BDNF and impairs adult hippocampal neurogenesis in a\ncorticosterone-induced mouse model of depression. Theranostics 13 (3), 1059–1075.\ndoi:10.7150/thno.81067\nZhang, L., Jia, Z., Wu, Q., Bai, T., Wang, B., Hu, X., et al. (2023). Alleviating symptoms\nof neurodegenerative disorders by astrocyte-specific overexpression of TMEM164 in\nmice. Nat. Metab. 5 (10), 1787–1802. doi:10.1038/s42255-023-00887-8\nZhang, N., Lin, R., Gao, W., Xu, H., Li, Y., Huang, X., et al. (2025). Curcumin\nmodulates PTPRZ1 activity and RNA m6A modifications in neuroinflammation-\nassociated microglial response. Adv. Sci. 12 (15), e2405263. doi:10.1002/advs.202405263\nZhang, N., Yan, F., Liang, X., Wu, M., Shen, Y., Chen, M., et al. (2018). Localized\ndelivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-\ntargeted microbubble destruction for improved parkinson’s disease therapy.\nTheranostics 8 (8), 2264–2277. doi:10.7150/thno.23734\nZhang, W., Xiao, D., Mao, Q., and Xia, H. (2023). Role of neuroinflammation in\nneurodegeneration development. Signal Transduct. Target Ther. 8 (1), 267. doi:10.1038/\ns41392-023-01486-5\nZhang, Y., Yang, C., Wang, W., Liu, J., Liu, Q., Huang, F., et al. (2016). Co-delivery of\ndoxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination\ntherapy of cancer. Sci. Rep. 6 (1), 21225. doi:10.1038/srep21225\nZhao, G., Liu, Y., Yi, X., Wang, Y., Qiao, S., Li, Z., et al. (2017). Curcumin inhibiting\nTh17 cell differentiation by regulating the metabotropic glutamate receptor-4\nexpression on dendritic cells. Int. Immunopharmacol. 46, 80–86. doi:10.1016/j.\nintimp.2017.02.017\nZhao, Y., Qin, L., Pan, H., Liu, Z., Jiang, L., He, Y., et al. (2020). The role of genetics in\nparkinson’s disease: a large cohort study in Chinese mainland population. Brain 143 (7),\n2220–2234. doi:10.1093/brain/awaa167\nZheng, Q., Liu, H., Zhang, H., Han, Y., Yuan, J., Wang, T., et al. (2023). Ameliorating\nmitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated\nmitochondrial biogenesis to boost the therapy of parkinson’s disease. \nAdv. Sci. 10 (22),\ne2300758. doi:10.1002/advs.202300758\nZhong, L., Cai, B., Wang, Q., Li, X., Xu, W., and Chen, T. (2022). Exploring the\nneuroprotective mechanism of curcumin inhibition of intestinal inflammation against\nparkinson’s disease based on the gut-brain axis. Pharmaceuticals 16 (1), 39. doi:10.3390/\nph16010039\nZhou, Y., Tang, J., Lan, J., Zhang, Y., Wang, H., Chen, Q., et al. (2023). Honokiol\nalleviated neurodegeneration by reducing oxidative stress and improving mitochondrial\nfunction in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis.\nActa Pharm. Sin. B 13 (2), 577–597. doi:10.1016/j.apsb.2022.07.019\nZhu, H., Tonelli, F., Turk, M., Prescott, A., Alessi, D. R., and Sun, J. (2023). Rab29-\ndependent asymmetrical activation of leucine-rich repeat kinase 2. Science 382 (6677),\n1404–1411. doi:10.1126/science.adi9926\nZou, Y., Li, H., Graham, E. T., Deik, A. A., Eaton, J. K., Wang, W., et al. (2020).\nCytochrome P450 oxidoreductase contributes to phospholipid peroxidation in\nferroptosis. Nat. Chem. Biol. 16 (3), 302–309. doi:10.1038/s41589-020-0472-6\nFrontiers in Pharmacology frontiersin.org22\nWang et al. 10.3389/fphar.2025.1625821",
          "version": "5.3.31"
        }
      ],
      "1. Get Rated Paper1": [
        {
          "id": 473,
          "created_at": "2025-07-30T00:15:57.118433Z",
          "updated_at": "2025-07-30T00:15:57.118433Z",
          "doi": "10.3389/fphar.2025.1625821",
          "s3_link": "https://s3.hidrive.strato.com/paper-store/40709087.pdf",
          "rating": 8,
          "confidence_score": 0.95,
          "category": "Priorität 1: Content-Gold",
          "ai_summary": "Dieser Übersichtsartikel fasst die Forschung zu Curcumin bei neurodegenerativen Erkrankungen wie Alzheimer zusammen. Die Analyse zeigt, dass Curcumin im Labor starke antioxidative und entzündungshemmende Eigenschaften besitzt, seine Wirkung im menschlichen Körper jedoch durch eine extrem schlechte Bioverfügbarkeit stark eingeschränkt ist. Zukünftiger Erfolg hängt daher entscheidend von neuen Formulierungen ab, die die Aufnahme des Wirkstoffs verbessern.",
          "key_findings": "Curcumin besitzt vielfältige neuroprotektive Mechanismen wie Antioxidation und Entzündungshemmung, seine klinische Wirksamkeit wird jedoch durch eine sehr geringe Bioverfügbarkeit stark behindert, weshalb fortschrittliche Verabreichungsformen wie Nanopartikel oder die Kombination mit anderen Stoffen entscheidend sind, um therapeutische Konzentrationen zu erreichen.",
          "study_strengths": "Umfassender Übersichtsartikel (Review), Kritische Auseinandersetzung mit dem Hauptproblem der Bioverfügbarkeit, Systematische Zusammenfassung von Human-, Tier- und In-vitro-Daten.",
          "study_limitations": "Ist eine Zusammenfassung bestehender Forschung, keine neue Primärstudie, Zitiert viele präklinische Studien (Tier/Labor), deren Übertragbarkeit auf den Menschen unsicher ist, Die evaluierten klinischen Studien sind oft klein und heterogen.",
          "content_idea": "Curcumin fürs Gehirn: Warum die meisten Kapseln nicht wirken und worauf du bei der Einnahme wirklich achten musst.",
          "content_status": "idee",
          "processed": false,
          "added_rag": true,
          "pmid": "40709087",
          "substance": "curcumin"
        }
      ]
    },
    "meta": {
      "instanceId": "e29847cb0d85386a381a01c77c5a370e3c3dcd4f4ebcacf20107c8e6e234123a"
    }

  }